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ABSTRACT 
Microencapsulation is commonly used in the food industry to provide functional and 
sensory benefits to a variety of compounds. Tributyrin (TB), a source of butyric acid, is 
characterized by a highly bitter taste and negative odor attributes. Its use in the maintenance of 
intestinal health and treatment of intestinal disorders shows promise. However, due to the 
negative sensory qualities and necessity to target the intestinal epithelium, TB has yet to be 
widely utilized in a food system for treatment. The overall objectives of this study were to: 1) 
determine the impact of protein type, inulin chain length, and gamma-cyclodextrin (GCD) on the 
stability and retention of microencapsulated TB, 2) measure which TB microcapsule formulation 
imparts the least overall sensory difference in an infant formula system, 3) determine the site of 
intestinal delivery and release of butyrate from microencapsulated TB, and 4) determine the 
sensory properties of food products containing microencapsulated TB. Microencapsulated TB in 
whey protein isolate (WPI)-based microcapsules resulted in higher (p<0.001) retention than soy 
protein isolate (SPI)-based microcapsules. The inclusion of inulin WPI-based wall materials 
improved (p<0.01) the retention of TB for all chain lengths over WPI-based microcapsules 
without inulin. The creation of altered surface morphology from inulin is due to the ability of 
inulin to interact with the WPI-based wall material. This interaction creates added wall flexibility 
during drying and may be responsible for increased TB retention. The use of GCD resulted in the 
highest TB retention (95%) when oven dried but the lowest when spray dried (62%). In infant 
formulas, GCD and TB oven dried (GCT OD) microcapsules were able to reduce the sensory 
perception of TB to a level indistinguishable from a control infant formula containing no TB. All 
other WPI, WPI-inulin, and GCD-based microcapsules were significantly different from the 
control (R-index above 57% or at p<0.05) but not from free TB (p>0.05) as indicated by the 
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rating method. During in vitro digestion, all microcapsules containing TB showed limited 
butyrate release (<5%) during oral and gastric stages. In then simulated small intestine, TB 
microcapsules released approximately 75% of their total butyrate content with no significant 
differences (p>0.05) across formulations. During fermentation, GCD-based microcapsules 
produced significantly more butyrate (p<0.001) on a molar basis than all WPI-based 
microcapsules. The microcapsule GCT OD was able to effectively deliver and produce butyrate 
in the small and large intestines. Results from the descriptive analysis (DA) test conducted using 
GCT OD in apple sauce, infant formula, and crackers, revealed that GCT OD behaved 
differently in each system due to the matricies physical properties. Combined common attribute 
principal correlation analysis (PCA) biplots show samples containing free TB were highly 
characterized by bitter taste and aftertaste. Cracker samples were not significantly different 
(p>0.05) for all measured attributes intensities as compared to free TB-containing samples, and 
were significantly higher in bitter taste and aftertaste. Apple sauce and infant formula containing 
GCT OD were significantly (p<0.05) reduced in bitter taste and aftertaste as compared to free TB 
samples. This bitter taste and aftertaste intensity for GCT OD was still, however, significantly 
higher (p<0.05) than the control for apple sauce and infant formula. The inclusion of GCT OD in 
infant formula had the least overall impact on the attributes that characterize control infant 
formula samples.  
Overall, findings from this research can be used to guide the production and application 
of microencapsulated TB for use in these and additional food products for the potential 
improvement of intestinal health or disease states.  
Key Words: microencapsulation; spray drying; whey protein isolate; soy protein isolate; 
gamma-cyclodextrin; complexation; tributyrin; butyric acid; sensory evaluation; R-index; in 
vitro digestion; targeted release; descriptive analysis. 
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Chapter 1: Introduction 
1.1 Research background 
Many functional ingredients have the ability to impart negative sensory characteristics on 
food products into which they are included (Drewnowski and Gomez-Carneros 2000). Despite 
the functional benefits an ingredient may possess, generally, consumers are unwilling to 
compromise on taste (Urala and Lähteenmäki 2004). With taste being the most important 
consideration for consumers when choosing foods (Drewnowski 1997; Glanz and others 1998; 
Verbeke 2006), a dilemma is faced with the incorporation of functional ingredients. Furthermore, 
some functional ingredients need to be released or protected from certain areas of the digestive 
tract (oral, stomach, small intestine, large intestine) in order to provide the most benefit; 
microencapsulation may be a solution to these issues. Microencapsulation is widely used in the 
food industry, has the potential to alleviate some of the negative sensory qualities of functional 
ingredients, and can provide added ingredient functionality (such as controlled release) (Jackson 
and Lee 1991; Shahidi and Han 1993; Gibbs and others 1999; Desai and Park 2005; Sobel and 
others 2014). 
Tributyrin (TB) is a functional health ingredient that provides a source of butyric acid. 
Butyric acid, or butyrate as it is present in the body, is produced via anaerobic fermentation 
(Wong and others 2006). Butyrate serves a variety of functional benefits contributing to small 
intestinal health (Koruda and others 1990; Kotunia and others 1994), an energy source for 
colonic epithelium (Hamer and others 2008), and has shown beneficial effects in individuals with 
short-bowel syndrome (SBS) (Bartholome and others 2004), inflammatory bowel disease (IBD) 
(Scheppach and others 1992; Steinhart and others 1996; Vieira and others 2012), irritable bowel 
syndrome (IBS) (Berni and others 2004; Scarpellini and others 2007), and exhibited anti-cancer 
properties (Hague and others 1993; Heerdt and others 1994). However, due to the negative odor 
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(cheesy, fecal, vomitus) and taste/aftertaste (highly bitter) of TB, its oral use is difficult, if not 
impossible, in foods. Microencapsulation may provide a method to improve the sensory 
properties and control the intestinal release of TB. 
Microencapsulation can be accomplished through a variety of physical and chemical 
methods. Two commonly used methods in the food industry include spray drying and chemical 
complexation using cyclodextrins (CDs) (Gibbs and others 1999). A variety of wall materials can 
be used in spray drying such as gums, carbohydrates, and proteins (Shahidi and Han 1993; Gibbs 
and others 1999; Gharsallaoui and others 2007). Two commonly used proteins sources are soy 
and whey. These ingredients can form low viscosity solutions, produce microcapsules with dent 
free surfaces, retain volatiles, and improve probiotic viability (Young and others 1993; Young 
and others 1993; Sheu and Rosenberg 1995; Rosenberg and Sheu 1996; Sheu and Rosenberg 
1998; Picot and Lacroix 2004; Lapsiri and others 2012; Tang and Li 2012; Nesterenko and 
others 2013). Carbohydrates, such as inulin, possess the ability to modulate wall structures for 
the improvement of microencapsulated probiotics (Fritzen-Freire and others 2012) and may 
provide additional applications with other core ingredients. 
Existing as tubular, cyclic structures, CDs contain repeating units of glucopyranose 
connected by an α-(1, 4) bond (Del Valle 2004). The outer area of CDs is hydrophilic and inner 
cavity is increasingly hydrophobic; this differential allows CDs to serve as a microencapsulation 
substrates for complexing hydrophobic compounds. The complexation of CDs has been studied 
in the literature to improve the solubility, enhance sensory properties, and increase 
environmental stability (heat, acid, or light) of various ingredients (reviewed extensively in 
Szente and Szejtli (2004), Del Valle (2004), Astray and others (2009), and Das and others 
(2013). 
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Due to the negative sensory qualities associated with TB, it is important that its sensory 
influence is reduced before being used in food. Sensory testing can be used to measure the 
influence a microencapsulated ingredient, such as TB, has on a food product. Using the rating 
method, R-index measures allow researchers to calculate the probability that a panelist can 
correctly identify a “signal” (modulated sample) from a “noise” (control sample) (O'Mahony 
1992). The rating method, used to collect R-index measures, is a powerful testing technique, as it 
accounts for the common psychological error of response bias associated with many difference 
testing methods (O'Mahony 1992; O'Mahony 1995). The sensory testing method of descriptive 
analysis (DA) allows for the complete profiling of all sensory attributes (appearance, aroma, 
taste, aroma-by-mouth, texture, aftertaste) for a product by a group of highly trained judges 
(Murray and others 2001; Drake and Delahunty 2011; Stone and others 2012). Descriptive 
analysis allows for the quantitative (intensity scaling) and qualitative (attribute descriptors) 
information about a product to be developed (Meilgaard and others 1999). Both of these sensory 
methods could be used to determine if the microencapsulation matrix developed is different from 
a control sample, and further explain in detail the specific impact a microencapsulated matrix has 
on the sensory attributes of food system as a whole. 
Aside from minimizing sensory problems, the targeted delivery of TB to the intestinal 
tract is important for its use. Without delivery to this area of the digestive tract, butyrate would 
not be able to stimulate its previously mentioned beneficial effects. To assess the area of 
intestinal release of bioactive compounds, in vitro digestion and fermentation models have been 
developed and used. In vitro model gastrointestinal systems are a useful research tool to assess 
the digestibility and fermentative qualities of a wide range of food ingredients. They are 
beneficial over in vivo procedures due to their cost effectiveness, rapidness, and reproducible 
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nature (Boisen 1991; Ji and Xiao 2006). In vitro techniques vary in the number of steps used, 
digestive fluids or enzymes employed, and the type of physical stresses placed on the system 
(Hur and others 2011). Many available reviews describe the differences between in vitro 
methods employed (Boisen 1991; McClements and Lia 2010; Hur and others 2011; Alminger 
and others 2014). 
1.2 Research rationale and significance 
With over 10,000 cases of SBS in the United States (Bartholome and others 2004), colon 
cancer being the second leading cause of cancer-related deaths (combining both genders) 
(American Cancer Society 2013), and IBS impacting 1.6 million people around the world 
(Scheppach and others 1992; Crohn’s and Colitis Foundation of America 2012; Kumari and 
others 2013), the intestinal health of individuals impacts the lives of millions each day. Butyrate 
has shown beneficial effects in a wide variety of these intestinal disorders, syndromes, and 
associated cancers (Scheppach and others 1992; Kotunia and others 1994; Hague and others 
1995; Bartholome and others 2004; Scarpellini and others 2007). The current treatment methods 
using butyrate can be challenging and inconvenient for individuals (Breuer and others 1997; 
Immerseel and others 2010; Leonel and Alvarez-Leite 2012). The production of an easy-to-use 
butyrate supplement that could be added to food has the potential to benefit the lives of millions 
across the world. As a source of butyrate, TB has the potential to accomplish this goal. Issues 
with the oral administration of TB, stemming from its unpleasant sensory qualities and the need 
for targeted intestinal release, make its utilization in food challenging. The use of 
microencapsulation techniques, such as spray drying and cyclodextrin complexation, may 
resolve the complications associated with the use of TB in food. By microencapsulating TB, the 
potential to produce an easy-to-use butyrate with decreased sensory impact and improved 
intestinal release in foods is possible. 
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1.3 Overall goal and central hypothesis 
The overall goal of this research is to microencapsulate TB to improve sensory qualities 
for oral delivery and targeted intestinal release in food systems for the treatment of various 
intestinal disorders. The central hypothesis investigating this overall goal is that 
microencapsulated TB will possess modified sensory and controlled intestinal release 
characteristics in relation to its free form in food systems. 
1.4 Specific research aims, hypotheses, and approaches 
To investigate the central hypothesis, four specific aims were developed. Specific 
research aim one (Chapter 3) identified the effects of wall material, processing method, and wall 
additives on the retention and morphology of tributyrin microcapsules. When investigating this 
specific aim, several working hypotheses were proposed. In relation to wall material, it was 
hypothesized that whey protein (whey protein isolate, or WPI)-based wall materials, due to their 
primary protein fractions, would improve retention of TB over soy protein (soy protein isolate, or 
SPI)-based wall materials. Gamma-cyclodextrin (GCD), due to its ability to chemically complex 
with TB, would have improved retention of TB compared with physical interactions in protein-
based microcapsules. In relation to wall additives, inulin molecules of longer chain length would 
increase wall plasticity during drying, which would result in a smoother microcapsule surface 
and improved TB retention as compared to shorter chain length inulin. In regards to processing 
method, it was hypothesized that oven-dried GCD, due to mild heat exposure, would result in 
higher TB retention over spray-dried GCD processed with higher temperatures. To test these 
hypotheses, the research approach involved the use of different proteins (WPI, SPI), wall 
additives (inulin’s of varying chain length), and GCD to encapsulate TB with spray or oven 
drying. Stability parameters such as water activity, morphological structure, rheological 
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properties of spray dried slurries, and TB retention were investigated to determine how wall 
material and processing conditions could impact microcapsule parameters. 
Specific aim two (Chapter 4) determined the influence of encapsulation and wall material 
on the sensory perception of tributyrin in an infant formula. When investigating this specific aim, 
several working hypotheses were proposed. It was hypothesized that microencapsulated TB 
would be less likely to be perceived by consumers than free TB when incorporated in infant 
formula. It was also hypothesized that microencapsulated TB in GCD, due to their ability to 
chemically complex TB, would create microcapsules that were less likely to be perceived as 
different from a control than WPI-based microcapsules in infant formula. It was also 
hypothesized that spray dried microcapsules, due to their matrix style microstructure, would be 
more likely to be perceived as different from a control compared to the oven dried GCD 
microcapsules. To test these hypotheses, the research approach utilized an R-index measure by 
rating method to determine the probability that a panelist would be able to correctly distinguish a 
sample containing encapsulated or free TB from the control which does not contain TB in any 
form.  
Specific aim three (Chapter 5) iidentified the influence of wall material and encapsulation 
method on the release and production of butyrate from microencapsulated TB in vitro. When 
investigating this specific aim, several working hypotheses were proposed. During in vitro 
digestion, it was hypothesized that microencapsulated TB, due to its physical or chemical 
protection from environmental conditions, would result in a decreased release of butyrate in the 
oral, gut, and small intestinal phases as opposed to free TB. It was further hypothesized that 
microcapsules containing GCD, due to their non-digestible but fermentable nature, would result 
in higher protection of TB in the oral, stomach, and small intestinal environments and higher 
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production of butyrate in the large intestine than free TB or WPI-based microcapsules. To test 
these hypotheses, an in vitro model was used to examine the effects of wall materials and drying 
methods on the release of TB in the oral, gastric, and small intestinal phases as well as on the 
production of butyrate during in vitro fermentation. 
Specific aim four (Chapter 6) cvaluated the sensory properties of food products 
containing microencapsulated TB. When investigating this specific aim, several working 
hypotheses were proposed. It was hypothesized that overall, GCT OD and free TB would 
significantly impact the intensity of sensory attributes of food matrices based on the physical 
properties of each system. It was further hypothesized, that due to the complexation of TB by 
GCD, free TB would have increased intensity for the attributes of bitter taste and aftertaste than 
GCT OD in all food matrices. It also was hypothesized that GCT OD would result in a greater 
decrease of bitter taste and aftertaste intensity in infant formula and apple sauce samples, due to 
the ability of solubilized GCD to complex excess free TB in the higher water content matrices, 
and their lack of heat treatment, than in cracker samples. To test these hypotheses, a DA panel 
was conducted to quantify the specific sensory influences the GCD and TB microcapsules and 
free TB have on the sensory properties of three food systems: apple sauce, infant formula, and 
crackers. 
Finally, Chapter 7 summarizes all research findings in the preceeding chapters. It also 
offers a discussion on the properties and future use of the gamma-cyclodextrin and tributyrin 
oven dried (GCT OD) microcapsule in foods. Finally, future directions are proposed in this 
chapter. 
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Chapter 2: Literature Review 
2.1 Microencapsulation  
Microencapsulation involves the incorporation of food ingredients, enzymes, or other 
materials (cores) in surrounding matrices (walls) to provide functional benefits such as the 
enhancement of core stability, maintenance of cell viability, masking unwanted odors or taste, 
improving solubility, isolation from environmental stresses such as heat or moisture, and 
controlled release (Jackson and Lee 1991; Shahidi and Han 1993; Desai and Park 2005; 
Gharsallaoui and others 2007). Microencapsulation is widely utilized in the food (Shahidi and 
Han 1993), pharmaceutical, and cosmetic industries. The first commercial uses of 
microencapsulation were in the manufacture of carbonless copy paper that utilized gelatin 
spheres containing a colorless dye that reacted with a layer of acidic clay (Fanger 1974). A 
variety of microencapsulation methods have emerged from the first commercial use of this 
technology. Microencapsulation can be accomplished by physical and chemical means. Physical 
means include spray drying, spray chilling, spray coating and extrusion while chemical methods 
include cyclodextrin complexation or liposome entrapment (Gibbs and others 1999).  
2.1.1 Microencapsulation using spray drying 
The most commonly used method of microencapsulation in the food industry is spray 
drying. This is due to the availability of equipment, flexibility, and cost-effectiveness of this 
method (Jackson and Lee 1991; Shahidi and Han 1993; Walton and Mumford 1999; Gibbs and 
others 1999; Desai and Park 2005; Gharsallaoui and others 2007). Spray drying works by 
feeding a liquid slurry into a stream of heated air using an atomization method. Methods of 
atomization are designed to create small droplets that maximize the heat and mass transfer 
between the particle surface and the heated air (Gharsallaoui and others 2007). Upon 
atomization, the droplet will expand as water in the droplet instantly begins to evaporate. This 
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instant evaporation creates a cooling effect limiting the particle exposure to the high heat in the 
spray dryer. This evaporative cooling phenomena is the primary reason heat-labile compounds 
can be spray dried (Jackson and Lee 1991). Drying is completed when the temperature of the 
particle reaches that of the surrounding air. This temperature is referred to as the outlet 
temperature (Gharsallaoui and others 2007). This is a dependent temperature based on the inlet 
temperature, flow rate, atomization pressure or speed, and slurry viscosity and makeup (Walton 
and Mumford 1999). The outlet temperature can be adjusted based on the core sensitivity and 
wall properties to ensure a successful encapsulation and drying process occurs. 
2.1.1.1 Wall materials and additives used in spray drying 
A variety of wall materials can be used in spray drying such as gums, carbohydrates, and 
proteins (Shahidi and Han 1993; Gibbs and others 1999; Gharsallaoui and others 2007). A 
suitable wall material is one that exhibits low viscosity at high concentration, can disperse or 
emulsify the encapsulated ingredient, is soluble, unreactive with the encapsulated material, low 
cost, and food grade (Shahidi and Han 1993; Desai and Park 2005). A commonly investigated 
group of materials that exhibit these characteristics include whey (Young and others 1993; 
Young and others 1993; Sheu and Rosenberg 1995; Moreau and Rosenberg 1996; Rosenberg and 
Sheu 1996; Sheu and Rosenberg 1998; Picot and Lacroix 2004; Ying and others 2012) and soy 
proteins (Kim and others 1996; Charve and Reineccius 2009; Molina Ortiz and others 2009; 
Rascón and others 2011; Tang and Li 2012; Nesterenko and others 2013). These ingredients can 
form low viscosity solutions, produce capsules with dent free surfaces, retain volatile 
compounds, and improve probiotic viability (Young and others 1993; Young and others 1993; 
Sheu and Rosenberg 1995; Rosenberg and Sheu 1996; Sheu and Rosenberg 1998; Picot and 
Lacroix 2004; Lapsiri and others 2012; Tang and Li 2012; Nesterenko and others 2013).  
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While proteins have served as excellent wall materials for spray drying, other research 
has examined how carbohydrates such as maltodextrin and inulin influence protein-based wall 
matrices (Young and others 1993; Young and others 1993; Sheu and Rosenberg 1995; Sheu and 
Rosenberg 1995; Rosenberg and Sheu 1996; Hogan and others 2001). Maltodextrins with higher 
dextrose equivalence (DE) have a larger proportion of low molecular weight, short chain units. 
Research conducted by Sheu and others (Sheu and Rosenberg 1998) showed that maltodextrins 
of higher DE create whey protein-based microcapsules with fewer surface cracks and smoother 
particle surfaces than with whey alone or in combination with lower DE maltodextrins. The 
inclusion of higher DE maltodextrins also has improved microencapsulation efficiency (ME) of 
spray dried compounds (Hogan and others 2001; Gharsallaoui and others 2012). The mechanism 
for maltodextrins influence on particle morphology, and how this influences core retention, is 
related to the ability of this compound to act as a plasticizer. During spray drying, droplets 
entering the drying chamber expand as water evaporates and quickly contract as they fall to the 
lower temperature areas of the drying chamber. This rapid expansion and contraction can create 
dented or cracker microcapsule surfaces. It is believed that the higher DE maltodextrins allow 
the wall structures to expand and contract during the drying stage more evenly and smoothly. 
This flexibility forms surfaces that are less porous and contain fewer cracks and dents. 
The role that other carbohydrates, aside from maltodextrin, play in the improved stability 
of microencapsulated wall systems has been investigated (Young and others 1993; Young and 
others 1993; Sheu and Rosenberg 1995; Rosenberg and Sheu 1996). The understanding of how 
varying the degree of polymerization (DP) of non-digestible carbohydrates, such as inulin, on the 
viability of probiotics in reconstituted skim milk (RSM) wall systems has been explored in recent 
years (Corcoran and others 2004; Fritzen-Freire and others 2012). The results of these 
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experiments are not in complete agreement. Corcoran and others (2004) observed no significant 
effect on viability enhancement, while Fritzen-Freire and others (2012) found improved initial 
probiotic survival of RSM and inulin combinations of higher DP. Comparison of these studies 
becomes difficult as differences in the probiotic used and drying parameters were present.  
The underlying mechanism that allows inulin, and other carbohydrates, to modify surface 
structure of microcapsules involves the carbohydrates ability to interact with protein on a 
molecular level. Inulin has excellent hydrogen bonding capacity. One proposed mechanism of 
inulin functionality is called the “water replacement theory” (Hinrichs and others 2001; 
Grasmeijer and others 2013). This theory states that when proteins are dried, and water is 
evaporated, carbohydrates can replace the hydrogen bonds during water evaporation. In the 
amorphous state, these newly developed carbohydrate interactions maintain protein structure and 
form a glassy matrix. This glassy matrix can limit the molecular movement of encapsulated 
compounds. This limited movement can lead to the improved long-term stability and retention of 
these compounds. (Glibowski and Glibowska 2009).  
2.1.2 Microencapsulation using cyclodextrin complexation 
Another method of microencapsulation by the use of chemical complexation is through 
the use of cyclodextrins. Cyclodextrins are cyclic structures containing repeating units of 
glucopyranose connected by α-(1, 4) bonds approved for food use (Del Valle 2004). 
Cyclodextrins are linked to form a tube-like structure that possesses a hydrophilic outside and an 
inner hydrophobic cavity. This internal cavity gives cyclodextrins the ability to serve as a 
microencapsulation vehicle for a variety of compounds including pharmaceutical and food 
ingredients (Szente and Szejtli 2004; Del Valle 2004; Szejtli and Szente 2005).  
Cyclodextrins often are used in the food industry for the encapsulation of added flavors to 
food products or to mask the sensory properties of functional ingredients. While complexation is 
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usually formed before the addition of the cyclodextrin to the food system, sometimes “empty” 
(free or uncomplexed) cyclodextrins are added to food systems to reduce negative sensory 
properties. Using cyclodextrins in this manner has shown benefits in a variety of liquid (Shaw 
and others 1984; Binello and others 2008; Astray and others 2009; Tamamoto and others 2010; 
Gaudette and Pickering 2012), solid (Baba and others 1980; Specht and others 1981), and semi-
solid foods (Hashimoto 1996). Alternatively, cyclodextrin complexation can occur with 
compounds before the addition of a functional ingredient. Successful complexation in previous 
literature has been able to improve the solubility, sensory, and environmental stability (heat, 
acid, or light) of ingredients (Szente and Szejtli 2004; Del Valle 2004; Astray and others 2009; 
Das and others 2013). 
2.1.2.1 Cyclodextrin structure and mechanism of complex formation 
Cyclodextrins are commonly found in 6 (α-cyclodextrin), 7 (β-cyclodextrin), and 8 (γ-
cyclodextrin) membered rings. Complexations are formed when compounds of interest enter the 
center of the cyclodextrin replacing water in an energetically favorable reaction (Astray and 
others 2009). Compounds best fit in cyclodextrins according to their size and structure. Alpha-
cyclodextrins, with an internal diameter of 4.7-5.3Å, typically complex small, low molecular 
weight compounds such as fatty acids and triglycerides (Szente and others 1993; Del Valle 
2004). Beta-cyclodextrins, with an internal diameter of 6.0-6.5 Å, typically complex mid-sized, 
aromatic compounds (Reineccius and others 2002; Tamamoto and others 2010). Gamma-
cyclodextrins, with an internal diameter of 7.5-8.0 Å, can complex multiple small or single large 
compounds like steroids (Del Valle 2004). Their internal cavity volume follows the same 
increase as their diameter, with γ-cyclodextrins having a volume nearly three times that of α-
cyclodextrin (Del Valle 2004). 
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The formation of cyclodextrin complexes is highly dependent on the core and type of 
cyclodextrin being used. Therefore, many factors must be considered when deciding upon a 
complex formulation and method. The molar ratio of cyclodextrin and target compound needs to 
be considered and is often, but not always, combined at a 1:1 ratio (Das and others 2013). The 
size of the target compound can change this ratio, with smaller molecules often occupying more 
than one cyclodextrin or larger compounds utilizing more than one cyclodextrin (Del Valle 
2004). Heat and water can improve and drive complexation but must be used cautiously (Hedges 
1998; Del Valle 2004) as temperature increases above 50-60 °C can disrupt complexations. 
While water content can help the dissolution of cyclodextrin, increased water content can lead to 
diminishing contact between the core and the cyclodextrin wall limiting interaction. Determining 
appropriate formulations for complexes often involves the continued exploration of these 
variables and others in order to determine the most appropriate method. 
While the appropriate formulation for complexation is determined, the method of 
complexation formation must also be considered. Complexes can be formed by a variety of 
methods including but not limited to dry mixing, kneading, slurry complexation, and co-
precipitation (Hedges 1998; Del Valle 2004; Das and others 2013). Dry mixing is similar to 
kneading but no water is used and mixing time can vary considerably. Kneading involves the 
mixture of an extremely small amount of water with the cyclodextrin of interest and mixing until 
a hard paste is formed. This complex must be ground or milled to produce a fine powder that can 
be used. The issue with both of these methods is that the relatively small amount of water used 
can create uneven distribution of the guest complex and increased difficulty with scaling up this 
process into a larger production (Del Valle 2004; Das and others 2013). Slurry complexation 
differs from dry mixing and kneading by increasing the volume of water utilized. Complexes are 
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most commonly prepared at a solids content ranging from 40-60%. The amount of heating, 
mixing speed, and time is dependent on the complex. When the complex is formed, it will 
generally precipitate out of solution and can be collected by physical separation techniques 
(Hedges 1998; Del Valle 2004). Co-precipitation, unlike previous methods used, involves the 
most water of all the previously mentioned complexation methods. A large quantity of water is 
added to a cyclodextrin solution followed by addition of the compound of interest. The formed 
complex will fall out of solution when formed and can be collected by a variety of physical 
separation methods. This method, while useful in the laboratory, is inefficient when utilized on a 
larger scale due to the excessive amount of water used (Hedges 1998; Del Valle 2004). Slurry 
complexation offers advantages over co-precipitation due to the use of less water allowing scale-
up to be more reasonably achieved (Del Valle 2004). 
Microencapsulation involves the utilization of both physical and chemical mechanisms to 
achieve a desired system. The use of methods, such as spray drying and cyclodextrin 
complexation, have been successful in the production of microencapsulated food ingredients. 
Consideration of formulation, processing conditions, and processing methods make the 
development of microencapsulated products a complex process. Considering all of these factors, 
continued investigation can lead to the production of stable and beneficial encapsulated systems. 
 
*This was published in: Lee Y, Lee S, Donovan JD. 2014. Chapter 28 - Stability Characterization and Sensory 
Testing in Food Products Containing Microencapsulants. In: Anilkumar G. Gaonkar, Niraj Vasisht, Atul Ramesh 
Khare, Robert Sobel, editors. Microencapsulation in the Food Industry. San Diego: Academic Press. p 367-81. 
Reprinting has been granted by the publisher (Appendix A) 
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2.2 Stability characterization and sensory testing in food products containing 
microencapsulants* 
2.2.1 Introduction 
The field of microencapsulation encompasses a wide variety of technologies that are 
discussed in detail throughout this book. Many technologies are used in research and the food 
industry such as spray drying, spray chilling, extrusion coating, fluidized-bed coating, liposomes, 
and molecular inclusion (Shahidi and Han 1993; Gibbs and others 1999; Desai and Park 2005; 
Gharsallaoui and others 2007; Gharsallaoui and others 2012). Products are microencapsulated in 
the food industry for a variety of reasons including but not limited to: improving the ease of 
ingredient handling, protecting the core stability from its specific environmental sensitivities, 
targeted release of ingredients, flavor masking, or to provide a physical barrier between the core 
and the food matrix (Shahidi and Han 1993; Desai and Park 2005; Gharsallaoui and others 
2007). The purpose of encapsulation will influence the choice of processing variables such as 
ingredient cost, availability of equipment, functionality, and ease of use (Jackson and Lee 1991; 
Desai and Park 2005). Cost and food-grade nature of ingredients are of primary concern for the 
food industry as some technologies use non-food grade ingredients or are cost prohibitive 
(Shahidi and Han 1993; Gibbs and others 1999; Desai and Park 2005). The reader is suggested to 
explore sources for specific details relating to the microencapsulation technologies mentioned 
throughout this chapter (Jackson and Lee 1991; Shahidi and Han 1993; Gibbs and others 1999; 
Desai and Park 2005). Regardless of the technology used to produce the microcapsules, stability 
assessments of microcapsules are used to determine the success of a microencapsulation process. 
Stability can be measured by focusing on several of core or wall parameters. A variety of 
processing variables and environmental factors can influence the stability of microcapsules. 
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There is no set guideline of what makes a microcapsule stable, a variety of measurements are 
commonly referred to in scientific literature to examine the stability of microcapsules.  
2.2.2 Assessing stability 
When evaluating the stability and integrity of the microencapsulated system, a universal 
set of parameters to examine has not been identified. Researchers and industry professionals 
alike have thus employed a variety of methods to determine the stability. These methods 
generally examine a variety of physical and chemical properties relating to the wall and 
encapsulated core.  
2.2.2.1 Factors affecting wall stability 
Understanding the structure, physical, and chemical properties of the wall material of 
microcapsules is important in determining the stability of the entire system. Factors generally 
include surface morphology, particle size, moisture content, and water activity. 
2.2.2.1.1 Surface morphology and characteristics 
The surface structure of microcapsule is one of the key parameters in understanding the 
microencapsulated system (Desai and Park 2005). The surface morphology of the 
microencapsulated system is influenced by the encapsulation technique and the processing 
variables associated with the technique (Shahidi and Han 1993). For example, variables such as 
inlet temperatures, size of the drying chamber, atomization method, slurry viscosity, and drying 
properties all heavily influence the particle size of spray dried microcapsules (Walton and 
Mumford 1999). Other encapsulation methods such as extrusion, liposome entrapment, and 
molecular complexation will all have their own sets of parameters dictating formation of the wall 
structure (Desai and Park 2005).  
The ideal integrity and structure of a wall material will vary depending on the specific 
goals of encapsulation. While one of the goals is to isolate a core material, the degree that the 
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core is isolated from the environment can change based on the wall structure. For example, if 
encapsulation of a core is meant to only protect it for a defined amount of time under the set of 
environmental conditions (pH, enzyme, temperature, etc.) the wall material should degrade in the 
targeted location (Sinha and Kumria 2003; de Vos and others 2010). Similarly, it would be 
especially important in applications where core materials possess negative sensory qualities to 
leave no residue on the particle wall (Shahidi and Han 1993; Gibbs and others 1999; Sohi and 
others 2004; Szejtli and Szente 2005). For this reason, the wall structure and composition is often 
something experimenters aim to observe. Monitoring the structure and composition of the wall 
through microscopy can help ensure a successful microencapsulation process. 
2.2.2.1.2 Microscopy 
Microscopic observations can be used to elucidate the surface structure microcapsule. 
The ability to observe cracks, dents, surface imperfections, wall thickness, uniformity and 
smoothness are useful in understanding particle properties and bulk characteristics related to 
morphology (Walton and Mumford 1999). Often scanning electron microscopy (SEM) is used to 
examine the structural differences of a variety of microencapsulated systems (Sankarikutty and 
others 1988; Young and others 1993; Young and others 1993; Rosenberg and Sheu 1996; Kim 
and others 2002; Tonon and others 2009; Fritzen-Freire and others 2012; Ying and others 2012; 
Gharsallaoui and others 2012). This microscope scatters an electron beam across the surface of a 
sample, producing secondary electrons that are then interpreted by the microscope to produce 
images. In order for this secondary electron beam to be produced the sample needs to have a 
conductive surface. For this reason, food particles analyzed with SEM often need to be coated 
with a reactive precious metals such as gold, palladium, or alloy mixtures (Rosenberg and others 
1985). 
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This technology allows for the investigation of surface cracks, dents, and irregularities. 
The presence of these characteristics may be undesired in the microencapsulated system and may 
adversely affect important parameters such as long-term stability, microencapsulation efficiency, 
volatile retention, or flowability (Rosenberg and others 1985; Sheu and Rosenberg 1998). 
Examples of researchers using microscopic techniques to evaluate the structure of microcapsules 
can be found throughout the literature. Microencapsulated systems formulated using 
maltodextrins produced microcapsules with a spherical shape but cracked surfaces. These cracks 
are believed to result in lower oil retention (Sankarikutty and others 1988). Other researchers 
observed adding maltodextrins of high dextrose equivalence to whey protein-based wall 
materials aids in the formation of smooth particle surfaces and increased volatile retention (Sheu 
and Rosenberg 1998). A smooth particle surface, however, may not always be optimal. Work 
done by Sankarikutty and others (1988), noted that microencapsulated cardamom oil in gum 
acacia-based wall matrices with dented surfaces had higher volatile retention than smoother 
surfaces produced by maltodextrins. For this reason, the wall structure and composition is often 
something experimenters aim to observe for their specific system. Monitoring the structure and 
composition of the wall through microscopy can help ensure of successful microencapsulation 
process. 
2.2.2.1.3 Electron spectroscopy for chemical analysis (ESCA) 
Electron Spectroscopy for Chemical Analysis (ESCA but sometimes called X-ray 
photoelectron spectroscopy, XPS) is a technology used to examine the major chemical 
components and relative distribution on particle surfaces. The technology allows the 
determination of elements on the surface (about the first 10 nm) of a particle. Electron 
spectroscopy for chemical analysis uses an x-ray source to provide photoelectron signals via 
electrons that are unique to atoms of interest. Once the signals are analyzed, it becomes possible 
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to identify the ratios of fat, protein, and lactose on the surface of powders. Described in detail in 
by Fäldt and others (1993), they have used the relative ratios of carbon, hydrogen, and nitrogen 
to determine the signal produced associated with surface fat. Electron spectroscopy for chemical 
analysis has been adapted for the surface analysis of powders in various studies (Fäldt and 
Bergenståhl 1996; Kim and others 2002; Kim and others 2005; Kim and others 2009). 
ESCA has been used to examine various dairy powders. Research conducted by Fäldt and 
Bergenståhl (1996), was able to showcase the power of ESCA in observing and quantifying 
surface fat content in ways that are not possible through SEM or extraction techniques. These 
researchers were able to observe movement of fat onto particle surfaces over time due to lactose 
recrystallization using ESCA that was not visible in SEM images. In spray dried whey and 
lactose emulsions, surface fat content can range between 40 to 60% according to ESCA. Due to 
this high content of surface fat, it was concluded by Fäldt and Bergenståhl (1996), that whey 
protein and lactose wall materials serve only as “mediocre” encapsulants. They cited similar 
studies that reported successful, yet contradicting results when microencapsulating using whey 
proteins as wall materials. On the basis of SEM and extraction techniques alone, it was observed 
that low surface fat was achieved using whey proteins and that whey proteins were excellent wall 
materials (Young and others 1993; Young and others 1993). The comparison of these two studies 
is challenging due to the use of different wall materials, oil phases, emulsification steps, and 
other spray drying parameters. Due to this a definitive conclusion on the superiority of either 
method may be inaccurate. Further research may be necessary to determine ideal way to 
characterize the surface composition of particles. 
2.2.2.1.4 Particle size 
Particle size of microcapsules is often measured in the investigation and characterization 
of microcapsules (Sankarikutty and others 1988; Young and others 1993; Hogan and others 
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2003; Picot and Lacroix 2003; Turchiuli and others 2005; Fritzen-Freire and others 2012) 
Microencapsulated particles generally are classified in the size range of 0.2- 5000 µm 
(Anandaraman and Reineccius 1980; King 1995). Particle size can influence physical properties 
such as moisture content, water activity, mass transfer, dispersion, core retention, and stability of 
wall and core materials (Chang and others 1988; Walton and Mumford 1999; Reineccius 2004). 
Due to the influence of particle size on stability, a variety of methods can be used to measure 
particle size including visual optical microscopy, laser diffraction, dynamic light scattering, 
centrifugal separation and time of flight (O'Hagan and others 2005). Each of these methods has 
their optimal size ranges and sample types they best accommodate. While these and many more 
methods exist, the most popularly explored methods of particle size determination are laser 
diffraction and optical microscopy. Laser diffraction uses static light that is passed through a 
dispersion of particles in order to produce a light scattering signal that is interpreted by the 
device (O'Hagan and others 2005). Optical methods are often employed by investigators 
counting a large number of particles in several specified ranges and then averaging to determine 
a measurement.  
Particle size in relation to stability of the microencapsulated system is often investigated 
in scientific literature. Research done by Hogan and others (2001), observed that 
microencapsulation efficiency of dried emulsions increased as the dextrose equivalent (DE) 
value (ranging from 0-50) and particle size increased. The same researchers observed that when 
only considering the ratio of wall/ DE value decreased, despite particle size increases, 
encapsulation efficiency decreased. These conflicting conclusions led to the belief that particle 
size was not the only factor influencing microencapsulation efficiency. Larger particles generally 
take longer to dry, causing them to expand, balloon, and form surface imperfections (Chang and 
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others 1988). This extended drying time can also lead to loss of volatiles and/or increased 
exposure of sensitive encapsulated compounds to atmospheric conditions (Chang and others 
1988). While a larger particle may have a lower surface area to volume ratio that would aid in 
core retention it also takes longer to dry. This increased drying time can lead to core loss, 
especially when encapsulating a volatile compound (Chang and others 1988). While the 
definitive correlation between particle size and stability varies between the literature, it should be 
noted that information on particle size has the potential to impact a variety of physical, chemical, 
and sensory properties. 
2.2.2.1.5 Moisture content and water activity 
While moisture content and water activity are both indicators of the amount of water 
contained within a system, they both measure different “types” of water. Both values are 
important for the stability of dried products (Picot and Lacroix 2004). Moisture content is the 
measure of total moisture contained within a system. The moisture content is expressed as a 
percentage ranging from 0-100%. Water activity is a measure of the available water in a system 
for chemical and microbial reactions. The water activity of a system is normally expressed as a 
value between 0 (no free water) to 1 (all free water). The range of moisture content and water 
activity that keeps the microencapsulated system stable will vary greatly depending on the glass 
transition temperatures (Tg) of the matrix. Preserving this glassy matrix is influential to stability 
preservation in dried products (Bruni and Leopold 1991). The glassy state forms a protective 
environmental barrier to limit molecular mobility (Ananta and others 2011). This limited 
movement helps to lessen the impact of external stressors, such as oxidation, that may influence 
stability of microencapsulated core (Crowe and others 1998). In microencapsulation methods 
producing dried capsules, it is important to store them at temperatures below their given Tg. 
Storing above Tg may allow the microcapsuels to return to a rubbery state that does not provide 
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the same protection (Crowe and others 1998). Most dried microcapsules fall on the lower end of 
both these moisture scales. Moisture content between 1 to 6% and water activity below 0.3 is 
generally produced via microencapsulation (Reineccius 2004; Reid and Fennema 2008). As an 
example, spray dried microcapsules exhibiting a water activity below 0.3 would be considered 
stable. This is because at this level of water activity, microcapsules are unable to participate in 
microbial or biochemical reactions that could lead to degradation (Reid and Fennema 2008). 
Particle size may also influence moisture content; an important factor in to particle 
stability (Reid and Fennema 2008). In terms of moisture content, Sankarikutty and others (1988), 
observed that their spray dried particles in the ranges of 1-28 µm did not exhibit free flowing 
properties due to elevated moisture content of the samples while some researchers reported that 
particle size did not influence moisture content (Chang and others 1988). Perhaps these 
differences are related to increases in particle size leading to decreased hygroscopic properties. 
This decreased hygroscopic properties lead to a slower rate of moisture uptake and can result in 
long term particle stability. Therefore, producing a particle of a different size may influence the 
way its moisture content plays a role in stability. Techniques used to measure both water activity 
and moisture has been thoroughly reviewed in other books (Reid and others 2001; Fontana and 
Campbell 2004; Fontana 2007). Examples of both water activity and/or moisture content being 
used as part of microencapsulation stability analysis can be found extensively in a wide variety 
of published literature (Chang and others 1988; Sankarikutty and others 1988; Rosenberg and 
Sheu 1996; Sheu and Rosenberg 1998; Hogan and others 2001; Picot and Lacroix 2003; 
Corcoran and others 2004; Ying and others 2012; Fritzen-Freire and others 2012). 
2.2.2.2 Factors affecting core stability 
While the purposes of microencapsulation are numerous, they generally surround the 
protection, isolation, or controlled release of core ingredients (Shahidi and Han 1993; Gibbs and 
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others 1999). Due to this, the effective and efficient encapsulation of core ingredients in the 
microencapsulated system is of primary importance. Efficient encapsulation of these materials 
will improve core stability from environmental factors such as light, pH, temperature, and 
oxygen. 
2.2.2.2.1 Environmental factors affecting core stability 
The way that environmental factors affect the stability of core materials varies depending 
on the core in the microcapsule. Despite this variability, major environmental factors and related 
analytical techniques can be explored. 
2.2.2.2.1.1 Light 
One of the common reasons for the microencapsulation of a variety of core materials is 
due to their sensitivity to light (Shahidi and Han 1993). When exposed to light and the right 
environmental factors a variety of core materials such as carotenoids (Barbosaa and others 2005; 
Shu and others 2006), vitamins (Wilson and Shah 2007; Riaz and others 2009), polyphenols 
(Trela and Waterhouse 1996), flavors (Szente and Szejtil 1987), and lipids (Scrimgeour 2005), 
can degrade, isomerize, cyclize, and/or generate free radicals due to their unique chemical 
structures. 
The compound bixin, a carotenoid found in seed of the annatto tree, is highly sensitive to 
light. When exposed to UV radiation, the compound can isomerize and decrease the intensity of 
color (Montenegro and others 2004). Decreased intensity could be a problem for the food 
industry, as annatto extracts are primary used for the coloring of a variety of liquid, solid, and 
semi-solid food systems (Scotter 2009). In order to avoid this problem, Barbosa and others 
(2005), microencapsulated bixin by spray drying using gum Arabic or maltodextrin as wall 
materials. They were able to observe longer decay times with encapsulation as compared to non-
encapsulated bixin (Barbosaa and others 2005). Investigation into optimal formulations for other 
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light sensitive carotenoids processed by spray drying to improve encapsulation yield and 
efficiency is also of importance to other research groups (Lee and Chen 2002; Shu and others 
2006). Methods used to observe the stability of light sensitive ingredients in their encapsulated 
forms will vary based on the individual core compound. Generally, the method most appropriate 
for the encapsulated ingredient will depend on commonly used methods to analyze the 
compound. It is important to identify a sample preparation method appropriate for the chosen 
method of analysis, but also that allows for the full release of the core for accurate quantification. 
Most widely used analytical techniques include, but are not limited to, gas chromatography 
(GC), gas chromatography mass spectrometry (GC-MS), high performance liquid 
chromatography (HPLC), or spectrophotometric analysis. 
2.2.2.2.1.2 pH conditions 
The isolation of core materials from harsh pH conditions is one of the many reasons to 
encapsulate materials. While the stability issues due to pH are also core specific, a variety of 
detrimental reactions can occur due to exposure to not optimal pH such as a decrease probiotic 
viability (Kailasapathy and Chin 2000; Picot and Lacroix 2004; Champagne and Fustier 2007), 
chemical structure changes (Trela and Waterhouse 1996), and autoxidation (Kirby and others 
1991). For these reasons and others, microencapsulation technologies can be utilized to improve 
the pH stability of core materials. 
Microencapsulation is a technology that can be used to enhance the viability of probiotic 
bacteria in foods, during processing, and during the transit through the human stomach (Ding and 
Shah 2009). The pH of the stomach is extremely acidic making it inhospitable for many 
microorganisms including the two major genera of probiotic bacteria, Lactobacilli and 
Bifidiobacterium (Kailasapathy and Chin 2000; Picot and Lacroix 2004; Ding and Shah 2009). 
This harsh environment is a challenge for probiotic supplementation into foods. Probiotic 
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bacteria should be present in high amounts (~106 bacteria per gram) in the product and be able to 
withstand the harsh environment of the stomach to reach the large intestine to elicit their 
beneficial effects (Shah 2000; Lourens-Hattingh and Viljoen 2001; Shah 2007). Researchers 
have observed that microencapsulation of probiotic bacteria in whey protein based 
microcapsules, certain strains of Bifidiobacteria showed significantly higher viability after 
storage in yogurt for 28 days (Picot and Lacroix 2004). The same strain of Bifidiobacteria 
(Bifidiobacteria breve R070) also exhibited higher rates of survival in simulated gastric 
conditions than free cells. However, even within this study, another strain of Bifidiobacteria 
breve saw no improved viability in the yogurt or simulated gastric solution (Picot and Lacroix 
2004). It is important to realize that the ability of probiotic bacteria to survive these harsh 
conditions regardless of microencapsulation method is genus, species, and/or strain specific 
(Lian and others 2002; Picot and Lacroix 2004; Ding and Shah 2009). 
2.2.2.2.1.3 Temperature 
Elevated temperatures due to environmental conditions and processing parameters can 
pose problems for a variety of heat labile core materials. While the microencapsulation process 
does not always involve elevated or lowered temperatures, some methods such as spray drying, 
spray chilling, freeze drying, and air suspension use extreme temperatures to perform 
microencapsulation (Shahidi and Han 1993; Gibbs and others 1999). Other techniques such as 
molecular complexation involve methods of encapsulation preparation that occur only slightly 
above room temperature (depending on the cyclodextrin and guest compound used). This can 
allow the investigator to avoid extreme temperature conditions all together (Del Valle 2004). It is 
important to understand the sensitivity of the particular core material being microencapsulated as 
well as the principles behind each technique to ensure the maximum stability for the 
microencapsulated core material. 
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While high temperatures are ideal for the inactivation of pathogenic microorganisms, 
they can destroy beneficial bacteria. This poses an interesting challenge for researchers wishing 
to use spray drying for the delivery of probiotic bacteria. Probiotic bacteria are defined as “live 
microorganisms, which when ingested or locally applied in sufficient numbers confer one or 
more specified demonstrated health benefits for the host” (FAO/WHO Experts' Report 2001). 
Microencapsulation is adapted for manufacturer’s need to protect the bacteria against the harsh 
conditions of the processing, the stomach, and upper GI tract (Naidu and others 1999; Shah 
2000). Research has shown that despite the high temperatures used in spray drying, survival of 
bacteria has increased as compared to free bacteria in model GI (Picot and Lacroix 2004), 
storage (Goderska and Czarnecki 2008), and food systems (Kailasapathy 2006). Using outlet 
temperatures that would normally cause heat related damage to microorganisms, spray drying 
can actually increase the stability of probiotics (Lian and others 2002; Ananta and others 2005). 
When outlet temperatures are kept between 80-90 °C probiotic viability is higher than compared 
to elevated temperatures (Masters 1985; Ananta and others 2005). A comprehensive review 
regarding the microencapsulation and probiotic bacteria and ways to measure probiotic viability 
can be found within the literature (Shah 2000; Rokka and Rantamäki 2010; Silva and others 
2011). 
Additional examples of microencapsulated heat sensitive core materials include flavor 
compounds. Despite a sensitivity to heat, spray drying is the most widely used method for flavor 
encapsulation (Reineccius 1988; Sankarikutty and others 1988; Reineccius 2004; Desai and Park 
2005; Gharsallaoui and others 2007; Gharsallaoui and others 2012). Fast formation of the low 
moisture particle surface facilitates selective diffusion. This low moisture surface (7-23%) limits 
permeability of small flavor compounds but allows the diffusion of water which lowers the 
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particle temperature by evaporative cooling (Reineccius 1988; Judson King 1995; Reineccius 
2004). Flavor compounds are typically labile to heat during processing and the drying process 
should be carefully monitored to ensure proper retention (Chang and others 1988; Sankarikutty 
and others 1988; Galmarini and others 2008). Due to its versatility, volatile retention using spray 
drying can be improved by adjusting drying temperatures, infeed solids, wall materials, additives 
and a variety of other variables (Reineccius 1988; Walton and Mumford 1999; Reineccius 2004; 
Desai and Park 2005; Gharsallaoui and others 2007). Using inlet temperatures in the range of 
160-210°C and outlet temperatures above 100°C have been cited as optimum temperatures levels 
for flavor retention (Reineccius 2004). High infeed solids help in the fast formation of the initial 
semipermeable dry layer on the particle, therefore limiting diffusion and improving volatile 
retention (Reineccius 2004). Despite this, an optimum infeed concentrations will be based on the 
particular carrier and flavor encapsulated (Reineccius and Bangs 1985; Reineccius 1999). 
Additionally, the reviews covering the benefits of molecular encapsulation for sensitive flavor 
compounds can also be found in the literature (Reineccius and others 2002; Astray and others 
2009). 
2.2.2.2.2 Effect of oxidation on core stability 
Since one of the major goals and beneficial effects associated with microencapsulation 
involve the isolation of a core material from its environment (Shahidi and Han 1993), 
microencapsulation is particularly useful for core ingredients that are susceptible to oxidative 
degradation. Measuring the oxidation of the encapsulated ingredients can provide information 
regarding how successful the microencapsulation process was both immediately after processing 
and over long term storage. 
The usage of microencapsulation to reduce and delay the oxidation of oxygen-sensitive 
core materials dates back early as nearly 26 years ago with the work of Szente and Szejtil (1987), 
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looking into molecular inclusion. More recently, monitoring the long term and short term 
oxidation of core materials can be found in the literature. Although some processing techniques 
can cause lipids to initially oxidize (Gharsallaoui and others 2012), it is important to also look at 
the oxidative stability of the microcapsule over time. Oxidation can influence core materials in a 
variety of manners. It has been shown that the oxidation is responsible for the death of 
microorganisms during storage (Teixeira and others 1996). Utilizing headspace analysis coupled 
with gas chromatography, hexanal and oxygen uptake as markers of sample oxidation in a 
microencapsulated system was observed (Moreau and Rosenberg 1996). It was found that 
microencapsulated anhydrous milk fat (AMF) oxidized slower when stored in the dark as 
opposed to the light, exhibited no oxygen uptake, and lowered hexanal production. Another 
practical application of oxidation measurements to monitor stability of microcapsules was 
observed in research involving microencapsulated fatty acids. Due to their ability to oxidize 
easily, incorporation and long term stability of these ingredients into foods poses a challenge. 
Research involving the microencapsulation of fish oils, and omega-3 polyunsaturated fats is 
looking to overcome these challenges (Andersen 1995; Kolanowski and others 1999; Hogan and 
others 2003; Serfert and others 2010; de Conto and others 2012). One group of researchers 
(Hogan and others 2003), monitored the peroxide values of microencapsulated fish oil to observe 
the role of maltodextrins of varying lengths, core/wall ratios, and antioxidants on oxidation. This 
is just one example of the many listed above using microencapsulation to reduce the oxidation of 
core materials. 
2.2.2.2.2.1 Measurement of core oxidation 
Core oxidation not only influences lipid-based systems, but has also been shown to 
negatively affect the viability of microencapsulated probiotic organisms (Teixeira and others 
1996; Champagne and Fustier 2007). Oxidation of the core material, if applicable to the 
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microencapsulated system, can be measured in a variety of manners using sensory evaluation, 
chemical, or a combination of both techniques. While no singular oxidation detection 
methodology will identify all products of oxidation, a combination of methods can be employed 
to fully investigate the oxidation of a sample. Methodologies to measure oxidation include 
thiobarbituric reactive substances (TBARS), peroxide-oxygen value, conjugated dienes, and gas 
chromatography (GC). Information on how to perform these methods and what they identify 
explored elsewhere in the scientific literature in detail (Gray 1978; Guillén-Sans and Guzmán-
Chozas 1998; Dobarganes and Velasco 2002). 
2.2.2.2.2.2 Measurement of surface oxidation 
When using lipid-based core materials or carriers in a microencapsulated system, their 
presence on the surface of a microcapsule is not only an issue from a microencapsulation 
efficiency standpoint, but also an issue of storage and stability. Lipids on the surface of particles 
can decrease powders flowability and dispersability (Fäldt and others 1993; Fäldt and 
Bergenståhl 1996; Kim and others 2005). Due to a lipids ability to oxidize, the 
microencapsulated system may degrade prematurely if the lipid on the surface of the particle is 
exposed to oxygen, light, heat, or any other oxidation-promoting factor (Fäldt and others 1993; 
St. Angelo and others 1996; Hardas and others 2000; Kim and others 2005) . It is therefore 
important to be able to quantify a lipid present on the microcapsule surface. 
Quantification of surface fat can be accomplished through the use of modified extraction 
techniques. These techniques are described as modified due to the relatively short exposure time 
to an organic solvent as opposed to more traditional extraction techniques to measure total fat 
content. While methodological specifics may vary, when examining the surface fat of a 
microcapsule, the basic steps remain similar from procedure-to-procedure. A small amount of 
microencapsulated powder is exposed to a solvent (typically petroleum ether (Sankarikutty and 
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others 1988) for a short amount of time (under 15 minutes) with slight agitation. The solvent 
with extracted fat is then filtered through a membrane followed by solvent evaporation to 
determine the amount of fat in the solvent (Fäldt and others 1993; Young and others 1993; Picot 
and Lacroix 2003; Turchiuli and others 2005; GEA Niro 2005; Kim and others 2005). It is, 
therefore, important to be able to quantify a lipids presence on the microcapsule surface. The 
knowledge of surface fat on particles has helped explain the stability and functionality of 
microcapsules for several studies. The agglomerative nature of microencapsulates produced by 
Picot and Lacroix (2003), was attributed to the relatively low microencapsulation efficacy (a 
function of the surface or free fat) of their microcapsules. When fat is used as core ingredient, 
microencapsulated fat will oxidize at a slower rate than non-encapsulated fat (Turchiuli and 
others 2005). Therefore, its presence on the surface is an indication of decreased 
microencapsulation efficiency and may lead to an ultimate decrease in the oxidative stability of 
the matrix (Sankarikutty and others 1988). 
2.2.3 Sensory impacts of microencapsulated ingredients in foods 
2.2.3.1 The field of sensory evaluation 
While sensory evaluation has been carried out on foods and consumer goods since 
humans have existed, formal testing and evaluation is traced back to the wartime efforts of 
World War II with the desire to improve the quality of the American soldiers’ food (Dove 1946). 
There was a strong desire to establish a systematic and scientific methodology to test for sensory 
qualities and acceptance of these foods (Foster 1954; Stone and Sidel 1985). The scientific 
discipline of sensory evaluation is most commonly described (Stone and Sidel 1985; Lawless 
and Heymann 1999), using the definition developed by the Sensory Evaluation Division of the 
Institute of Food Technologists (IFT). This definition describes sensory evaluation as, “a 
scientific discipline used to evoke, measure, analyze and interpret reactions to those 
35 
 
characteristics of foods and materials as they are perceived by the senses of sight, smell, taste, 
touching and hearing” (Anonymous 1975). While defining a field of study with a singular 
definition is not completely inclusive, this definition seeks to describe the overarching goals and 
focus of sensory evaluation (Stone and Sidel 1985). Each sense addressed in the definition could 
be elaborated upon in great detail. While each is important to the overall acceptance and quality 
of foods, basic knowledge surrounding each sense and the perception they relate to will be 
discussed briefly in this chapter. 
2.2.3.2 Appearance and vision 
When a food is first received initial judgments are typically made based on appearance. 
Appearance is perceived by the eye when reflected light is transmitted to the brain by signals that 
are then interpreted into images (Lawless and Heymann 1999). Appearance can serve as a 
marker for quality (ripened vegetables), safety (the existence for green mold), completeness in 
processing (if bread has darkened enough), can influence the acceptance (liking or preference) 
and perception (flavor and intensity) of food products (DuBose and others 1980; Francis 1995; 
Lawless and Heymann 1999; Zellner and Durlach 2003; Delwiche 2004; Shankar and others 
2010). 
Color is considered a three-dimensional property consisting of hue (the observable 
specific colors), value (the lightness or darkness of a color) and chroma (the brightness of a 
color) (Munsell 1905; Lawless and Heymann 1999). This is the primary reason why human 
subjects should not be asked to measure color directly. Asking sensory panelists to score three 
properties on a single scale would be comparable to asking a panelist to rate texture, color, and 
flavor on the same scale. Mathematical relationships describing color exist, and are highlighted 
in several outside sources (Clydesdale and Ahmed 1978; Lawless and Heymann 1999). 
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2.2.3.3 Taste and gustation 
The five basic tastes associated with human perception known as gustation are sour, 
sweet, salty, bitter, and savory (umami). These chemical senses are perceived by taste buds 
located in the oral cavity and in portions of the throat and esophagus (Meilgaard and others 1999; 
Roper 2012). The five basic tastes are perceived in all areas of the tongue and are not limited to 
specific indicated by the popularized “tongue map” (Lindemann 2001; Roper 2012). The 
physiological and biochemical mechanisms associated with the perception of each basic taste are 
further described in several excellent scientific review articles and book chapters (Lindemann 
2001; Chandrashekar and others 2006; Sugita 2006; St. John and Boughter Jr. 2008).  
2.2.3.4 Odor and olfaction 
The perception of olfaction is the most complex and elusive of the human senses (Savic 
2001). Olfaction is highly sensitive in comparison to gustation: thousands of odors are 
recognized at much low concentrations compared to some of the most potent taste compounds 
(Nef 1998). Olfaction is important not only in food selection, preference, and acceptance but also 
in biological and physiological functions (Nef 1998; Axel 2006; Stevenson 2010). The senses of 
olfaction and gustation are combined with the perception of chemical feeling factors (cooling, 
heating, etc.) in order to produce the common sensory descriptor of flavor (Meilgaard and others 
1999). 
During the process of olfaction, volatile compounds enter the nasal cavity either 
orthonasally (through the nose) or retronasally (through the mouth, throat to nasal cavity) and 
bind to cilia extending from the olfactory epithelium. These cilia start a cascade of signals 
eventually ending at the olfactory bulb that serves as a relay station to the portion of the brain 
responsible for aroma processing (Axel 2006). Information relating the specific theories of 
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olfactory transduction and signaling are further described in other sources (Ache and 
Zhainazarov 1995; Roper 2012).  
2.2.3.5 Texture and touch 
Texture is another complex sensory perception. The complexity of texture is clearly 
outlined by the multidimensional nature of the definition given by the International Standards 
Organization. The definition includes not only the mechanical and geometrical attributes 
perceived by tactile and mechanical sensations but visual and auditory responses as well 
(International Standard ISO 5492 and British Standard BS 5098:1992 1992). Texture perceived 
via proprioception in the oral cavity corresponds to deeper pressure responses, while somesthesis 
refers to lighter surface responses. These two perceptions can function during the process of 
mastication and swallowing (Szczesniak 2002; Kilcast and Leatherhead Food International 
2004). In depth looks into each of these perceptive touch mechanisms can be found in the 
literature (Christensen 1984).  
Existing at somewhat of a dichotomy, texture is regarded as one of the primary drivers of 
liking for food products (Szczesniak 1990; Moskowitz and Krieger 1995; Wilkinson and others 
2000), yet it often goes unnoted by consumers unless specifically asked (Szczesniak and Kahn 
1971). The lexicon used to describe textural attributes is vast (Szczesniak 1963; Civille and 
Szczesniak 1973). Specific textural attributes listed are often associated with negative or positive 
connotations. Although these connotations may be linked to cultural and psychological factors 
general trends have been observed (Szczesniak and Kahn 1971). 
2.2.3.6 Considerations for sensory testing of microencapsulated food ingredients 
A variety of sensory methods can be employed to measure the sensory impact of 
microencapsulated food ingredients on the food system. Before deciding on a sensory method, 
the safety and legality regarding the use of the microencapsulated ingredient must be considered. 
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Microcapsules must be produced in a food grade facility, utilizing only food grade materials 
(Gibbs and others 1999). This includes the core, wall, and any other additives used in the 
production of a microcapsule. Legal limits surrounding the preparation, inclusion, and 
administration of the particular core to human subjects need to be considered and followed 
throughout sensory testing. In an industrial setting, a governing body to make decisions 
regarding the ethical nature of a sensory study may not exist. While the presence of such a body 
is not required, the ethical treatment of all those involved should always be considered (Morris 
1967). 
The decision to run a sensory test on a microencapsulated system should, like all other 
aspects of a research design, be considered at the beginning stages of investigation. When 
sensory is seen as an integral component of the research rather than an afterthought, the results 
produced will undoubtedly be of more value to the investigator. What the investigator wants to 
determine through sensory analysis will dictate the methodology of the test, the way the results 
are analyzed, and the conclusions they will be able to draw. 
2.2.3.6.1 Choosing a sensory methodology for testing 
The initial choice of a particular sensory test is one of the most important decisions an 
investigator can make in regards to sensory analysis. The selection of a specific method should 
be based on the experimental goals of the research. There are three major types of sensory tests: 
discrimination, affective, and descriptive testing. Discrimination tests are employed to simply 
determine if the two samples are different. Commonly used discrimination tests include the 
triangle test, duo-trio test, tetrad test, and two- and three-alternative force choice (AFC) tests. 
Affective testing is used to assess a products preference or acceptance using target consumers. 
Affective tests can be classified into qualitative (focus groups, one-on-one interviews, 
observations) or quantitative (preference, acceptance) tests. Descriptive testing uses trained 
39 
 
judges to assess a complete sensory profile of a given product by identifying qualitative and 
quantitative aspects. Various methodologies for descriptive analysis exist, including but not 
limited to the Spectrum™ Method, Quantitative Descriptive Analysis (QDA), Flavor Profile, and 
Texture Profile. Best practices for the above mentioned sensory test methodologies are outlined 
in various textbooks published by leaders and pioneers in the sensory field (ASTM Committee 
E-18 on Sensory Evaluation of Materials and Products 1981; Stone and Sidel 1985; ASTM 
Committee E-18 on Sensory Evaluation of Materials and Products 1992; ASTM Committee E-18 
on Sensory Evaluation of Materials and Products 1996; Lawless and Heymann 1999; Meilgaard 
and others 1999). 
2.2.3.7 Sensory impacts of microencapsulated food ingredients 
The materials used in microencapsulation could affect a myriad of sensory properties 
including taste, odor, flavor, and texture. Considerations for these sensory properties need to be 
addressed when including encapsulated products into food. Despite the use of relatively inert 
wall materials in terms of taste and odor (Sanguansri and Ann Augustin 2010), and the attempt to 
completely isolate encapsulated flavor and aroma compounds from their environment, how 
microencapsulated ingredients affect sensory properties is widely investigated in the literature 
(Hinton 1970; Minifie 1989; Boccio and others 1996; Xia and Xu 2005; Kailasapathy 2006; 
Muthukumarasamy and Holley 2006; Galmarini and others 2008; Homayouni and others 2008; 
Serfert and others 2010; de Conto and others 2012). 
2.2.3.7.1 Textural impacts of microencapsulated food ingredients 
Research in the field of sensory evaluation regarding particle size influence on food 
matrices has led to varying conclusions regarding their influence on texture. General conclusions 
on absolute size detection thresholds and acceptability are hard to make because results are 
particle shape, concentration, and matrix specific (Hinton 1970; Cook 1972; Evans and others 
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1991; Tyle 1993; Imai and others 1995; Imai and others 1997; Engelen and others 2005). For 
example, in a confectionary literature it has been observed that the minimum particle size 
detected by the palate to be 25 µm (Hinton 1970). Therefore, incorporating a particle greater than 
this size into a chocolate matrix may elicit a negative textural response due to lack of 
smoothness. However, the value for milk (65 µm) and dark chocolate (35 µm) vary considerably 
(Minifie 1989). It is generally observed that as particle size and concentration increases in a 
medium, so does the perceived grittiness of the sample (Tyle 1993; Imai and others 1995; Imai 
and others 1997; Kilcast and Clegg 2002; Engelen and others 2005).  
The influence of a particular particle size on textural attributes is not only dependent on 
particle size and concentration, but also on the particles surface morphology and matrix of 
application (Tyle 1993). Thus, microencapsulation research that looks at the textural impact of 
these particles on matrices can only truly describe the particular product of application. It is 
hoped that these particle influences can be extrapolated to other similar food systems. It is also 
noted, that particle shapes of various ingredients such as sucrose or cocoa powder, also influence 
the textural properties of grittiness and roughness (Minifie 1989). Investigating the influence 
alginate encapsulated probiotics have on the hedonic, textural, flavor, and purchase intent of 
fermented sausages, Muthukumarasamy and Holley (2006), used two different methods to 
produce microencapsulated Lactobacillus reuteri: extrusion and emulsion. These methods 
produced dramatically different sized microcapsules. Microencapsulation by extrusion produced 
particles with diameters in the micrometer range while emulsion technology produced spheres in 
the millimeter range. Despite these differences, neither microcapsule influenced the texture of 
the food system. The authors attribute this to the matrix, noting that the extruded capsules 
resemble fat and, despite being visible, went undetected at the usage level.Textural impacts of 
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microencapsulated ingredients are not only a result of particle size. The ingredient in its native 
form may impart textural characteristics such as astringency on the food matrix (Peleg and others 
1999). An example of an ingredient that may impact textural astringency of a food matrix is 
grape seed extract (GSE) (Chira and others 2009). These extracts, containing a variety of 
polyphenolic compounds, present a challenge for food incorporation due to their sensory 
attributes, ability to oxidize, polymerize, and react with proteins (Chira and others 2009; 
Davidov-Pardo and others 2011). Researchers investigated the influence of these spray dried 
microencapsulated antioxidants on the sensory quality and consumer perception of baked goods 
(Davidov-Pardo and others 2012). Conducting a complete Quantitative Descriptive Analysis 
(QDA) as well as a consumer test, they were able to both qualitatively and quantitatively 
describe their products. The QDA results revealed that that while the encapsulated GSE helped 
to slightly reduce the color changes and improved antioxidant activity, flavor, aroma, and 
textural attributes were affected by the microencapsulated ingredients. The QDA panel noted 
changed textural attributes such as the development of a dryer mouthfeel and decreased 
tenderness with the inclusion of the microencapsulated GSE. Despite these changes, results of 
the consumer evaluation and purchase intent yielded positive results; no significant differences in 
mouthfeel liking existed between the cookie formulations. While the researchers were unable to 
eliminate the flavor and textural impacts of GSE on this food matrix microencapsulation did aid 
in improving antioxidant activity. Furthermore, consumers did not notice differences in textural 
attributes of the product that the trained panel did. These results are promising and will hopefully 
lead to further investigation. 
In summary, when considering the sensory impact of the microcapsule in a food system, 
the particle shape, concentration, size, sample matrix, and ingredient properties should be 
42 
 
considered for each product and its influence quantified and understood through sensory analysis 
(Tyle 1993). 
2.2.3.7.2 Flavor and odor impacts of microencapsulated food ingredients 
As mentioned previously, ingredients are often microencapsulated to mask or hide 
unpleasant tastes and or odors (Gibbs and others 1999). Being able to do so may allow the 
application or inclusion of an ingredient into a food that it may otherwise negatively impact. 
Microencapsulation can help to entrap added or naturally present compounds in foods like 
artificial sweeteners, soy beans, citrus juices, vitamin, ginseng beverages, cholesterol, and coffee 
as summarized by Szejtli and Sezente (2005), and Dell Valle (2004).  
Ferrous sulfate is a readily soluble and highly bioavailable form of iron, an essential 
micronutrient (Boccio and others 1997). Despite these benefits, this compound has the ability to 
interact with other components of the matrix (lipids, vitamins, amino acids) producing metallic 
and oxidized off-flavors (Boccio and others 1997; Xia and Xu 2005). Incorporating this this form 
of iron into food systems would be beneficial as iron deficiency is the most common nutritional 
deficiency in the world (Horton and Ross 2003). To overcome these challenges, researchers have 
turned to microencapsulation (Boccio and others 1996; Xia and Xu 2005). Through the use of 
liposomes, milk was successfully fortified with ferrous sulfate with high efficiency (67%) and 
improved stability using cholesterol and Tween 80 (Xia and Xu 2005). Limited sensory work 
was conducted using a small number of panelists to determine if flavor differences arose due to 
the inclusion of the encapsulated ferrous sulfate. While specific data are not reported, the article 
states that the fluid milk, “did not differ greatly from control milk in color and off-flavor” (Xia 
and Xu 2005). These results are promising but details including testing methodology, 
significance levels, ratings, and statistics would help to strengthen the authors’ findings. Another 
published article regarding the microencapsulation of ferrous sulfate using lecithin suffers from 
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the same lack of specific details on sensory analysis (Boccio and others 1996). While the article 
highlights the successful microencapsulation of ferrous sulfate, it is only stated that the sensory 
properties of the milk were unchanged. No analysis or specifics regarding testing methodology 
was given (Boccio and others 1996). The aforementioned papers address the incorporation of 
microencapsulated food ingredients without altering sensory properties. This is promising, but 
specific details regarding their sensory methodologies leave some unanswered questions. Despite 
these instances other detailed research has been published utilizing sensory analysis to observe 
effects of microencapsulated ingredients on flavor (Kailasapathy 2006; Muthukumarasamy and 
Holley 2006; Galmarini and others 2008).   
Microencapsulation can change the basic sensory properties of the core material. The 
aromatic sensory properties of six microencapsulated orange oils spray dried in carbohydrate-
based coatings were investigated using both difference testing and descriptive analysis 
(Galmarini and others 2008). For the discrimination test (difference test) portion of the study, 
assessors were asked to generate attributes that characterized differences existing between the 
paired samples with the triangle test. Frequencies of these generated terms for specific samples 
were used for the identification of control samples for descriptive analysis portion of the study. 
Results of the difference tests concluded that all samples, when paired, exhibited significant 
differences except for one pairing. Descriptive analysis using 14 different aroma attributes using 
control samples (uniquely identified for each attribute from the difference test) identified several 
significant differences among the samples. The test revealed that the incorporation of trehalose 
and sucrose into the encapsulation matrix generated particles with different aroma compositions. 
Samples containing sucrose were characterized as having aromatic attributes such as, “freshly 
squeezed”, “tangerine”, “candy” and, “pungent” while trehalose containing samples were 
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characterized by, “woody” and, “marmalade”. The influence of these two ingredients on every 
encapsulated matrix will not be identical, but is important to note how microencapsulation 
processing and matrices can alter sensory flavor properties. 
2.2.3.7.3 The impact on hedonic ratings and consumer perception due to 
microencapsulated food ingredients 
The inclusion of microencapsulated ingredients into food products may not be advertised 
by a manufacturer. Despite this, these microcapsules have the potential to modify consumer 
perception and acceptance. The sensory attributes that specifically contribute to overall 
acceptance and liking are determined by the individual consumers (Moskowitz and Krieger 
1995), but generally contribute in the following hierarchy: flavor/taste, texture, appearance 
(Moskowitz and Kreiger 1993; Moskowitz and Krieger 1995). The impacts that 
microencapsulated ingredients have on these attributes has been addressed in the above sections, 
however, their impact on the specific overall liking is also of importance. 
When a microencapsulated ingredient possesses sensory attributes in misalignment or 
unfavorable to a food matrix, the goal is to either provide little or no change to primary sensory 
qualities to the product. If sensory changes are desired, it is hoped that they occur in a manner 
favorable for the product. These changes and their impact on overall liking of the product can be 
monitored through acceptance testing. Using overall acceptance tests many of the following 
studies and others found no difference (Boccio and others 1996; Xia and Xu 2005; Kailasapathy 
2006; Muthukumarasamy and Holley 2006; Homayouni and others 2008; Davidov-Pardo and 
others 2012), from a control formulation to one or more of their microencapsulated included 
formulations. This is seen as positive due to a majority of the above core materials possessing 
negative sensory attributes when not encapsulated.  
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With the knowledge that microencapsulated ingredients are present in a food matrix, 
consumer perception of the product may change. Many microencapsulated ingredients, 
especially if the core is nutritionally based, incorporated into food matrices can create what are 
known as functional foods; foods that provide nutritional benefits beyond basic needs (Bech-
Larsen and Grunert 2003). Some research has shown consumers are willing to compromise on 
taste for added health benefits (Urala and Lähteenmäki 2004), but not all are in agreement 
(Verbeke 2006). Due to this disparity of opinions, it is important to understand the influence a 
specific food system has on consumer perception. The research mentioned previously utilizing 
GSE in cookies found several significant impacts of added antioxidants on consumer perception 
(Davidov-Pardo and others 2012). Their work showed that the best rated cookies had the highest 
purchase intent (p<0.01) signifying the importance of high hedonic scores. Despite this 
significant correlation, only 25% of participants said they definitely and probably would pay 
more for these antioxidant cookies. This may be a result of mistrust or lack of knowledge 
concerning the usage and benefits of functional foods. Over 70% of participants found the 
content of antioxidants in the cookies (as much as 4 oz. serving) somewhat or not at all 
believable. Educating the consumer on the encapsulated ingredient may lead to an increased 
interest in purchasing the enriched food, as belief in the antioxidant statement and a willingness 
to pay a higher price was significantly and positively correlated. Therefore, success is not only 
achieved from producing a good tasting product; it is also important to have a market of 
consumers interested, and willing to pay for the new product.  
2.2.3.8 Resources for detailed case studies on microencapsulation 
For the scientist looking to understand the practical application of microencapsulation 
technology and how it is used in an industrial setting, looking into case studies is an excellent 
resource. Many of the articles referenced in this text and detailed throughout the various sections 
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serve to accomplish this goal. Additional resources for case studies are also available in the 
scientific literature. Highlighting the power of molecular complexation using cyclodextrins, 
Szejtil and Szente (2005), outlined two drug products that benefited from this type of 
microencapsulation. Other papers have similarly highlighted the benefits of microencapsulation 
in pharmaceutical uses (Del Valle 2004; Sohi and others 2004). 
Focusing on food products, Ubbink and Kruger (2006), looked into microencapsulation 
as a stabilization method for complex flavors in a variety of food powders with two case studies. 
One case study focused on how glassy matrices help delay the loss and oxidation of flavors in 
instant coffee. The authors further discuss the specific application of probiotics in dried food 
products to increase viability. This review article is excellent at providing a step-by-step method 
for using microencapsulation to protect both flavors and probiotics highlighting analysis 
methods, ingredient functionality, and the technologies necessary for their use. 
Characterizing the stability of microencapsulated food ingredients involves the 
determination of a variety of both chemical and physical properties. The researcher is entitled to 
investigate whatever parameters they see fit for their specific system, although many methods 
presented in this chapter are commonly used. It is suggested that both the wall and core stability 
is considered when determining which methods to utilize. The importance of any chemical or 
physical properties, however, will ultimately be determined based upon the driver for 
microencapsulation and the method used. Encapsulated ingredients have the ability, even when 
microencapsulated, to influence a myriad of sensory properties. Basic knowledge of these 
sensory properties and the methodologies used to measure them will help the researcher 
determine how the microencapsulated ingredient may affect their product. The figure provided at 
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the end of this chapter, Figure 2.2.1, may aid the researcher in determining the stability 
parameters and evaluation techniques most appropriate for their system. 
With the knowledge concerning the stability of their ingredient and its effect on sensory 
properties, food products containing microencapsulated ingredients can be produced and sold on 
the market. These products may have the ability to prevent disease states, provide increased 
shelf-life, functionality, or increase stability. The possibilities are endless in the 
microencapsulation of food ingredients with a variety of topics needing further investigation in 
this emerging field. 
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2.3 Butyrate and tributyrin: functions in intestinal health 
2.3.1 Fermentation and fiber in the intestine 
In the intestinal lumen of humans, the anaerobic fermentation of foods including 
carbohydrates, oligosaccharides, dietary fibers, resistant starches, and proteins by 
microorganisms in the colon occurs (Wong and others 2006; Tappenden 2010). This 
fermentative action plays an important role in health of the intestine. The consumption and 
fermentation of fermentable foods in the intestinal lumen are associated with reduced risk of 
cardiovascular disease, obesity, stroke, and improvements in blood pressure, regularity, bacterial 
flora, and immunity (Anderson and others 2009). Despite this, the consumption of fiber 
consistently remains lower than the amount reccomended by the Institute of Medicine (Grooms 
and others 2013). 
Fiber consumption benefits are associated with its stool bulking ability and the 
production of fermentation by-products (Flamm and others 2001; Anderson and others 2009). 
Products of fermentative action include short-chain fatty acids (SCFA, acetate, propionate, and 
butyrate, primarily), gases (CO2, H2, CH4), and other products (phenols, amines, indoles) 
depending on the location of and type of bacteria present in the large intestine. Fermentative 
action by saccharolytic bacteria primarily dominates the proximal colon, producing linear SCFA, 
hydrogen, and carbon dioxide gas. This area, along with the cecum, is the primary site of colonic 
fermentation due to the high number of bacteria and ready available fermentative substrate 
(Macfarlane and others 1992; Wong and others 2006). Fermentative action by the microbiota 
inhabiting the distal colon is dominated by the production of branched-chain fatty acids, carbon 
dioxide, and hydrogen and nitrogen gas by proteolytic bacteria (Wong and others 2006; Hamer 
and others 2008; Guilloteau and others 2010). The growth of these bacteria, primarily 
Bifidobacterium and Lactobacillus, are stimulated by the presence of these non-digestible food 
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components that in turn, improves the production of SCFA’s (Flamm and others 2001; Wong 
and others 2006; Hamer and others 2008; Raninen and others 2011). 
2.3.2 Butyrate: origin, uses, and benefits 
The three primary SCFA's produced in the large intestine include acetate, propionate, and 
butyrate. In structure, SCFA’s are those fatty acids that contain less than 6 carbon chain lengths. 
These fatty acids exist in their anionic forms while in the intestine due to their weak pKa (~4.8) 
and the relatively neutral pH of the gastrointestinal tract (Bergman 1990). These three SCFA 
account for a majority of the SCFA produced (roughly 85%) through fermentation of 
fermentable dietary fiber (Topping and Clifton 2001; Wong and others 2006; Guilloteau and 
others 2010; Tappenden 2010). The relative percentage of acetate, propionate, and butyrate in 
humans is derived from fecal measurements. Although some variability exists, the molar ratios 
of acetate: propionate: butyrate generally resides around 60:20:20 (Cummings 1981; Cummings 
1984; Topping and Clifton 2001).  
Of the three SCFA’s mentioned, research has identified butyrate as the SCFA of primary 
importance to colonic epithelium (Bartholome and others 2004; Wong and others 2006; Hamer 
and others 2008; Immerseel and others 2010) despite being produced in the lowest amount. In 
the gut, roughly 95% of butyrate is rapidly absorbed and utilized by colonocytes (Pryde and 
others 2002). Serving in this role, butyrate is responsible for a variety of health effects including 
improvement of the intestinal structure of infant piglets with simulated short-bowel syndrome 
(Bartholome and others 2004), decreasing the proliferation of colon cancer cells in human cell 
lines (Lupton 2004), decreasing the incidence of diarrhea (Berni Canani and others 2004), 
improving inflammatory bowel disease (IBD) (Scheppach and others 1992; Steinhart and others 
1996; Vieira and others 2012) and irritable bowel syndrome (IBS) (Berni and others 2004; 
Scarpellini and others 2007) in pateints, and improvements in small (Koruda and others 1990; 
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Kotunia and others 1994) and large (Mentschel and Claus 2003) bowel health. Naturally present 
in food products like Parmesan cheese, milk, yogurt, and other fermented foods, butyric acid 
often is associated with unpleasant oral and odor qualities (Kotunia and others 1994; Edelman 
and others 2003; Leonel and Alvarez-Leite 2012; Pituch and others 2013). Due in part to these 
sensory qualities, butyrate is commonly administered through enemas in patients (Wong and 
others 2006; Leonel and Alvarez-Leite 2012). This form of treatment has low long-term 
compliance rates and can be easily misused (not retained long enough, entire contents not 
emptied into bowel, etc.) (Breuer and others 1997; Immerseel and others 2010; Leonel and 
Alvarez-Leite 2012). 
The mode of action of how butyrate imparts its beneficial effects on the intestinal 
epithelium at the cellular level is often referred to as the “butyrate paradox” (Scheppach and 
others 1992; Lupton 2004). The reason for this paradox, or controversy, stems from butyrate’s 
ability to inhibit cell proliferation of some cells but stimulate the growth of others (Scheppach 
and others 1992; Leonel and Alvarez-Leite 2012). Some research has hypothesized butyrate’s 
success in the reduction of colon carcinoma cells could be connected to its ability to induce 
specific mRNA that blocks the beginning stages of cancer cell development (Archer and others 
1997) and by inducing apoptosis in cancerous cells by specific cellular proteins and pathways 
(Mentschel and Claus 2003). Butyrate also has been shown to increase the growth of healthy 
epithelium in the intestinal tract by mediating an intestinal hormone, GLP-2 (Bartholome and 
others 2004). Butyrate can simultaneously up-regulate the production of healthy cells and down-
regulate or induce apoptosis of cancerous cells due to the difference in utilization of butyrate by 
these cells. Healthy cells allow for the complete oxidation of butyrate to an energy source (ATP) 
while cancerous cells inefficiently oxidize butyrate where it is used as a histone deacetylase 
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(HDAC) inhibitor to block cell progression (Zhou and others 2011; Leonel and Alvarez-Leite 
2012). Extensive reviews addressing many of the specific pathways, gene regulation and 
inhibition, and epigenetic factors relating to butyrate’s exact mechanism are available in the 
scientific literature (Scheppach and others 1992; Hamer and others 2008; Guilloteau and others 
2010; Canani and others 2012).  
2.3.3 Tributyrin: origin, uses and benefits 
To overcome some of the known issues associated with butyrate, a compound known as 
tributyrin has been proposed as an alternative (Chen and Breitman 1994; Conley and others 
1998; Egorin and others 1999; Gaschott and others 2001; Edelman and others 2003; Su and 
others 2004; Li and others 2009). Tributyrin contains three butyric acid groups attached to a 
glycerol backbone. Tributyrin is a food additive that is generally regarded as safe (GRAS) by the 
FDA (21CFR184.1903), is a natural component of many dairy foods, and is considerably less 
expensive than USP sodium butyrate. Tributyrin often is characterized by a cheesy or fecal odor 
and a highly bitter taste. 
Despite the negative sensory qualities associated with tributyrin, it can serve as a source 
of butyrate and also exhibits many beneficial qualities in itself. Tributyrin is rapidly absorbed 
and chemically stable in plasma where it can be broken down into butyric acid by intracellular 
lipases in order to elicit its beneficial actions upon the host (Gaschott and others 2001). 
Additionally, a more immediate release and conversion of tributyrin to butyric acid in the 
intestinal tract can be achieved upon exposure to pancreatic or other lipases and esterases 
(O'Connor and Bailey 1988; Egorin and others 1999; Su and others 2004; Leonel and Alvarez-
Leite 2012). This compound has been used in a variety of studies showing its effective and safe 
nature in animal (Egorin and others 1999; Su and others 2004; Piva and others 2008), human 
(Conley and others 1998; Edelman and others 2003), and in vitro models (Chen and Breitman 
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1994; Gaschott and others 2001; Li and others 2009). While direct investigation into the 
utilization of this compound is limited, the beneficial effects associated with these above studies 
show tributyrin is well tolerated (Edelman and others 2003) and elicits similar beneficial effects 
compared to butyrate, including reduction of colon cancer cells (Gaschott and others 2001; Li 
and others 2009) and the improvement of small intestinal structure in piglets (Piva and others 
2008). 
The importance of butyrate to intestinal health is widely supported by the scientific 
literature. Uses of butyrate in vitro and in vivo have elicited beneficial results as a treatment for a 
variety of intestinal disorders and maladies. The use of a pro-drug, or precursor, of butyrate 
known as tributyrin, also is promising in this regard. While tributyrin can be utilized as a 
delivery system for butyrate, the compound itself has been used to elicit beneficial effects to the 
intestinal lumen. Both products are characterized by poor sensory qualities and need to reach the 
targeted area of the intestine to impart their beneficial effects. These two factors make the oral 
delivery of both butyrate and tributyrin challenging. Methods to minimize their sensory qualities 
and ensure targeted delivery would be necessary in order to transition to the oral delivery of 
these compounds. 
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2.4 Model gastrointestinal systems 
2.4.1 Introduction  
In vitro model gastrointestinal systems are useful research tools to assess the digestibility 
and fermentative qualities of a wide range of food ingredients. They are beneficial compared 
with in vivo procedures due to their cost effectiveness, rapidness, and reproducible nature 
(Boisen and Eggum 1991; Ji and Xiao 2006). In vitro digestion models are excellent for 
understanding the site of intestinal release of food or drug components (Chourasia and Jain 2004; 
de Vos and others 2010). However, the limitations of in vitro techniques must be recognized as 
the complexity of the human gut is difficult to model perfectly (Hur and others 2011). Despite 
this, many methods have been developed and verified for their effectiveness in the simulation of 
digestion against animal digestion. 
2.4.2 In vitro digestion: technique components  
In vitro digestion techniques vary in the number of steps used, digestive fluids or 
enzymes employed, and the type of physical stresses placed on the system (Hur and others 
2011). Methods investigating the digestion of monograstric systems typically include the stages 
of digestion including the oral phase, stomach, small, and large intestine (Boisen and Eggum 
1991; Bourquin and others 1993a; Bourquin and others 1993b; Hernot and others 2005; de 
Godoy and others 2009; Li and others 2012; Benedé and others 2014). They are typically 
performed in the temperature range of 37-39°C. Enzymes such as pancreatin are commonly used 
in the small and large intestinal digestion while anaerobic conditions using microbial inoculum 
simulate the large intestine (Coles and others 2005; Hur and others 2011). The design of the 
model gastrointestinal system, however, also can vary considerably based on the food system 
being investigated. Many reviews have been published in the literature specifically describing 
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the differences between the various methods employed (Boisen and Eggum 1991; McClements 
and Lia 2010; Hur and others 2011; Alminger and others 2014). 
2.4.3 In vitro digestion: stages examined 
First, simulating the oral phase involves recreating the short residence time of a food in 
the mouth and its exposure to saliva. Saliva is composed of 99% water, but also contains 
minerals, and proteins (McClements and Lia 2010). Because of this, in vitro oral phase 
conditions often include a brief exposure of the digested material to a neutral buffer (pH of 
roughly 7) with agitation (Boisen 1991; de Godoy and others 2009; McClements and Lia 2010). 
Simulated oral phases, however, also can become increasingly complex with the inclusion of 
salts, amylase, minerals, and enzymes (Versantvoort and others 2005; Benedé and others 2014; 
Alminger and others 2014). 
Second, conditions of the stomach are simulated by creating an acidic pH (roughly 2.0) 
environment that mimics the physiological acid level of the gut using hydrochloric acid 
(Alminger and others 2014). Temperature conditions remain between 37-39°C with mild 
agitation. Most commonly, the digestive enzyme, pepsin, is added at this stage (Boisen and 
Eggum 1991; Boisen 1991; Englyst and others 1999; Versantvoort and others 2005; de Godoy 
and others 2009; Hur and others 2011). Other additives that could be included at this stage of 
digestion include gastric lipases, electrolytes, amylase, or other enzymes (Koh and others 2009; 
Hur and others 2011; Lipkie and others 2014).  
After the stomach, the small intestine is simulated. The pH is most commonly increased 
to a near neutral pH (ranging between 6.0 and 7.5) (Alminger and others 2014). Temperature and 
agitation conditions remain constant from the stomach phase. Most commonly, pancreatin is 
added at this stage of the in vitro digestion process (Boisen 1991; Boisen and Eggum 1991; 
Englyst and others 1999; Versantvoort and others 2005; de Godoy and others 2009; McClements 
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and Lia 2010); however, additional enzymes, proteases (trypsin, chymotrypsin), pepsidases, 
amylase, pancreatic lipases, minerals, salts, and simulated bile extracts (salts and/or juices) can 
be included (Boisen and Eggum 1991; Englyst and others 1999; Versantvoort and others 2005; 
Abdel-Aal 2008; Benedé and others 2014). 
Finally, the simulation of the large intestine is considerably challenging (McClements 
and Lia 2010). This region of the gut is primarily responsible for the fermentation of foods not 
digested in the other phases of the gastrointestinal tract (Alminger and others 2014). This is 
accomplished through the complex and vast microbial ecology of the region (Guarner and 
Malagelada 2003). To simulate this region of the gastrointestinal tract, conditions are kept in an 
anaerobic state with occasional stirring of substrate. Most commonly, intestinal microflora from 
pooled human/animal fecal samples (n=3; pooled or kept seperate) are used to inoculate tubes 
containing the targeted material (Bourquin and others 1993; Guillon and others 1995; Granito 
and others 2001; Hernot and others 2005; de Godoy and others 2009). However, other methods 
have utilized several of the enzymes most commonly produced by bacteria in this region to 
simulate the presence of bacteria in this region (Boisen and Fernández 1997; Yang 2008). These 
enzyme models, however, have not been well explored and thus may not be suitable (Coles and 
others 2005). 
Modeling the monogastric intestinal system can provide a wealth of information related 
to the digestion and utilization of specified materials throughout regions of the gut. Many 
monograstic models, while differing in certain respects, utilize the same overall design and 
principles. Choosing a model to utilize is largely dependent on the digestive system being 
modeled, resources available, type of product being analyzed, and the end goal of the 
experimenter. While the complexity of the human digestive system in vivo is nearly impossible 
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to fully replicate, careful design and execution of validated in vitro systems can produce 
comparable results to those obtained in vivo. 
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2.5 Sensory evaluation techniques in descriptive analysis and difference testing 
2.5.1 Introduction 
Sensory evaluation is a comparatively new discipline in the field of food science 
beginning in the 1940’s and 50’s with the advent of the triangle test (Bengtsson and Helm 1946), 
the hedonic scale (Peryam and Pilgrim 1957), and the wartime efforts to improve soldiers food 
through the Quartermaster Food and Container Institute (Dove 1946; Jones and others 1955). 
Since these times, sensory evaluation has developed into a complex discipline utilized in the 
food, cosmetic, and consumer goods industries to observe the human sensory response to 
products using a variety of testing methods. Sensory evaluation can be broken into three distinct 
categories of testing: discrimination, descriptive, and consumer testing (Lawless and Heymann 
1999d). Discrimination and descriptive testing will be explored in this section, 
2.5.2 Discrimination testing methods 
Discrimination, or difference testing, is a type of sensory testing that determines if two or 
more products differ from one another (Lawless and Heymann 1999d; Stone and others 2012a). 
Commonly used discrimination testing methods include general (triangle, duo-trio, difference-
from-control, signal detection) and specific (2-Alternative Force Choice (AFC), 3-AFC) tests 
(Lawless and Heymann 1999d; Meilgaard and others 1999d; Stone and others 2012a). 
Discrimination tests, regardless of methodology, should only be conducted between confusable 
stimuli. When samples are obviously different, it would be more suitable to perform affective or 
acceptance testing to identify product differences (O'Mahony and Rousseau 2003).  
Choosing a discrimination testing methodology is determined by several factors: the 
sample being tested, the objective of the test, the preparation needed, the amount of sample, and 
resources available (Stone and others 2012a). When samples are highly fatiguing, it is best to 
utilize a discrimination test that uses the least amount of samples as possible. This same 
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rationale, choosing methods that utilize fewer samples, would also hold true when considering 
samples that are in limited supply, expensive, or difficult to prepare. Considering the objective, if 
it is to find an overall or specific difference between the products, one testing method would be 
more appropriate than the other. Resources available (supplies, space, time, employees, and 
reimbursement funds) may affect the amount of panelists that can be recruited for a given test.  
Some difference tests are more powerful than others. Power refers to the amount a null 
hypothesis will be correctly rejected when false (Ennis 1993). More powerful tests will find 
statistically significant differences between products at a given alpha level more often. Powerful 
tests also require fewer panelists to detect a difference between samples at the same d’. The 
variable, d’, represents the sensory difference between two samples expressed in units of 
standard deviation from the mean (O'Mahony and Rousseau 2003). For example, a 3-AFC and 
triangle test are relatively similar in execution in that they are both difference tests and both 
require the tasting of three samples. However, they differ because one is a specific difference test 
(3-AFC, “whch is the product with more of a given attribute”) while the other is a general test 
(triangle, “which is the odd sample”). Despite this, if power, d’, and significance level are held 
constant, for example, it would require 15 participants in a 3-AFC and 198 in a triangle test to 
identify the same statistically significant difference (Ennis 1993). Knowing that a more powerful 
test saves time, resources, and money, the sensory scientist can choose the most powerful test 
that answers the specific research question they are investigating (O'Mahony and Rousseau 
2003). 
2.5.3 Psychological biases 
During sensory testing, human subjects can be influenced by many psychological biases 
(Meilgaard and others 1999b; Lawless and Heymann 1999b). One issue that is associated with 
many discrimination testing methods is the psychological error known as response bias 
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(O'Mahony 1992; O'Mahony 1995). Response bias is a psychological error related to the internal 
mind criteria established by judges used when determining sample differences. When judges 
have a “lax” or less strict criterion, they will more often indicate two samples are different. When 
judges have a more “strict” criterion, they will less often indicate two samples are different. This 
criterion is often referred to as the β-criterion and serves as the internal marker for how different 
a sample needs to be from one another in order to be marked as such. This β-criterion is 
independent of the judge’s sensitivity for the samples and can vary widely by day or even 
between samples (O'Mahony 1992; O'Mahony 1995; O'Mahony and Rousseau 2003). Without 
controlling, or accounting for this, response bias can influence judges to be inconsistent. 
Response bias can be mitigated or accounted for by using forced choice tests (2-AFC, 3-AFC) or 
by utilizing multiple criteria such as signal detection theory (O'Mahony 1992; O'Mahony 1995). 
2.5.4 Signal detection and the rating method 
To account for response bias, the theories of signal detection have been implemented in 
the sensory evaluation discipline. Signal detection theory was developed by psychophysicists and 
involves the subject being tested to indicate if a sample is a “signal” or a “noise” along with a 
degree of sureness. The “noise” is a sample that represents a theoretical baseline. All judgments 
are made in comparison to this noise. Anything that varies from this baseline perceived as a 
“signal” according to the judge (O'Mahony 1992). Judges are also asked to indicate their degree 
of sureness (sure or unsure) for their judgment resulting in four possible choices (Green and 
Swets 1966). From this data, a response matrix can be produced showing the number of “hits” 
(correct judgments) and “false alarms” at the different internal mind criteria levels of the judges. 
For example, the matrix would show an area where only signal-sure responses were given by the 
judge. The proportion of “hits” (correct signal detection) and “misses” (incorrect signal 
detection) can be plotted for this strict criteria. Plotting the proportion of hits and misses creates 
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what is known as a receiver operating characteristic (ROC) curve. Points of the ROC curve 
represent judgments at different criterion levels. Together they create this curve, and thus, the 
varying criterion from the judge (O'Mahony 1992). The area under this curve (represented by 
P(A)) is directly related to a value known as R-index (Green and Swets 1966). In sensory 
evaluation, we use the theory of signal detection to calculate R-index using the rating test.  
The R-index measure is the probability of detecting a signal from a noise in a paired 
comparison setting (O'Mahony 1992). The use of R-index measure in signal detection theory is 
common as the concept of probability is easier to understand in comparisons to ROC curves 
(O'Mahony 1992). R-index measures can be calculated using the equation developed by Brown 
(1974) and are directly related to d’ values (BI 2006). R-index values range from 50-100%. 
Chance level discrimination is at 50; the probability of detecting the signal from the noise is only 
50%. With only two samples compared, the signal and the noise, this indicates that the sample is 
only different from the noise by chance. Conversely, an R-index of 100% would symbolize 
perfect discrimination from the noise. Values ranging between 51% and 99% indicate various 
iterations of discrimination between the two samples (O'Mahony 1992). In threshold testing, an 
R-index of 75% indicates threshold or the point at which a sample difference can be detected 
(Robinson and others 2005). However, when R-index is not used in a threshold setting, the R-
index value that indicates a signal is significantly different from a noise can be determined using 
available tables (Bi and O'Mahony 2007). 
2.5.5 Descriptive testing 
Descriptive testing, more commonly referred to as descriptive analysis, is one of the most 
complex of all sensory testing methodologies (Lawless and Heymann 1999d; Stone and Sidel 
2003; Stone and others 2012b). Descriptive testing allows for the complete profiling of all 
sensory attributes (appearance, aroma, taste, aroma-by-mouth, texture, aftertaste) for a product 
61 
 
by a group of highly trained judges (Murray and others 2001; Drake and Delahunty 2011; Stone 
and others 2012b). Descriptive testing generates both quantitative (intensity scaling) and 
qualitative (product descriptors) information about a product (Meilgaard and others 1999a). 
Different methods for descriptive are available and vary widely (Lawless and Heymann 1999c). 
Commonly referenced methods of descriptive testing (Lawless and Heymann 1999c; Meilgaard 
and others 1999a; Murray and others 2001; Stone and others 2012b) include Flavor Profile® 
(Cairncross and Sjöström 1950), Texture Profile® (BRANDT and others 1963), time intensity, 
Free-choice Profiling, Quantitative Descriptive Analysis® (QDA) (Stone 1992; Stone and others 
2004), and the Spectrum™ Method (Muñoz and Civille 1992; Meilgaard and Civille 1999a).  
2.5.6 Qualitative Descriptive Analysis® and the Spectrum Method™ 
Of those descriptive methods previously mentioned, QDA® and the Spectrum™ Method 
are two of the most commonly used descriptive analysis techniques. Both of these methods were 
developed independently and differ in their ideology, methods of training, rating, and data 
analysis but also share some similarities. A brief summary of these two methods addressing the 
points below can be found at the conclusion of this chapter. 
QDA® uses highly trained panelists that are: users and regular consumers of aproduct, 
have basic discrimination ability, adequate performance in basic discrimination tasks, verbal 
ability, and availability (Stone 1992; Stone and others 2012b). Using 10-12 judges, these 
participants evaluate all sensory aspects of a product using non-technical, everyday language 
through reference and language development by group consensus (Lawless and Heymann 1999c; 
Murray and others 2001). QDA® panelists are trained for roughly four to eight sessions by a 
panel facilitator who does not participate in the panel. Generally, many sensory descriptors 
(>100) categorizing the products will be initially produced (Stone and others 2012b). Later in 
training, panelists will develop a more succinct list of terms, references, and definitions of those 
62 
 
references characterizing the products. The scale used in QDA® uses a horizontal, un-numbered, 
anchored scale where panelists indicate the perception of the sensory descriptor on using a 
vertical line (Stone 1992). Panelists are never communicated the values on the scale or 
associated with references. What instead is important, is the relative distance between the 
products being evaluated. This is due to the assumption that subjects utilize different areas of the 
scale (Lawless and Heymann 1999c) and that numbered values may create panel bias. 
Measurements are often repeated several times in QDA® to reduce variability and increase the 
reliability of the results (Stone and others 2012b). 
The Spectrum™ method also uses highly trained panelists that are extensively screened 
for basic taste acuity, rating ability, interest, availability, positive attitude, health, and abstract 
reasoning capacity. They are also screened for taste, odor, texture, appearance, and detection 
acuity (Muñoz and Civille 1992). Spectrum™ panels contain normally 15 panelists that evaluate 
all sensory aspects of a product using a standard lexicon of terms (Muñoz and Civille 1992; 
Meilgaard and Civille 1999a). Panelists are trained for months (~100 hours) and led by a panel 
leader who is much more directive than the QDA® method (Muñoz and Civille 1992; Lawless 
and Heymann 1999c; Stone and others 2012b). Initial panel training includes an orientation to 
the method anddiscussion of sensory properties and demonstrations to familiarize the panels with 
the product category. Training continues to generate lists of sensory descriptors that describe the 
food products. These descriptors are then related to pre-developed references and intensities that 
represent the product category (Muñoz and Civille 1992; Meilgaard and Civille 1999a; Murray 
and others 2001; Drake and others 2001). References include a variety of food products (raw 
ingredients, finished products, varied preparation methods) with given intensities that cover the 
attribute intensity range for most products. Panelists then undergo extensive practice sessions 
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before rating of the actual products begins (Muñoz and Civille 1992). The scale used in the 
Spectrum™ method is a 15 cm, labeled (0-15), universal scale (Muñoz and Civille 1992; 
Lawless and Heymann 1999c; Stone and others 2012b). This means that an intensity of one 
attribute is equal to the intensity of another at the same reference value. Unlike QDA®, where 
judges use the scale differently, all judges are trained to use this scale in a uniform manner 
(Lawless and Heymann 1999c; Murray and others 2001). 
 Due to the specific nature and design of these methods, slight modifications to their 
methods make it difficult to claim either method was used in research. Therefore, aside from the 
companies who created them, researchers frequently utilize hybrid versions combining principles 
from one or more of the aforementioned methods (Lawless and Heymann 1999c; Murray and 
others 2001). 
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2.7 Tables and figures  
Figure 2.1: Microencapsulation decision tree based on motivation and desired stability parameter 
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Isolate Sensory Properties
Flavor/ Aroma Masking Discrimination, consumer, or descriptive analysis
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Table 2.1: Summary of QDA® and The Spectrum™ Methods of descriptive analysis 
Characteristics QDA® The Spectrum™ Method 
Basic panelist abilities 
Users, basic discrimination 
ability, task performance, 
verbal ability 
Acuity, rating ability, interest, 
availability, positive attitude, 
health, and abstract reasoning 
capacity, taste, odor, texture, 
appearance, and detection 
acuity 
Number of subjects 10-12 15 
Scale used 
Word anchored (1.5 cm from 
end), unnumbered, 15 cm line 
scale 
End anchored (none and 
extreme), numbered (0, 7.5, 
15) 15 cm universal scale 
Method of reference 
generation 
Generated by participant 
consensus 
References and intensities 
provided for product category 
Training required 10-15 hours Three months (100 hours) 
References used: (Muñoz and Civille 1992; Stone 1992; Meilgaard and others 1999; Lawless and 
Heymann 1999; Murray and others 2001; Stone and others 2004) 
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Chapter 3: Development and Analysis of Microencapsulated Tributyrin 
3.1 Abstract 
 Butyric acid, or butyrate when in the intestine, is an important short-chain fatty acid for 
intestinal health and has been shown to improve certain intestinal disease states. Tributyrin (TB), 
a source of butyric acid, has been proposed as an alternate source of butyric acid for intestinal 
treatment. The focus of this research was to investigate various forms of microencapsulated TB 
and observe their stability and ability to retain TB. The effect of wall material (whey protein 
isolate (WPI) and soy protein isolate (SPI), gamma-cyclodextrin (GCD)), wall additives (inulin 
of varying degrees of polymerization) and encapsulation method (spray drying and cyclodextrin 
complexation) was investigated for the microencapsulation of TB. SPI retained significantly less 
TB compared to WPI (70% vs. 80%, respectively). The inclusion of inulin in the spray dried 
WPI formulation significantly (p<0.001) increased TB retention over formulations without 
inulin. Additionally, inulin use also modified the microstructure of the capsule resulting in a 
smooth, minimally-dented, circular microcapsule. The use of GCD that were spray dried had the 
lowest TB retention of all formulations (61%) which was significantly lower (p<0.0001) than in 
the oven-dried GCD-based microcapsules. The formulations that resulted in maximum retention 
of TB were all spray dried WPI-inulin and GCD and tributyrin oven dried (GCT OD) 
microcapsules, with GCT OD retaining significantly more (p<0.001) TB than WPI-inulin 
formulations. The use of WPI-inulin based spray dried and GCT OD microcapsules are both 
viable formulations to produce microencapsulated TB while minimizing TB loss for functional 
food applications. 
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3.2 Introduction 
Three major short chain fatty acids (SCFA) produced in the human gastrointestinal tract 
are acetate, propionate, and butyrate (Cummings 1981; Wong and others 2006). Butyrate is the 
primary energy source of colonic epithelium despite being produced in the smallest amount 
(Wong and others 2006; Hamer and others 2008; Immerseel and others 2010). Butyrate is 
responsible for various health benefits including the improvement of intestinal structure for 
piglets with short-bowel syndrome (SBS) (Bartholome and others 2004), decreasing the 
proliferation of colon cancer cells in human cell lines (Lupton 2004), decreasing the incidence of 
diarrhea (Berni Canani and others 2004), improvement in inflammatory bowel disease (IBD) 
(Scarpellini and others 2007; Vieira and others 2012), and improving overall small intestinal 
health (Koruda and others 1990; Kotunia and others 1994). Butyrate is associated with 
unpleasant oral qualities (Kotunia and others 1994; Edelman and others 2003; Leonel and 
Alvarez-Leite 2012) and commonly administered using enemas (Wong and others 2006; Leonel 
and Alvarez-Leite 2012). 
 To overcome some of the hurdles associated with butyrate, tributyrin (TB) has been 
proposed as an alternative source of butyrate (Chen and Breitman 1994; Conley and others 1998; 
Egorin and others 1999; Gaschott and others 2001; Edelman and others 2003; Su and others 
2004; Li and others 2009). Tributyrin contains three butyric acids attached to a glycerol 
backbone. Tributyrin has been used in a variety of studies showing its effective and safe nature 
in animals (Egorin and others 1999; Su and others 2004; Piva and others 2008), humans, (Conley 
and others 1998; Edelman and others 2003), and in vitro models (Chen and Breitman 1994; 
Gaschott and others 2001; Li and others 2009). The benefits associated with the aforementioned 
studies show TB is well tolerated and elicits similar beneficial effects compared to butyrate 
(Leonel and Alvarez-Leite 2012). However, TB also is associated with poor oral taste (bitter) and 
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odor qualities (cheesy, vomit) like butyrate and needs to be delivered to the intestinal region to 
confer the most health benefits. 
Microencapsulation may provide a way to reduce the sensory qualities of TB and target 
its intestinal release. Microencapsulation is the physical or chemical process used to surround a 
core material (solid, liquid, or gaseous) in a specified wall or coating (Gibbs and others 1999; 
Champagne and Fustier 2007; Sobel and others 2014). Microencapsulation has been performed 
in the food industry for over 60 years (Desai and Park 2005) and is done for a variety of 
functional purposes including: core protection from environmental stresses or other ingredients 
in a system, improved handling by physical property modification, controlled release, and odor 
and taste masking (Shahidi and Han 1993; Desai and Park 2005; Sobel and others 2014). 
Microencapsulation is accomplished through physical and chemical means including spray 
drying, spray chilling, extrusion, complexation, coacervation, and liposome entrapment (Lee and 
others 2014; Sobel and others 2014).  
The most commonly used method of microencapsulation in the food industry is spray 
drying due to equipment availability, flexibility, and cost effectiveness (Jackson and Lee 1991; 
Shahidi and Han 1993; Walton and Mumford 1999; Gibbs and others 1999; Desai and Park 
2005; Gharsallaoui and others 2007). A variety of wall materials such as gums, carbohydrates, 
proteins, polysaccharides, and cyclodextrins (CD) can be used as wall materials for spray drying 
(Shahidi and Han 1993; Gibbs and others 1999; Szente and Szejtli 2004; Gharsallaoui and others 
2007; Astray and others 2009; Sobel and others 2014). An acceptable wall material exhibits low 
viscosity at high concentration, can disperse or emulsify the encapsulated ingredient, is soluble, 
unreactive with the encapsulated material, inexpensive, and food grade (Shahidi and Han 1993; 
Desai and Park 2005). Commonly investigated materials that exhibit these characteristics include 
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whey proteins, (Young and others 1993a; Young and others 1993b; Sheu and Rosenberg 1995; 
Moreau and Rosenberg 1996; Rosenberg and Sheu 1996; Sheu and Rosenberg 1998; Picot and 
Lacroix 2004; Ying and others 2012), soy proteins, (Kim and others 1996; Charve and 
Reineccius 2009; Molina Ortiz and others 2009; Rascón and others 2011; Tang and Li 2012; 
Nesterenko and others 2013), and CDs (Del Valle 2004; Szente and Szejtli 2004; Szejtli and 
Szente 2005; Ubbink and Krüger 2006; Astray and others 2009; Tamamoto and others 2010).  
Whey proteins, including whey protein isolate (WPI) and concentrate (WPC), have been 
used to encapsulate core materials to provide functional benefits. They possess all of the 
characteristics a good spray dried wall material should as previous mentioned (Shahidi and Han 
1993; Desai and Park 2005). The functionality of WPI during spray drying has been improved 
upon in previous research with the supplementation of lactose (Young and others 1993). In these 
whey-based formulations, lactose may help to limit the movement or loss of volatile aroma 
compounds during spray drying (Young and others 1993).  
Wall additives such as maltodextrin (MD) and inulin have been shown to improve protein 
wall matrices in spray drying (Young and others 1993; Young and others 1993; Sheu and 
Rosenberg 1995; Rosenberg and Sheu 1996; Hogan and others 2001). Those MDs of higher 
dextrose equivalence (DE) create protein microcapsules with less surface cracks, smoother 
surfaces, and improved microencapsulation efficiency (retention) (Sheu and Rosenberg 1995; 
Sheu and Rosenberg 1998; Gharsallaoui and others 2012). Inulin, like MD, may be able to 
modify the structure of microencapsulated wall materials as well. The effect of the degree of 
polymerization (DP) of inulin on the viability of probiotics in reconstituted skim milk (RSM) 
wall systems has been explored (Corcoran and others 2004; Fritzen-Freire and others 2012; 
Fritzen-Freire and others 2013). The results of these experiments are not in complete agreement. 
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Corcoran and others (2004) observed no significant effect on viability enhancement, while 
Fritzen-Freire and others (2013) observed improved initial probiotic survival (Fritzen-Freire and 
others 2012) and gastrointestinal survival (Fritzen-Freire and others 2013) of RSM and inulin 
combinations using higher DP. Comparison of these studies becomes difficult due to the 
differences in methodologies.  
A core carrier often is included in WPI-based wall material in order to house 
encapsulated, lipophilic ingredients. These core carriers include anhydrous milk fat (AMF), 
(Young and others 1993; Young and others 1993; Picot and Lacroix 2003; Picot and Lacroix 
2004) and other lipids of various melting points (Fäldt and others 1993; Fäldt and Bergenståhl 
1995; Hogan and others 2001; Charve and Reineccius 2009; Gharsallaoui and others 2012). 
Using core carriers that are susceptible to oxidation can lead to unwanted sensory qualities 
developing or core degradation (Teixeira and others 1996). Encapsulation with whey proteins 
has been able to limit the oxidation of core materials by providing a physical barrier to oxygen 
(Moreau and Rosenberg 1996). Additional oxidation of spray dried microcapsules can occur if 
cracks, folds, dents, or high surface oil exits on the microcapsule (Sankarikutty and others 1988; 
Young and others 1993; Kim and others 2002; Picot and Lacroix 2003; Turchiuli and others 
2005; Kim and others 2005; GEA Niro 2005; Gharsallaoui and others 2012). Core carriers are 
not required for all microencapsulated systems, but may be beneficial if a hydrophilic core is 
being encapsulated. 
As wall materials, CDs are cyclic structures containing repeating glucopyranose units 
connected by α-(1, 4) linkages. They are approved for food use in food (Del Valle 2004). CDs 
are commonly found in 6 (α-CD), 7 (β-CD), and 8 (γ-CD) repeating units. CDs possess a 
hydrophilic outside and an inner hydrophobic cavity. Complexations are formed when 
89 
 
compounds of interest enter the center of the CD, displacing water in an energetically favorable 
reaction (Astray and others 2009). Compounds best fit in CDs according to their size and 
structure. The α-CD molecule has internal diameter of 4.7-5.3 Å, and typically complexes with 
small, low molecular weight compounds such as fatty acids and triglycerides (Szente and others 
1993; Del Valle 2004). The β-CD molecule has an internal diameter of 6.0-6.5 Å, and typically 
complexes with mid-sized, aromatic compounds (Reineccius and others 2002; Tamamoto and 
others 2010). With an internal diameter of 7.5-8.0 Å, γ-CDs (GCD) can complex with multiple 
small or single large compounds like steroids (Del Valle 2004). Cyclodextrin complexation can 
be achieved through a variety of methods (Del Valle 2004; Szente and Szejtli, 2004) and has 
been used in the literature to encapsulate flavors (Reineccius 1985) and reduce the bitterness of 
functional compounds in foods (Tamamoto 2010). 
 The specific aim of this research was to identifiy the effects of wall material, processing 
method, and wall additives on the retention and morphology of TB microcapsules. When 
investigating this specific aim, several working hypotheses were proposed. In relation to wall 
material, it was hypothesized that WPI-based microcapsules, due to their primary protein 
fractions, would improve retention of TB compared with soy protein isolate (SPI)-based wall 
materials. In relation to wall additives, inulin molecules of longer chain length would increase 
wall plasticity during drying, which would result in a smoother microcapsule surface and 
improved TB retention as compared to shorter chain length inulin. Gamma-cyclodextrin, due to 
its ability to chemically complex with TB, would have improved retention of TB over physical 
interactions in protein-based microcapsules. Regarding processing method, it was hypothesized 
that oven-dried GCD, due to mild heat exposure, would result in higher TB retention over spray-
dried GCD processed with higher temperatures.  
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3.3 Materials and methods 
 3.3.1 Materials 
Five different microcapsules containing TB (tributyin, 97% FG, Sigma-Aldrich Co. LLC, 
St. Louis, MO) were produced using varying combinations of WPI (Hilmar 9400, Hilmar 
Ingredients, Hilmar, CA), SPI (Profam 974, Archer Daniels Midland Company, Decatur, IL), 
anhydrous milk fat (AMF) (Anhydrous Butter Oil, Dairy Farmers of America, Kansas City, MO, 
USA), inulin ([CLR (short (S), 7-9 monomers), IQ (medium (M), 8-13 monomers), TEX! (long 
(L), ≥22 monomers)], Sensus America, Inc., Lawrenceville, NJ), and GCD (CAVAMAX W8 
Food, Wacker Chemie AG, München, Germany) to create the following microcapsule 
formulations: WPI, AMF, with TB (WAT) and without (WA); SPI, AMF, with TB (SAT) and 
without TB (SA); WPI, AMF, and TB with short (WAST), medium (WAMT), or long (WALT) 
chain inulin; GCD and TB spray dried (GCT SD) or oven dried (GCT OD). All formulations 
were produced at least two times. Complete formulation information is included in Table 3.1. 
3.3.2 Methods 
3.3.2.1 Experimental design 
The experimental design of microcapsule development was initially a full factorial design 
(3 x 3 x 2), with the possibility of producing all combinations of tributyrin microcapsules using 
wall materials (factor 1, 3 treatments), wall addititives (factor 2, 3 treatments), and processing 
methods (factor 2, 2 treatments); however, experimental findings resulted in the elimination of 
certain combinations to simplify the experimental design. In terms of processing, all WPI and 
SPI-based microcapsules were not oven dried due to their high moisture content. The GCD-
based microcapsules were either spray or oven dried using an identical formulation. In regards to 
wall material, WPI and SPI-based microcapsules were produced; however, due to the improved 
sensory qualities and ability of WPI-based microcapsules to retain significantly more tributyrin 
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over SPI-based microcapsules, all SPI-based microcapsules were no longer investigated. 
Combinations of WPI and GCD were produced, however, these two wall materials were not 
soluble within one another as shown by ESEM images. This produced a non-homogenous 
mixture of different microcapsules and was no longer investigated. All combinations of WPI and 
inulin chain lengths were produced via spray drying. All microcapsule formulations were 
produced in duplicate. 
3.3.2.2 Protein-based microcapsule preparation 
WPI or SPI was first mixed in distilled water and agitated for 60 minutes using an 
overhead shear mixer (Heidolph RZR 1, Heidolph Instruments GmbH & Co.KG, Schwabach, 
Germany) between 500 and 1,000 RPM. The solution then was hydrated for 30 minutes at room 
temperature. The solution was heated to 80°C for 30 minutes at 100 RPM using a shaking water 
bath (C76 Water Bath Shaker, New Brunswick Scientific, Enfield, CT). The solution was cooled 
down and stored at refrigeration temperature (4°C) for a minimum of 12 hours. The refrigerated 
solution was brought then to room temperature. Anhydrous milk fat was melted at 55°C, and TB 
was added over the course of three minutes using the same high shear mixer at 3,400 RPM. The 
AMF-TB mixture was then incorporated into the WPI, WPI-inulin, or SPI-based mixture over a 
three minute interval at 14,800 RPM. This coarse emulsion then was processed using a two-stage 
pressure homogenizer (SPX Flow Technology, Denmark) (7 MPa first stage and 55 MPa second 
stage) for two passes. If necessary, before spray drying, the emulsion was diluted in order to 
produce a liquid that could be pumped (~20% solids). 
3.3.2.3 Protein and inulin based microcapsule preparation 
 Water was heated using a stir plate to reach 80°C. Upon reaching this temperature, inulin 
was included over a 3 minute interval to ensure complete dissolution. Upon dissolving, the inulin 
solution was covered and stored in a refrigerator (4°C) until the temperature of the solution 
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reached 25°C. Upon reaching 25°C, the procedure for protein-based microcapsule preparation 
described in 3.3.2.1 was followed. 
3.3.2.4 GCD-based microcapsule preparation 
 Gamma-cyclodextrin was mixed in distilled water at a 50% solids content using a high-
shear mixer (IKA T25 Digital Ultra-Turrax, IKA Works, Inc., Wilmington, NC) for one minute 
at 8,000 RPM. Tributyrin was added at a molar excess of 3:1 to TB and mixed for 20 minutes at 
8,000 RPM. The GCD-TB mixture was allowed to sit at room temperature for a total of 26 hours. 
Six hours into this process, the mixture was agitated briefly to re-suspend the two-phase mixture 
(precipitated GCD and water/TB layer). After this brief mixing, the solution was not agitated 
until the end of the total 26 hours. 
3.3.2.5 Spray drying conditions for protein, protein-inulin, and GCD-based microcapsules 
For the microcapsules that were spray dried (Buchi Mini Spray Dryer B-290, BÜCHI 
Labortechnik AG, Flawil, Switzerland), the following variables were consistently maintained: 
inlet temperature: 160 °C; outlet temperature: 90 °C; compressed air pressure: 80 psi; Q-Flow: 
35. Feed pump rate was adjusted in order to maintain the outlet temperature and varied 
depending on the particular samples viscosity. Solids content was adjusted for WPI-inulin 
formulations and verified using a microwave solid/moisture analyzer (CEM MDS-2000 
Microwave Digestor Oven, CEM Co., Matthews, NC). The temperature of the feed was 
maintained around 40°C (±5°C) using a water bath. Dried samples were stored in tightly sealed 
glass jars in a cool, dark place. All WPI and WPI-inulin based microcapsules had their storage 
jars covered by aluminum foil in order to protect the powder from potential oxidation due to the 
presence of AMF. 
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3.3.2.6 Oven drying conditions for GCD-based microcapsules 
After 26 hours, the two-phase mixture of precipitated GCD and water had 5 mL of water 
pipetted from the top to facilitate drying. This remaining precipitate and water was then 
centrifuged (IEC HN-SII Centrifuge, International Equipment Company, Chattanooga, TN) for 
15 minutes at 2,138 x g (3,000 RPM) to remove the remaining water. After centrifugation, the 
liquid phase was decanted and the solid sediment was spread thinly (≤ 2 mm) onto a glass 
surface. This was then placed into an oven (Isotemp Incubator, Thermo Fischer Scientific, Inc., 
Waltham, MA) at 46°C and allowed to dry for 3.5 hours. The dried paste was scraped off from 
the glass surface and ground into a fine powder using a mortar and pestle. Moisture content of 
the ground powder was measured using a moisture content analyzer (HR83 Halogen Moisture 
Analyzer, Mettler-Toledo, LLC, Columbus, OH). Drying was complete when the powder 
reached a moisture content of 8-10%. If the ground powder did not fall within the moisture 
content specification, it was spread evenly as a powder onto a glass surface and placed back into 
the oven at 46°C for 30 minute time intervals until the targeted moisture content was reached. 
Dried samples were stored in tightly sealed, aluminum wrapped, glass jars in dark cabinet at 
room temperature (25°C). 
3.3.2.7 Tributyrin quantification for protein and protein-inulin based microcapsules 
 In order to determine the amount of TB retained in the given formulation gas 
chromatography mass spectrometry (GC-MS) and gas chromatography equipped with a flame 
ionization detector (GC-FID) were utilized. For all quantification methods, the internal standard 
used was tripropionin (Sigma-Aldrich Co. LLC, St. Louis, MO).  
The GC-MS system used was Hewlett-Packard 6890 gas chromatograph (Agilent 
Technologies, Inc., Santa Clara, CA, USA) equipped with a DB-5ms, fused-silica capillary 
column (30m x 0.25mm x 0.25µm) using splitless injection mode with a sampling time of one 
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minute and the injection port set to 250°C. The carrier gas used was helium, and the flow rate 
was 1.0 mL/min. The oven temperature was kept at 60°C for 3 min and then increased at 
60°C/min to 120°C, which was held for 3 minutes. Then the oven temperature was increased at 
80°C/min to 200°C for 7 minutes. Finally, the oven was held at 250°C for 2 minutes to 
regenerate the column for the next sample. The compounds present in the sample were identified 
using a HP 5973N mass selective detector (Agilent Technologies, Inc., Santa Clara, CA, USA). 
Using standards containing TB and tripropionin in hexane: isopropanol (3:2) mixtures, the MS 
was able to successfully identify the peaks of both TB and tripriopionin so that their relative 
distance and elution order could be used for later identification on GC not containing the MS 
function. Standard calibration curves consisting of TB and tripriopionin in varying ratios 
(dissolved in hexane: isopropanol, in a 3:2 ratio) were constructed to obtain response factors for 
quantification. 
The GC-FID used was a Hewlett-Packard 6890 gas chromatograph (Agilent 
Technologies, Inc., Santa Clara, CA, USA) equipped with a flame ionization detector (FID) and 
a HP-1 Crosslinked Methyl Siloxane column (30m x 0.32mm x 0.25µm, HP 19091Z-413, 
Agilent Technologies, Santa Clara, CA) with a Restek polar deactivated guard column (1m x 
0.35mm ID, Restek Corporation, Bellefonte, PA) using splitless injection mode with a sampling 
time of 1 minute and the injection port set to 300°C. The carrier gas used was helium at 7.5 PSI, 
with a calculated flow rate of 0.65 mL/min, μ= 22.3 cm/sec, under constant pressure. The oven 
temperature was kept at 125°C for 5 min and then increased at 10°C/min to 325°C, where it was 
held at 320°C for 20 minutes to regenerate the column for the next sample. Standard calibration 
curves consisting of TB and tripropionin in varying ratios in the solvent used were constructed to 
calculate response factors used in quantification. 
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In order to prepare protein-based microcapsules for analysis by GC-MS or GC-FID, one 
gram samples were dissolved into one mL of water, vortexed, and a known quantity of the 
internal standard was added. A solvent consisting of hexane and isopropanol (in a 3:2 ratio, 
respectively) was added to the mixture and briefly vortexed. This entire solution was sonicated 
(Digital Ultrasonic Processor Cell Disruptors, Thomas Scientific, Swedesboro, NJ) for 30 
seconds at 50% power. The sonicated sample was then vortexed and centrifuged (IEC HN-SII 
Centrifuge, International Equipment Company, Chattanooga, TN) for 15 minutes at 2,138 x g. 
The two-phase supernatant then had the hexane layer removed by pipette and transferred into 
another vial where it was dried (granular sodium sulfate, Thermo Fischer Scientific Inc, 
Waltham, MA) prior to injection into the GC-FID. 
3.3.2.8 Tributyrin quantification for GCD-based microcapsules 
 The GC-FID program utilized for quantification of GCT OD and GCT SD was identical 
to that of the method in 3.3.2.6. Standard calibration curves consisting of TB and tripropionin in 
varying ratios dissolved in (N,N-Dimethylformamide, (DMF) [Sigma-Aldrich Co. LLC., St. 
Louis, MO]) was constructed to obtain a calibration curve and response factors. 
In order to prepare GCD-based microcapsules for analysis by GC-FID, one gram of 
sample was placed into a glass centrifuge tube along with the appropriate amount of internal 
standard (tripropionin). Immediately following, 5 mL of DMF was added and vortexed until the 
GCD-complex dissolved. This tube was then sonicated (Digital Ultrasonic Processor Cell 
Disruptors, Thomas Scientific, Swedesboro, NJ, USA) for 30 seconds at 50% power before 
being heated for 20 minutes at 85°C to facilitate the release of the TB from the complex. The 
sample was then cooled to room temperature and allowed to rest for several hours before 
injection.  
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 In order to ensure the above extraction method completely released all available TB, 
standard addition analysis was completed. For this, GCT OD or GCT SD was extracted as 
previously mentioned, and solutions were divided into four equal volumes spiked with a TB 
solution of known quantity (0.150 g/ of TB/ mL) at 0 µL, 10 µL, 20 µL, and 30 µL 
concentrations. Samples were then injected into the GC-FID using the time/temperature program 
listed in 3.3.2.6. 
3.3.2.9 Tributyrin quantification and retention calculations 
 In order to identify the relative positioning and elution times of both TB and tripropionin, 
GC-MS measurements indicated that tripropionin shows a distinct signal before TB consistently. 
These were the only two compounds with strong signals in the GC-MS and GC-FID 
chromatograms after extraction and injection. Upon injecting standard curve solutions, the 
presence of tripropionin and TB was consistent with that of the presence of these peaks in the 
sample for both GC-MS and GC-FID injections.  
The average estimated TB, as measured by the GC-FID, content per milligram was 
calculated using peak areas of both TB, the internal standard, a response factor (determined 
through calibration) with the following equation: 
𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝑇𝑇𝑇𝑇𝐸𝐸𝑇𝑇𝑇𝑇𝐸𝐸𝑇𝑇𝑇𝑇𝐸𝐸𝑇𝑇 = 𝑅𝑅𝐸𝐸𝐸𝐸𝑅𝑅𝑅𝑅𝑇𝑇𝐸𝐸𝐸𝐸 𝐹𝐹𝐸𝐸𝐹𝐹𝐸𝐸𝑅𝑅𝑇𝑇 ∗ 𝐴𝐴𝑇𝑇𝐸𝐸𝐸𝐸 𝑅𝑅𝑜𝑜 𝑇𝑇𝑇𝑇𝐸𝐸𝑇𝑇𝑇𝑇𝐸𝐸𝑇𝑇𝑇𝑇𝐸𝐸𝑇𝑇
𝐴𝐴𝑇𝑇𝐸𝐸𝐸𝐸 𝑅𝑅𝑜𝑜 𝑇𝑇𝑇𝑇𝐸𝐸𝑅𝑅𝑇𝑇𝑅𝑅𝑅𝑅𝐸𝐸𝑅𝑅𝑇𝑇𝐸𝐸𝑇𝑇 ∗ 𝐸𝐸𝐸𝐸𝐸𝐸𝑅𝑅𝑠𝑠𝐸𝐸 𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 
Average retention refers to the total amount of TB present in a microcapsule relative to 
the amount of TB included in the original preparation calculated as a percentage. 
3.3.2.10 Additional properties of microcapsules 
Morphological structure was examined by coating a small amount of sample in gold-
palladium alloy (Denton Desk-1 TSC, Denton Vacuum, LLC., Moorestown, NJ) at 40 mA for 70 
seconds at 6.67 Pa on double sided black tape. These coated samples were placed into the 
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Environmental Scanning Electron Microscope (ESEM) (FEI XL30 ESEM-FEG, FEI Company, 
Hillsboro, OR) to obtain images of the microcapsules. While an ESEM was used, images were 
collected using the equipment as an SEM. Water activity (Aqualab Dew Point Water Activity 
Meter 4TE, Decagon Devices Inc., Pullman, WA) and moisture content (HR83 Halogen 
Moisture Analyzer, Mettler-Toledo, LLC, Columbus, OH) were also measured. 
3.3.3 Statistical analysis 
All statistical analyses were conducted using Statistical Analysis Software (SAS) ® 
Enterprise Guide® (Version 4.3, SAS Institute Inc., Cary, NC) to determine if significant 
(α<0.05) differences existed between microcapsule retention values using the analysis of 
variance (ANOVA) PROC ANOVA function. If significant differences were present, the least 
significant difference (LSD) test was conducted to determine specific differences amoung the 
samples. 
 3.3.4. Rheological behavior of emulsions 
WPI based emulsions were evaluated for their rheological properties using a rheometer 
(RFS III, Rheometric Scientific, Piscataway, NJ, USA). A 50 mm parallel plate was used. Shear 
rate and shear stress were plotted of the homogenized and diluted liquids at 50°C at the shear rate 
range of 0.5-50 1/sec with 1.0 mm gap. Data was collected (TA Orchestrator V 7.2.0.4, TA 
Instruments, Waters LLC, New Castle, DE, USA) and fit to the Power Law model producing K 
(flow consistency index, Pa∙sn) and n (flow behavior index) along with correlation values for the 
model. Additionally, G’ (storage modulus) and G’’ (loss modulus) were collected on emulsions 
before homogenization, after homogenization, and after dilution (where applicable) to 
characterize the rheological properties of the liquid as a function of temperature using a dynamic 
step test sequence. A 50 mm parallel plate was used at a frequency of 6.28 rad/sec, a strain 3%, 
and a gap set at 1.0 mm between the plates. This sequence exposed the emulsion to temperatures 
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ranging from 25°C up to 51°C in 2°C intervals every two minutes. The samples were then run 
from 51°C down to 25°C to monitor if changes in structure were permanent. All samples were 
covered with a plastic encasement and edges with light mineral oil (light mineral oil, Fisher 
Scientific, Waltham, MA, USA) to minimize drying during the measurements. 
3.3.4.1 Statistical analysis 
All statistical analyses were conducted using SAS ® Enterprise Guide® (Version 4.3, 
SAS Institute Inc., Cary, NC) to determine if significant (α<0.05) differences existed between K 
(flow consistancy index) values, the analysis of variance (ANOVA) PROC ANOVA function 
was utilized. If overall significant differences were present between samples, the LSD test was 
conducted to determine which samples were significantly different. 
 
 
3.4 Results and discussion 
The general recommendation for moisture content and water activity ranges for dried 
particles, including microcapsules, to achieve optimum stability is at or below 6% or 0.3, 
respectively (Reineccius 2004; Reid and Fennema 2008). All spray dried microcapsules met 
these water activity recommendations (Table 3.3). The GCT OD microcapsule met the 
recommended water activity (0.155 ± 0.014) but reached an average moisture content of 8.59 ± 
0.26 that was slightly higher than the recommendation. This was most likely due to the high 
moisture content (~11%) of native GCD. The amount of native TB both in WA and SA samples, 
6.84e-4 mg/mg of sample and 5.97e-4 mg/mg sample respectively, was considered negligible in 
the overall calculation of the sample retention values. These values and the average estimated TB 
content, are presented in Table 3.2. The addition of TB did not impact the WPI-based 
microstructure as shown by the similarity between WA (Figure 3.1) and WAT (Figure 3.2). The 
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WPI-based microcapsules exhibited a round structure with a large central indentation, deep folds, 
and variable particle size. 
Retention values as measured by GC-FID indicated that wall materials, additives, and 
processing conditions all play an important role in the retention of TB. It was noted that GCT SD 
statistically had the lowest retention of TB at 61.92% and was significantly different (p<0.001) 
from all samples including the GCT OD which had the highest (95.29%) retention value. When 
the retention values of WAT and SAT microcapsules were compared, it was determined that 
WAT had a significantly higher retention (p<0.001) than SAT (80.48% vs 69.16%, respectively). 
The higher TB retention WAT may be related to the superior ability of β-lactoglobulin (the 
primary protein constituent of WPI) to form strong emulsions and hydrophobic interactions with 
hydrophobic components such as flavor molecules and lipids (Brown 1984; Charve and 
Reineccius 2009). Due to the hydrophobic nature of protein-flavor interactions, increased chain 
length of flavor compounds has shown to increase their association with β-lactoglobulin (O'Neill 
and Kinsella 1987; Guichard and Langourieux 2000; Jouenne and Crouzet 2000; Reiners and 
others 2000; Andriot and others 2000; Guth and Fritzler 2004). Heating WPI can increase the 
exposure of hydrophobic residues that may facilitate these protein-flavor interaction. Previous 
research has also observed β-lactoglobulin’s ability to prevent the migration of flavor compounds 
from lipid to water phases (Guichard and Langourieux 2000). The protein fraction β-
lactoglobulin is also able to bind readily with triglycerides and fatty acids through nonpolar 
interactions (Brown 1984). The ability of β-lactoglobulin to bind with triglycerides and its 
prevention of flavor migration from lipid phases, may decrease the volatility of TB in the spray 
dried system. This may explain the significant increase in retention seen only in the WPI-based 
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samples. Because of the low retention of SPI-based microcapsules, these formulations were not 
investigated any further (no inulin inclusion or ESEM morphological observations). 
The addition of inulin at all chain lengths in WPI based microcapsules (WAST, WAMT, 
WALT) resulted in a significant increase (p<0.001) in TB retention as compared to the WPI-
based microcapsules without inulin. There was, however, no significant difference (p>0.05) in 
retention between short, medium and long chain fractions. Similar results have been observed in 
previous research looking at the retentive qualities of WPI and maltodextrin (MD) matrices 
where there was no significant difference in the retention of a flavor compound between MD of 
varied dextrose equivalents (DE) (10, 15, and 24) (Sheu and Rosenberg 1995). This lack of 
significant difference in retention upon the addition of increasing DE in MD aligns similarly with 
the findings of the different inulin chain lengths in this research. These two compounds, although 
different, may be interacting with WPI in a similar manner in order to confer their retention 
benefits. 
Additionally, the morphological modifications MD afforded on WPI-based 
microcapsules in previous research (Sheu and Rosenberg 1995; Sheu and Rosenberg 1998) also 
aligns with the behavior of WPI-inulin microcapsules in this research; less surface cracks, 
smoother surfaces, and significantly improved retention was observed through the use of inulin 
as shown in Figures 3.3-3.5 and Table 3.2. The addition of inulin caused the elimination of the 
large central indication and deep surface folds characteristic of the WA and WAT microcapsules 
(Figures 3.1 and 3.2). However, this modification was independent of DP or chain length; 
changes in microcapsule structure were apparent and similar across all inulin ranges. A similar 
result was seen in previous literature with no significant changes in morphological structure 
using MD with higher dextrose equivalents (DE) as compared to lower dextrose equivalents 
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(Sheu and Rosenberg 1998). The presence of inulin or MD affects the morphological structure of 
microcapsules, but, DE for MD or DP for inulin do not impact the WPI-based wall morphology 
differently. Inulin in reconstituted skim milk, however, does not impose the same morphological 
characteristics MD or inulin has on WPI-based microcapsules (Fritzen-Freire and others 2012). 
Therefore, interaction that inulin and MD have on the structure of spray dried microcapsules are 
wall material dependent. This is due to the structural interactions required between MD, inulin, 
and the wall matrix. These similarities suggest that inulin and MD in WPI-based microcapsules 
play a similar role in the retention of volatiles and morphological structure. 
Inulin is an excellent protein stabilizer due to its high glass transition temperature, 
hydrophilicity, and good hydrogen binding capacity. It is believed that partial denaturation 
during WPI-based microcapsule preparation led to the exposure of internal hydrophilic regions 
of the protein. This allowed for hydrogen bonding to occur between WPI and inulin (Glibowski 
and Glibowska 2009). The work of Hinrichs and others (2001) and Grassmeijer and others 
(2013) thoroughly described the role that carbohydrates play in the stabilization of proteins 
(Hinrichs and others 2001; Grasmeijer and others 2013). The water replacement theory states 
that carbohydrates replace water during protein drying. This aids in the maintenance of protein 
and glassy structure. This glassy structure limits molecular movement, and thus, the loss of small 
molecules such as TB during drying. This may partially explain the increase in TB retention seen 
in inulin-WPI microcapsules. 
In addition to the creation of a glassy matrix, inulin bonding interactions also imposed 
morphological changes in surface microcapsule structure as observed by SEM. During drying, 
expansion and contraction occurs in a smooth manner occurs when wall materials have increased 
flexibility (Sheu and Rosenberg 1998). Inulin can afford a wall matrix this flexibility through the 
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hydrogen bonding interactions (Glibowski and Glibowska 2009). The smoothed wall structure, 
void of cracks and deep indentations, exhibited in WPI-based microcapsules with inulin may 
partially explain the superior TB retentive qualities of this microcapsule. 
Researchers have observed that the rheological and viscoelastic properties of spray dried 
materials may influence their expansion and contraction during drying (Sheu and Rosenberg 
1998). Inulin, as a functional ingredient, is often used for its gelling and thickening properties 
(Franck 2002). These properties were experimentally observed by the values K, or consistency 
index (closely related to the viscosity or thickness of a sample) and G’ dominance exhibited by 
the spray dried WPI-slurries (Table 3.4). Rheological results shown in Table 3.4 revealed that the 
emulsions typically exhibit an n<1 (except for WA, n=0.966) indicating the emulsions exhibit 
non-Newtonian, shear thinning fluid behavior. Despite similar solids levels, homogenized 
samples containing TB and inulin possessed more shear-thinning behavior than samples without 
inulin. Samples containing inulin displayed significantly (p<0.001) higher K values than those 
not containing inulin. 
The presence of inulin, however, may not be the only factor leading to the increased 
viscosity of these samples. Samples that possess G’ dominance were characterized by solid-like 
properties. Samples with G’’ dominance were characterized as possessing liquid-like properties. 
The change of G’ and G’’ dominance was a function of temperature for WPI-based samples as 
shown in Figures 3.10 and 3.11. Before homogenization (Figures 3.9A, 3.9B, 3.9C, 3.9D, 3.9E), 
WPI-based slurries were liquid dominant (G’’>G’). These samples, however, became solid 
dominant (G’>G’’) during the temperature increase (25-50°C) program. The temperature where 
this transition occurs is shown in Table 3.4. After homogenization (Figures 3.9A’, 3.9B’, 3.9C’, 
3.9D’, and 3.9E’) the same samples, independent of temperature program, were G’ dominant. 
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The influence of temperature on the G’ and G’’ dominance of WPI-based samples was apparent 
during the temperature decrease program (51-25°C). In Figures 3.10A-E and 3.10A’-E’, G’ 
dominance was consistent throughout the entire temperature decrease program regardless of 
homogenization status. This indicates that after samples were subjected to the first temperature 
increase program, they were irreversibly converted to G’ dominance. This G’ dominant behavior 
was similar to that of the homogenized samples. The homogenization pressure and shear, 
coupled with the viscous samples, may have led to an increased temperature exposure for these 
homogenized samples. This resulted in G’ dominant homogenized samples. Therefore, the 
presence of inulin, and the homogenization of the sample, both contribute to the altered structure 
and state of the spray dried liquid. This altered state may represent an optimal formulation and 
rheological profile for the spray drying of TB or other volatile compounds using WPI and WPI-
inulin wall materials. 
Microcapsules that were GCD-based behaved differently when the same formulation was 
spray or oven dried. The retention of TB was the highest (95.29%) in the GCT OD microcapsule 
and significantly different (p<0.001) from all other WPI-based microcapsules (Table 3.2). 
Contrary to GCT OD, the statistically lowest retention of TB was observed in GCT SD 
(61.92%). Both GCT OD and GCT SD were identical in formulation (50% solids, 3:1, GCD: TB 
ratio) and only differed in their drying method. Additionally, the morphological structure was 
visually altered as shown by differences in native GCD (Figure 3.6), GCT OD (Figure 3.7) and 
GCT SD (Figure 3.8). These changes in morphological structure, however, may not be directly 
related to microcapsule retention as they were in WPI-based samples. Instead, the heat exposure 
during spray drying may have had the most significant effect on the retention of TB in GCT SD. 
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The CD complex can be enhanced or disturbed by certain environmental conditions 
including heat. Literature has noted that CD complexes can begin to decompose at temperatures 
ranging from 50-60°C (Del Valle 2004). Analysis techniques that require the release compounds 
within CD complexes (like GC-FID or GC-MS methods) for quantification often include the 
heating of complexes due to the sensitivity of complexes to elevated temperatures (~80°C) 
(Bhandari and others 1998; Reineccius and others 2002; Reineccius and others 2004; Hădărugă 
and others 2006; Kawakami and others 2009). Spray dried slurries can be exposed to high 
temperatures when their solids content is too high. While a high solids content can be beneficial 
for the retention of some spray dried volatile compounds (Judson King 1995; Rosenberg and 
Sheu 1996; Charve and Reineccius 2009), solids content that is too high can lead to ineffective 
atomization and delayed particle formation within the spray dryer (Reineccius 2004). This 
delayed particle formation can increase the exposure time of the particle to high inlet 
temperatures. The exposure to high heat within the spray dryer may have been enough to disturb 
the GCD complex, releasing TB from the GCT SD microcapsule leading to TB losses. 
The optimum solids content for each core compound that is spray dried may vary 
considerably (Reineccius and Bangs 1985; Reineccius 2004) and is largely dependent on the 
solubility of the compound and the rheological properties of the infeed material (Reineccius 
2004). Literature investigating the spray drying of a variety of volatile compounds at higher 
outlet temperatures (100°C) than this research has observed higher retention values (70-74%) 
using GCD’s at solids contents of 40% (Reineccius and others 2002). It then becomes evident 
that the optimal drying conditions, wall materials, solids content, and viscosity are very specific 
to each volatile compound and encapsulated system. The formulation of the GCT complex (50% 
solids, 3:1, CD: TB ratio) is suitable for encapsulating TB due to the high retention seen in GCT 
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OD. Therefore, the inability of TB to be retained within GCT SD during spray drying may be 
attributed more to the spray drying parameters and formulation rather than the CD ability to 
retain TB. Further investigation into the optimization of this formulation may improve retentive 
results. 
 
 
3.5 Conclusions 
Microcapsule composition and processing method have a significant role in the retention 
and morphological structure of microencapsulated TB. The optimal wall material and processing 
combinations for TB included spray dried WPI-inulin and oven dried GCD-based microcapsules. 
The use of inulin with varying DP was able to successfully modify the microcapsule structure 
and improved the retention of the TB in a similar manner. This improvement in wall structure 
may be attributed to the rheological and viscoelastic changes afforded by processing conditions 
and the molecular associations between inulin and WPI. The ability of GCD to retain TB was 
dependent on the processing technique utilized. When spray dried, GCT SD exhibited the lowest 
retention of TB while GCT OD retained the highest amount of TB. The success of GCT OD 
indicates a possible area of further exploration to elucidate optimized formulation and processing 
conditions to spray dry this complex.  
Microencapsulated TB, a potentially beneficial bioactive component for intestinal health, 
would allow for the easier administration and incorporation of this hydrophobic bioactive 
compound in a variety of food matrices. However, in order to be successful in foods, must 
possess improved sensory qualities and achieve targeted intestinal delivery. Investigation into the 
sensory impact these microcapsules have in food products is necessary. Differences in 
morphological structure and retention may play a role in the sensory perception of these 
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particles. In particular the difference in the crystalline morphology of GCT OD (Figure 3.7) and 
the more amorphous GCT SD (Figure 3.8) may reveal even more differences in the behavior of 
these two formulations aside from retention. 
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3.7 Tables and figures 
Table 3.1: Experimental formulations for the production of microencapsulated tributyrin 
 WA SA WAT SAT WAST WAMT WALT GCT†† 
Deionized Water 84 84 81 81 72 72 72 50 
Protein source 8 8 8 8 8 8 8 0 
Anhydrous milk 
fat 
8 8 8 8 8 8 8 0 
Inulin 0 0 0 0 8 8 8 0 
Gamma-
cyclodextrin 
0 0 0 0 0 0 0 47 
Tributyrin 0 0 3 3 4† 4† 4† 3 
WA: whey protein isolate, anhydrous milk fat; SA: soy protein isolate, anhydrous milk fat; WAT: whey protein isolate, 
anhydrous milk fat, tributyrin; SAT: soy protein isolate, anhydrous milk fat, tributyrin; WAST: whey protein isolate, 
anhydrous milk fat, tributyrin, short chain inulin; WAMT: whey protein isolate, anhydrous milk fat, tributyrin, medium 
chain inulin; WALT: whey protein isolate, anhydrous milk fat, tributyrin, long chain inulin; GCT: gamma-cyclodextrin 
and tributyrin 
All numerical values represent percentages 
†Inulin containing formulations have higher tributyrin content to maintain tributyrin content on a gram-for-gram 
basis in dried powder 
††The same formulation was used both for spray and oven dried samples 
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Table 3.2: Average estimated tributyrin content and retention based on microcapsule drying 
method and formulation 
Sample Drying method 
Average estimated 
tributyrin content 
(g TB/ g powder)† 
(±SEM)†† 
Optimal tributyrin 
content$  
(g TB/ g powder) 
Average retention 
 (%)# 
WA SD 6.84e-4 N/A N/A 
SA SD 5.97e-4 N/A N/A 
GCT SD 0.051 ± 0.002 0.082 61.93A 
SAT SD 0.128 ± 3.0e-4 0.185 69.01B 
WAT SD 0.148 ± 0.003 0.183 81.06C 
WALT SD 0.157 ± 0.001 0.183 85.98D 
WAMT SD 0.159 ± 0.002 0.183 86.75D 
WAST SD 0.162 ± 0.002 0.185 87.72D 
GCT OD 0.076 ± 0.001 0.080 94.58E 
WA: whey protein isolate, anhydrous milk fat; SA: soy protein isolate, anhydrous milk fat; WAT: whey protein isolate, 
anhydrous milk fat, tributyrin; SAT: soy protein isolate, anhydrous milk fat, tributyrin; WAST: whey protein isolate, 
anhydrous milk fat, tributyrin, short chain inulin; WAMT: whey protein isolate, anhydrous milk fat, tributyrin, medium 
chain inulin; WALT: whey protein isolate, anhydrous milk fat, tributyrin, long chain inulin; GCT: gamma-cyclodextrin 
and tributyrin; SD: spray dried; OD: oven dried 
†All observed averages are derived from six measurements taken from two experimental replicates 
# Samples with the same letter are not significantly different (α>0.05) from one another 
†† Standard error of the mean 
$ Optimal tributyrin content is based on microcapsule formulation and moisture content of each microcapsule tested 
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Figure 3.1: Scanning electron microscopy images of spray dried whey protein isolate and 
anhydrous milk fat microcapsules (10,000X) 
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Figure 3.2: Scanning electron microscopy images of spray dried whey protein isolate, anhydrous 
milk fat, and tributyrin microcapsules (10,000X) 
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Figure 3.3: Scanning electron microscopy images of spray dried whey protein isolate, anhydrous 
milk fat, short chain inulin, and tributyrin microcapsules (10,000X) 
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Figure 3.4: Scanning electron microscopy images of spray dried whey protein isolate, anhydrous 
milk fat, medium chain inulin, and tributyrin microcapsules (10,000X) 
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Figure 3.5: Scanning electron microscopy images of spray dried whey protein isolate, anhydrous 
milk fat, long chain inulin, and tributyrin microcapsules (10,000X) 
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Figure 3.6: Scanning electron microscopy images of native gamma-cyclodextrin (10,000X) 
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Figure 3.7: Scanning electron microscopy images of gamma-cyclodextrin and tributyrin oven 
dried microcapsules (10,000X) 
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Figure 3.8: Scanning electron microscopy images of gamma-cyclodextrin and tributyrin spray 
dried microcapsules (10,000X) 
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Table 3.3: Average moisture content and water activity for investigated formulations 
Sample  Drying Method Average Moisture Content (%)† Average Water Activity 
WA SD 2.43 ± 0.07 0.216 ± 0.058 
SA SD 1.54 ± 0.36 0.111 ± 0.004 
GCT SD 6.45 ± 1.69 0.178 ± 0.032 
SAT SD 2.24 ± 0.19 0.236 ± 0.011 
WAT SD 2.43 ± 0.17 0.268 ± 0.046 
WAMT SD 2.08 ± 0.22 0.163 ± 0.052 
WAST SD 2.22 ± 0.18 0.214 ± 0.021 
WALT SD 2.52 ± 0.42 0.161 ± 0.042 
GCT OD 9.52 ± 2.29 0.238 ± 0.091 
WA: whey protein isolate, anhydrous milk fat; SA: soy protein isolate, anhydrous milk fat; WAT: whey protein isolate, 
anhydrous milk fat, tributyrin; SAT: soy protein isolate, anhydrous milk fat, tributyrin; WAST: whey protein isolate, 
anhydrous milk fat, tributyrin, short chain inulin; WAMT: whey protein isolate, anhydrous milk fat, tributyrin, medium 
chain inulin; WALT: whey protein isolate, anhydrous milk fat, tributyrin, long chain inulin; GCT: gamma-cyclodextrin 
and tributyrin; SD: spray dried; OD: oven dried 
†All observed averages are derived from six measurements taken from two experimental replicates 
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Table 3.4: Rheological properties of homogenized whey protein emulsions 
Sample Code K†# n† Correlation†† G’G’’ Intersection (°C) 
WA 0.055A# 0.966 0.999 42.0 
WAT 17.036A 0.356 0.995 37.0 
WAST 111.698B 0.299 0.984 35.0 
WAMT 254.449C 0.165 0.997 31.5 
WALT 187.672D 0.221 0.995 35.0 
WA: whey protein isolate, anhydrous milk fat; SA: soy protein isolate, anhydrous milk fat; WAT: whey protein isolate, 
anhydrous milk fat, tributyrin; SAT: soy protein isolate, anhydrous milk fat, tributyrin; WAST: whey protein isolate, 
anhydrous milk fat, tributyrin, short chain inulin; WAMT: whey protein isolate, anhydrous milk fat, tributyrin, medium 
chain inulin; WALT: whey protein isolate, anhydrous milk fat, tributyrin, long chain inulin 
Samples presented were diluted to similar solids levels (17-20%) 
† Values are an average of two replications 
#Samples with the same letter are not significantly different (α>0.05) from one another 
†† Refers to the samples relation to the Power Law model, 𝜎𝜎 = 𝑘𝑘 ∗ ?̇?𝛾𝑛𝑛 
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Figure 3.9: G’ and G’’ behavior of whey protein based emulsions before and after 
homogenization (upward temperature sequence) 
 
 
 
A= whey protein isolate (WPI), anhydrous milk fat (AMF), before homogenization; B: WPI, AMF, tributyrin (TB), 
before homogenization; C: WPI, AMF, TB, short chain inulin before homogenization; D: WPI, AMF, TB, medium 
chain inulin before homogenization; E: WPI, AMF, TB, long chain inulin before homogenization A’: WPI, AMF, after 
homogenization; B’: WPI, AMF, TB, after homogenization; C’: WPI, AMF, TB, short chain inulin after 
homogenization; D’: WPI, AMF, TB, medium chain inulin after homogenization; E’: WPI, AMF, TB, long chain inulin 
after homogenization. 
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Figure 3.9 (continued): G’ and G’’ behavior of whey protein based emulsions before and after 
homogenization (upward temperature sequence) 
 
A= whey protein isolate (WPI), anhydrous milk fat (AMF), before homogenization; B: WPI, AMF, tributyrin (TB), 
before homogenization; C: WPI, AMF, TB, short chain inulin before homogenization; D: WPI, AMF, TB, medium 
chain inulin before homogenization; E: WPI, AMF, TB, long chain inulin before homogenization A’: WPI, AMF, after 
homogenization; B’: WPI, AMF, TB, after homogenization; C’: WPI, AMF, TB, short chain inulin after 
homogenization; D’: WPI, AMF, TB, medium chain inulin after homogenization; E’: WPI, AMF, TB, long chain inulin 
after homogenization. 
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Figure 3.10: G’ and G’’ behavior of whey protein based emulsions before and after 
homogenization (downward temperature sequence) 
 
 
A= whey protein isolate (WPI), anhydrous milk fat (AMF), before homogenization; B: WPI, AMF, tributyrin (TB), 
before homogenization; C: WPI, AMF, TB, short chain inulin before homogenization; D: WPI, AMF, TB, medium 
chain inulin before homogenization; E: WPI, AMF, TB, long chain inulin before homogenization A’: WPI, AMF, 
after homogenization; B’: WPI, AMF, TB, after homogenization; C’: WPI, AMF, TB, short chain inulin after 
homogenization; D’: WPI, AMF, TB, medium chain inulin after homogenization; E’: WPI, AMF, TB, long chain 
inulin after homogenization. 
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Figure 3.10 (continued): G’ and G’’ behavior of whey protein based emulsions before and after 
homogenization (downward temperature sequence) 
 
 
A= whey protein isolate (WPI), anhydrous milk fat (AMF), before homogenization; B: WPI, AMF, tributyrin (TB), 
before homogenization; C: WPI, AMF, TB, short chain inulin before homogenization; D: WPI, AMF, TB, medium 
chain inulin before homogenization; E: WPI, AMF, TB, long chain inulin before homogenization A’: WPI, AMF, 
after homogenization; B’: WPI, AMF, TB, after homogenization; C’: WPI, AMF, TB, short chain inulin after 
homogenization; D’: WPI, AMF, TB, medium chain inulin after homogenization; E’: WPI, AMF, TB, long chain 
inulin after homogenization. 
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Chapter 4: Sensory Perception of Microencapsulated Tributyrin in Infant 
Formula 
 
4.1 Abstract 
 Microencapsulation is used in the food industry for a variety of purposes including the 
taste-masking of bioactive compounds with negative sensory qualities. Tributyrin (TB), a source 
of butyric acid important in intestinal health, possesses negative aroma (cheesy, fecal) and taste 
(bitter) qualities limiting its use in food. Utilizing spray drying and low-temperature oven drying, 
microcapsules containing TB were produced using whey (WPI), WPI and inulin, and gamma-
cyclodextrin (GCD). Microencapsulated and free TB were incorporated into an infant formula 
system and evaluated using R-index measure by rating method to determine how microcapsule 
formulation affected the perception of TB relative to a control formula without added 
microcapsules or free TB. Findings showed the only microcapsule that was not significantly 
different from the control (R-index of below 57.95%, α=0.01, two-tailed, and n=170) was the 
GCD and TB oven dried (GCT OD) microcapsule. All other WPI and GCD and TB spray dried 
(GCT SD) microcapsules were all significantly different from the control and not significantly 
different from one another. Spray drying may produce microcapsules with free surface TB and 
disrupt the GCT SD complex due to high heat. The GCT OD microcapsule can be orally 
delivered for the potential treatment of intestinal disorders without possessing the negative 
sensory qualities typically associated with TB. 
 
 
4.2 Introduction 
Microencapsulation is a processing technique used in the food, pharmaceutical, and 
personal care industries. Microencapsulation can protect compounds from environmental 
stresses, improve handling and transport of ingredients, control compound release, add ingredient 
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functionality, and mask unwanted odors and tastes (Shahidi and Han 1993; Gibbs and others 
1999; Desai and Park 2005; Sobel and others 2014). Odor and taste masking using 
microencapsulation is a popular method utilized for functional ingredients with unpleasant 
sensory qualities such as iron (Boccio and others 1997; Xia and Xu 2005), polyphenols 
(Davidov-Pardo and others 2012), ginseng (Tamamoto and others 2010), fish oils (Serfert and 
others 2010), and other food products (Del Valle 2004; Szente and Szejtli 2004; Szejtli and 
Szente 2005).  
Microencapsulation methods differ in the mechanism that they reduce or eliminate the 
unpleasant sensory qualities of functional ingredients. Microencapsulation methods, such as 
spray drying, can provide a physical barrier of the core to the system in order to reduce taste and 
odor perception (Shahidi and Han 1993; Gharsallaoui and others 2007). Other encapsulation 
methods, such as complexation with cyclodextrins (CDs), can mask the taste and odor of a core 
through chemical interactions. This chemical complexation can limit or completely inhibit the 
cores ability to interact with sensory receptors, thereby reducing or eliminating the sensory 
perception of the core (Hedges 1998; Szejtli and Szente 2005).  
Tributyrin (TB) is an oil isolated from butter and milk sources and is generally regarded 
as safe (21CFR184.1903) for use as a food additive or flavor. The structure of TB contains three 
butyric acid moieties attached to a glycerol backbone. Butyric acid, or butyrate when in the 
intestine, is an important fatty acid for intestinal health produced by bacterial fermentation 
(Wong and others 2006; Guilloteau and others 2010). Butyrate serves as a primary energy source 
for colonic epithelium (Wong and others 2006; Hamer and others 2008). Both butyrate and TB 
have been associated with the improvement of intestinal health and structure (Koruda and others 
1990; Kotunia and others 1994; Bartholome and others 2004), decreased growth and increased 
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apoptosis of in vitro colonic cancer cells (Heerdt and others 1994; Hague and others 1995; Li and 
others 2009), and improvement of chronic disease states such as diarrhea (Berni Canani and 
others 2004), inflammatory bowel disease (IBD) (Vieira and others 2012; Scheppach and others 
1992; Steinhart and others 1996), irritable bowel syndrome (IBS) (Berni and others 2004; 
Scarpellini and others 2007) and short-bowel syndrome (SBS) (Bartholome and others 2004). 
Despite these benefits, both TB and butyrate suffer from unpleasant sensory qualities 
(Kotunia and others 1994; Edelman and others 2003; Leonel and Alvarez-Leite 2012). Butyrate 
and TB are described as having a cheesy and fecal odor with a highly bitter taste. These sensory 
attributes, combined with the insolubility of TB, makes the use of TB in a food system difficult. 
When currently used in treatment, TB and butyrate are often administered to patients using 
enemas (Wong and others 2006; Leonel and Alvarez-Leite 2012). This method of treatment has 
low long-term compliance rates and is easily misused (not fully administered, not retained long 
enough, etc.) (Breuer and others 1997; Immerseel and others 2010; Leonel and Alvarez-Leite 
2012). Creating forms of TB or butyrate that are more palatable by reducing their unpleasant 
sensory qualities would make their oral administration possible. Incorporating these new forms 
into commonly consumed food systems would create an easy-to-use method to administer these 
important compounds for the improvement and maintenance of intestinal health.  
Previous research has investigated the use of spray drying for the microencapsulation of 
bioactive components and flavor compounds using protein (Rosenberg and Sheu 1996; Charve 
and Reineccius 2009) and CD (Reineccius 1988) wall materials. These materials have been 
successful in the ability to promote the viability or retention of these core materials. However, 
little to no sensory work was completed on these systems. This represents a significant gap in the 
knowledge.  
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Taste is regarded as one of the most important sensory modalities in foods for consumers 
(Moskowitz and Kreiger 1993; Moskowitz and Krieger 1995). Consumers are also generally 
unwilling to compromise on taste for functional health benefits (Urala and Lähteenmäki 2004; 
Verbeke 2006). While core retention and other functionality such as targeted release are 
important, the sensory properties of microencapsulated compounds, and those properties they 
impart on the food system, are paramount to many other analytical measurements for 
microcapsules ultimate food use.  
It has been observed that microencapsulation has the ability to change the sensory profile 
of the encapsulated core ingredient (Galmarini and others 2008). As a result, the 
microencapsulated ingredient may not possess the same sensory quality as it did before being 
encapsulated. When included into foods, significant flavor-binding interactions involving wall 
materials and food components may modulate the sensory properties of the food further (Jasinski 
and Kilara 1985; Plug and Haring 1994; O'Neill 1996; Hansen and Booker 1996). Therefore, the 
knowledge of how a microencapsulated system behaves when included in food and its effect on 
the sensory properties of the food system is essential for its successful utilization. No work has 
been published on the sensory properties that TB or microencapsulated TB impart on foods. 
The sensory qualities TB possesses makes it nearly impossible to orally administer this 
compound through foods. Due to this, the ultimate success or failure of microencapsulated TB 
largely rests on the system’s ability to decrease or eliminate the perception of TB. The impact of 
TB on the food system can be determined by using sensory testing methods. 
One type of sensory discrimination testing is known as the rating method. This method 
can produce R-index measures. R-index measures can determine if a sample, containing a known 
signal, varies from a control, or “noise”, and determines the probability that a participant will 
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notice this difference (O'Mahony 1992). R-index measures range from 50-100%. Chance level 
discrimination is at 50; the probability of detecting the signal from the noise is only 50%. With 
only two samples compared, the signal and the noise, this indicates that the sample is only 
different from the noise by chance. Conversely, an R-index of 100% would symbolize perfect 
discrimination from the noise. Values ranging between 51% and 99% indicate various iterations 
of discrimination between the two samples (O'Mahony 1992). Using this testing method, it can 
be determined if the microencapsulation method and formulation employed is able to 
successfully mask the negative sensory attributes associated with TB and make it 
indistinguishable from a control infant formula. 
The specific aim of this research was to determine the influence of encapsulation and 
wall material on the sensory perception of TB in an infant formula. When investigating this 
specific aim, several working hypotheses were proposed. It was hypothesized that 
microencapsulated TB would be less likely to be perceived by consumers than free TB when in 
the same food matrix. It was also hypothesized that microencapsulated TB in CDs due to their 
ability to chemically complex TB, created microcapsules that were less likely to be perceived as 
bitter than WPI-based microcapsules in a food matrix. To test these hypotheses, the research 
approach utilized an R-index measure by rating method to determine the probability that a 
panelist would be able to correctly distinguish a sample containing encapsulated or free TB from 
the control that did not contain TB in any form.  
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4.3 Materials and methods 
 4.3.1 Materials 
Microencapsulated TB was produced via spray-drying and oven drying using 
combinations of: whey protein isolate (WPI), anhydrous milkfat (AMF), and TB (WAT); WPI, 
AMF, short chain inulin, and TB (WAST); gamma-cyclodextrin (GCD) and TB spray dried 
(GCT SD); GCD and TB oven dried (GCT OD). Specific information related to their formulation 
and preparation can be found in Chapter 3 sections 3.3.2.2-3.3.2.6. 
Previous studies have delivered butyric acid in quantities of 9 mmol (0.79 g) per 
treatment through the use of enemas in piglet intestinal models with induced simulated SBS 
(Bartholome and others 2004). All samples were formulated to contain 0.2 g of TB / 0.17 g of 
butyric acid/ serving (4 oz. of formula) based on their measured retention of TB as quantified in 
Chapter 3. At this concentration of butyric acid per serving, individuals would need to consume 
roughly 4.5 servings of formula a day to reach the quantity of butyric acid used in the 
aforementioned study (9 mMol) (Bartholome and others 2004). The actual content of TB per 
gram of capsule was determined according to methods outlined in Chapter 3, sections 3.3.2.7-
3.3.2.9 and was included into the formula based on the actual content of the particle. The TB 
content in each gram of microcapsule can be found in Table 4.1. 
The food system used was an infant formula specially designed for infants with a variety 
of intestinal maladies such as protein sensitive colitis, diarrhea, SBS (Abad-Sinden and Sutphen 
2003), or nutrient malabsorption issues (Abbott Laboratories 2014). The infant formula chosen 
was EleCare® Amino Acid-based Infant Formula with Iron (http://elecare.com) manufactured by 
Abbott Nutrition (Abbott Laboratories Inc., Abbott Park, IL). 
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4.3.2 Methods 
4.3.2.1 Experimental design 
The experimental design of the rating method used to determine R-index measures was a 
full factorial design (1 x 6), with the infant formula (factor 1, 1 treatment) being treated with all 
microcapsule/control formulations (factor 2, 6 treatments). For individual testing, one blocked 
replication was performed each session. The sample presentation order across judges was 
randomized within the block by the Williams Design. A total of five sessions were performed, 
for a total of five replications per microcapsule or control formulation. 
 4.3.2.2 Sample preparation 
Infant formula was prepared according to package directions (18.8 g of powder per 4 oz. 
water) with the specified amount of encapsulated or free TB as indicated in Table 4.2 to reach a 
TB content equivalent to 0.2 g TB/ serving. Formula samples had the following variables added 
to them to make a total of six treatments: a blinded control or noise; free TB, WAT, WAST, 
GCT SD, and GCT OD. Formula was prepared on the day of testing by vigorously shaking the 
encapsulate or free TB in infant formula for 2 minutes. Sample (1.5 oz.) was poured into 2 oz. 
plastic soufflé cups and stored at 4°C in a refrigerator until served to panelists. Before panelists 
arrived, samples were removed from the refrigerator for at least 30 minutes. 
 4.3.2.3 Recruitment and testing procedures 
All recruitment material, procedures, and testing materials were approved by the 
University of Illinois Institutional Review Board (IRB) (IRB Protocol Number: 4757). Panelists 
were recruited for the test using an email (Appendix B) sent through departmental list-servs. 
Panelists were required to complete a pre-screening survey on Qualtrics (Qualtrics, LLC, Provo, 
UT) (Appendix C) to indicate if they qualified for the study. Panelists who were under the age of 
18, had any food allergies, or lacked sufficient availability were disqualified from the study. The 
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recruited subjects (n=33, 23 females, 10 males, aged 23-56) attended three, 20 minute testing 
sessions. The first half of the first session involved a brief introduction to the research objective, 
and the rating procedure to determine R-index measures that would be used during the test.  
 Actual testing sessions were conducted in individual booths using red lighting to mask 
any possible color differences. Panelists recorded all responses using the Compusense five Plus 
(Version 5.0: Guelph ON, Canada) data acquisition system. Panelists were first presented with a 
sample labeled as the “noise”. This sample served as a background or baseline that all other 
samples were compared to. The noise in this study was the control sample that was the infant 
formula sample with nothing added. Panelists were asked to acquaint themselves with the noise. 
Panelists were presented with a tray of samples containing six, 2-oz plastic sample cups 
coded with 3-digit codes to prevent bias. Panelists then were asked to indicate if the coded 
sample was the same or different from the noise, and indicate how sure they were. They did this 
by selecting one of the following options: signal-sure; signal-unsure; noise-unsure; noise-sure.  
Panelists were required to expectorate the sample into a 16 oz. Styrofoam cup. Between 
each sample, panelists rinsed with bread (1/4 of a slice) (Bimbo soft white bread, Bimbo 
Bakeries USA, Inc., Horsham, PA), heavy whipping cream (5 oz. cup) (Ultra-pasteurized heavy 
whipping cream, Prairie Farms Dairy, Inc., Carlinville, IL), warm water (8 oz. cup) (43°C), and 
room temperature water (8 oz. cup) (25°C). All rinses were expectorated. The testing and rinsing 
procedure was repeated six times until all samples were evaluated. Panelists then were given a 
five minute break and asked to repeat the testing again with another set of coded samples. A total 
of five sample replications were completed over the course of three days. 
4.3.2.4 Statistical analysis 
The probability of determining a signal from a noise in a paired comparison setting is 
defined as the R-index measure of a sample (O'Mahony 1992). The R-index measure is 
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calculated by placing panelist’s individual or pooled responses for each sample into the matrix 
(Figure 4.1) and using the equation listed in Figure 4.2 to calculate the value. 
By summing the ratings for all sample replicates into an individual judge response matrix 
using equation 1 (where ns=sum of signal ratings, and nn=sum of noise ratings) individual judge 
R-index measures for each sample can be calculated. Each individual R-index judge measure for 
each sample was then used to complete the analysis of variance (ANOVA) using the PROC 
ANOVA function of the Statistical Analysis Software (SAS)® Enterprise Guide® (Version 4.3, 
SAS Institute Inc., Cary, NC) to determine if significant differences (p<0.05) existed among the 
samples. If significant differences existed, the Least Significant Difference (LSD) test was 
conducted to determine where those differences lied. 
By combining all the responses, for all sample replicates, from all judges into a single 
response matrix per product, a value known as a pooled R-index can be calculated. This value 
can be compared to the chance level probability (50%) and using available tables (Bi and 
O'Mahony 2007) and parameters (α=0.01, two-tailed, and n=170), it can be determined if a 
sample is significantly different from the noise. 
Individual and pooled R-index measures were tabulated using Microsoft Excel 2013 
(Version 15.0: Microsoft Corporation, Redmond, WA) while LSD calculations were done using 
XLSTAT (XLStat Pro 2015.1.01, Addinsoft SARL, New York, NY).  
 
 
4.4 Results and discussion 
Results showed that there was a clear differentiation in the sensory perception of 
microencapsulated TB in this infant formula system. According to pooled R-index measures 
(Table 4.3), any R-index value over 57.95% was determined as significantly different from the 
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control (Bi and O'Mahony 2007). The only microcapsule not significantly different from the 
control by this measure was GCT OD. Similar results were observed using the individual R-
index measure (Table 4.4), with the GCT OD microcapsule being the only sample not 
significantly different from the control (p<0.001). All other microcapsules (WAT, WAST, and 
GCT SD) were significantly different from the control (p<0.05) and not significantly different 
(p>0.05) from free TB. This indicates that when TB is microencapsulated as a GCT OD in infant 
formula, the probability of it being viewed as different from the control is no greater than that of 
chance probability. This demonstrates the ability of GCT OD to successfully reduce the sensory 
influence of TB making it indistinguishable from the noise. To explain why the results of GCT 
OD were significantly different from all other microcapsules, influences including processing 
method and microcapsule formulation must be considered. 
The difference in sensory perception exhibited by the different microcapsules may be 
partially explained by the processing method utilized to create the microcapsules. When spray 
drying, a matrix style microcapsule is most commonly produced (Sheu and Rosenberg 1995; 
Sheu and Rosenberg 1998; Hogan and others 2001). This type of structure is produced during the 
expansion and contraction of the particle feed during drying. The evaporation of moisture in the 
system causes the expansion of the particle leaving a central void. During cooling, the 
contraction and formation of the dried wall layer occurs (Gharsallaoui and others 2007) creating 
a circular structure shown in Chapter 3, Figures 3.4, 3.3, and 3.8. This hollow interior creates 
small pockets containing the encapsulated ingredient to form along the microcapsule wall 
surface. Differences in the presence of surface or near-surface TB in spray dried microcapsules 
influence their sensory perception. With the strong taste qualities of TB, a close proximity of this 
compound to the surface may allow for its facilitated release in the oral cavity and food matrix 
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leading to increased perception of TB. This may explain why panelists identified all spray dried 
formulations in this study as significantly different from the control. Contrary to our results, 
previous literature has used spray drying as a successful method to reduce or isolate compounds 
with taste active properties (Bora and others 2008; Molina Ortiz and others 2009; Kawakami and 
others 2009; Favaro-Trindade and others 2010). These findings suggests that potential 
adjustment of parameters related to spray drying (inlet/out temperature, flow rate, pressure) and 
formulation (solids content, viscosity, wall materials) may allow the encapsulation of TB using 
spray drying as a method to reduce the sensory impact of TB in food systems.  
Aside from the processing method, the microcapsule formulation also plays a significant 
role in the ability of the microcapsules to reduce the sensory influence of TB. Cyclodextrins are 
commonly used to mask off tastes and odors in food products. Utilizing the same formulation 
(50% solids, 3:1 GCD to TB ratio) as GCT OD, GCT SD performed identically to WAT and 
WAST in the R-index measure by rating test. Contrary to GCT OD, using CDs offered no benefit 
over WPI-based microcapsules for the GCT SD microcapsule. As previously mentioned in 
Chapter 3, the poor retentive qualities of GCT SD may be the result of sub-optimal spray drying 
conditions in GCT SD. It was previously hypothesized that the complex of GCT SD was 
damaged by the exposure of high temperatures during spray drying (Bhandari and others 1998; 
Reineccius and others 2002; Reineccius and others 2004; Hădărugă and others 2006; Kawakami 
and others 2009). The high solids content of GCT SD may have led to ineffective atomization 
and delayed particle formation during the hottest inlet drying temperatures (Reineccius 2004). 
The heat-damaged complexation may have released TB. This release may be what caused the 
GCT SD to behave no differently from free TB when included into the formula. If the TB in 
GCT SD had remained in complex with GCD, like in GCT OD, it would have had the same 
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improved taste masking ability as GCT OD. Therefore, GCT SD’s sensory performance supports 
the statement that the GCD-TB complex was damaged during drying, and caused the release of 
TB that was perceived by the panelists.  
While GCD complexation has not been analytically confirmed, it is assumed that 
complexation of TB is created and maintained in the GCD OD formulation due to its 
performance in the rating test. While CDs can provide some taste masking ability without any 
prior complexation (referred to as “empty CDs” addition) (Szente and Szejtli 2004), this is not 
the primary mechanism that GCT OD utilized in reducing the sensory impact of TB in formula. 
If this was the mechanism of taste masking seen in GCT OD, this microcapsule would have 
performed identically to GCT SD since they each contained identical amounts of GCD. Further 
research could investigate the nature of the GCD and TB complexation utilizing analytical 
techniques such as high performance liquid chromatography (HPLC), nuclear magnetic 
resonance (NMR), differential scanning calorimetry (DSC), or other spectroscopy methods such 
as Fourier transform (FT)-Raman, FT-infrared and ultraviolet-visible (UV-VIS) (Hedges 1998; 
Das and others 2013). 
The importance of sensory testing in the evaluation of microencapsulated materials is 
apparent through this research. While understanding the retentive ability of microcapsules is 
important, R-index measures indicate that TB retention was not indicative of how well an 
encapsulated system can isolate a core material from a food system. Microcapsules with similar 
retention values (Table 4.1) had dramatic differences in sensory perception in the rating method. 
Significant differences (p<0.05) in retention were observed between WAST microcapsules and 
WAT and GCT SD with GCT SD retaining the least TB. However, all three of these 
microcapsules were not significantly different (p>0.05) among one another or in comparison to 
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free TB in R-index measures. Therefore, the level of retention in a microcapsule may not be a 
proper indicator of an improved isolation and/or protection of the core material. The success of a 
microcapsule formulation on the isolation of a compound cannot be determined on retention 
alone, and should consider other stability factors, one of which is sensory testing (Lee and others, 
2014). 
 
4.5 Conclusions 
 The microencapsulation of TB using GCT OD produced a microcapsule that was able to 
reduce the sensory perception of TB to a level that was indistinguishable from a control infant 
formula without TB. The microcapsules WAT, WAST, and GCT SD were significantly different 
from the control formula for both pooled and individual R-index measures. These differences 
may be a result of the matrix style structured capsule produced during spray drying of WAT and 
WAST that allows for surface TB to be perceived by panelists. The unsuccessful ability of GCD 
SD to reduce sensory qualities of TB in formula most likely stems from heat-induced 
complexation disruption, due to the drying parameters and high solids content of the formulation 
that may lead to complexation disruption and the release of TB.  
Further improvement of the spray drying processes may improve the performance of the 
spray dried formulations. With the ability of GCT OD to reduce the sensory properties of TB 
indistinguishable to that of a control formulation, it is now possible to administer this important 
bioactive component through food delivery. The non-digestible nature of GCD holds promise for 
its ability to enable the targeted delivery of this compound to areas of the intestinal tract 
necessary for those suffering from intestinal disorders. This, however, must be thoroughly 
investigated using in vitro and in vivo models before any treatment could be proposed. 
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4.7 Tables and figures 
Table 4.1: Average estimated tributyrin content and retention based on microcapsule drying 
method and formulation 
Sample Drying method 
Average estimated 
tributyrin content 
(g TB/ g powder)† 
(±SEM)†† 
Optimal tributyrin 
content$ 
(g TB/ g powder) 
Average retention  
(%)# 
WA SD 6.84e-4 N/A N/A 
SA SD 5.97e-4 N/A N/A 
GCT SD 0.051 ± 0.002 0.082 61.93A 
SAT SD 0.128 ± 3.0e-4 0.185 69.01B 
WAT SD 0.148 ± 0.003 0.183 81.06C 
WALT SD 0.157 ± 0.001 0.183 85.98D 
WAMT SD 0.159 ± 0.002 0.183 86.75D 
WAST SD 0.162 ± 0.002 0.185 87.72D 
GCT OD 0.076 ± 0.001 0.080 94.58E 
WA: whey protein isolate, anhydrous milk fat; SA: soy protein isolate, anhydrous milk fat; WAT: whey protein isolate, 
anhydrous milk fat, tributyrin; SAT: soy protein isolate, anhydrous milk fat, tributyrin; WAST: whey protein isolate, 
anhydrous milk fat, tributyrin, short chain inulin; WAMT: whey protein isolate, anhydrous milk fat, tributyrin, medium 
chain inulin; WALT: whey protein isolate, anhydrous milk fat, tributyrin, long chain inulin; GCT: gamma-cyclodextrin 
and tributyrin; SD: spray dried; OD: oven dried 
†All observed averages are derived from six measurements taken from two experimental replicates 
# Samples with the same letter are not significantly different (α>0.05) from one another 
†† Standard error of the mean 
$ Optimal tributyrin content is based on microcapsule formulation and moisture content of each microcapsule tested 
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Table 4.2: Total amount of microencapsulated tributyrin added per serving of infant formula for 
the rating method to calculate the R-index measure 
Microcapsule 
formulation 
Amount of 
tributyrin/ 
g of powder 
(g) 
Amount of 
butyric acid/ 
g of powder 
(g) 
Amount 
added/ 
serving (g) 
Total 
tributyrin 
content/ 
serving (g) 
Total 
butyric acid 
content per 
serving (g) 
Noise (control) 0 0 0 0 0 
Free TB n/a 0.17 0.20 0.20 0.17 
WAT 0.16 0.14 1.25 0.20 0.17 
WAST 0.17 0.150 1.17 0.20 0.17 
GCT OD 0.069 0.060 2.90 0.20 0.17 
GCT SD 0.052 0.045 3.88 0.20 0.17 
Free TB: unencapsulated tributyrin; WAT: whey protein isolate, anhydrous milk fat, tributyrin; WAST: whey protein 
isolate, anhydrous milk fat, short chain inulin, tributyrin; GCT OD: gamma-cyclodextrin and tributyrin oven dried; 
GCT SD: gamma-cyclodextrin and tributyrin spray dried 
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Table 4.3: Pooled ratings and R-index measures for all panelists, replications, and formulations 
Formulation Signal sure 
responses 
Signal unsure 
responses 
Noise unsure 
responses 
Noise sure 
responses 
Calculated 
R-index# 
Free TB 110 25 18 12 80.6** 
WAT 110 20 24 11 80.3** 
WAST 89 35 22 19 76.1** 
GCT SD 77 30 32 26 71.6** 
GCT OD 26 24 41 74 50.2 
Noise (control) 29 15 48 73 50.0 
Free TB: unencapsulated tributyrin; WAT: whey protein isolate, anhydrous milk fat, tributyrin; WAST: whey protein 
isolate, anhydrous milk fat, short chain inulin, tributyrin; GCT SD: gamma-cyclodextrin and tributyrin spray dried; 
GCT OD: gamma-cyclodextrin and tributyrin oven dried; 
#Values with ** indicate significant difference (p<0.01) from the control as determined using tables in Bi and 
O’Mahony (2007) using an n=170, α=0.01, and two-tailed 
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Table 4.4: Individual average R-index measures for all panelists, replications, and formulations 
Formulation Average individual R-index# 
Free TB 80.5A*** 
WAT 80.2A*** 
WAST 77.3A*** 
GCT SD 72.8A*** 
GCT OD 49.5B*** 
Noise (control) 50.0 B 
Free TB: unencapsulated tributyrin; WAT: whey protein isolate, anhydrous milk fat, tributyrin; WAST: whey protein 
isolate, anhydrous milk fat, short chain inulin, tributyrin; GCT SD: gamma-cyclodextrin and tributyrin spray dried; 
GCT OD: gamma-cyclodextrin and tributyrin oven dried; 
# Samples that share the same superscript are not significantly (p<0.001 or ***) 
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Figure 4.1: Response matrix used for calculating individual and pooled R-index measures 
  SS  S? N? N  
Signal a b c d 
Noise e f g h 
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Figure 4.2: Equation used to calculated the R-index measure (Brown 1974) R − Index =  a(f + g + h) + b(g + h) + ch + 12 (ae + bf + cg + dh)nS + nn  
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Chapter 5: In vitro Digestion and Fermentation of Microencapsulated 
Tributyrin 
5.1 Abstract 
Butyrate possesses negative sensory qualities and is most effectively utilized in the small 
and large intestines to provide cellular energy for the maintenance of intestinal health. Butyrate 
also has shown promise in the treatment of intestinal disorders and diseases such as shortened 
bowel syndrome, inflammatory bowel disease, and colon cancer. To modify sensory properties, 
intestinal release, and butyrate production capabilities, tributyrin (TB), a butyrate source, was 
microencapsulated in whey protein isolate (WPI) - and gamma-cyclodextrin (GCD)-based 
materials. Using an in vitro digestion and fermentation model, microcapsules containing TB 
were monitored for their release and production of butyrate in vitro. All formulations containing 
TB showed limited butyrate release (<5%) during oral and gastric stages. In the small intestine, 
microcapsules containing TB released approximately 75% of their total butyrate content with no 
significant differences (p>0.05) across formulations. During fermentation, GCD-based 
microcapsules produced significantly more butyrate (p<0.001) on a molar basis than all WPI-
based microcapsules. Butyrate production increased (p<0.001) over time in GCD-based 
microcapsules significantly with the highest butyrate production noted in the 12th hour of 
fermentation. Gamma-cyclodextrin-containing TB microcapsules were able to effectively deliver 
butyrate to the small and large intestines, and may be beneficial for the maintenance of intestinal 
health and improvement of disease states.  
153 
 
5.2 Introduction 
Butyrate, a naturally occurring short chain fatty acid (SCFA), is essential to the 
maintenance of intestinal health, serving as a primary epithelial energy source (Wong and others 
2006; Hamer and others 2008; Immerseel and others 2010). Butyrate also has been associated 
with the improvement of certain disease states such as short-bowel syndrome (SBS) (Bartholome 
and others 2004), inflammatory bowel disease (IBD) (Scheppach and others 1992; Patz and 
others 1996; Steinhart and others 1996; Vieira and others 2012), and irritable bowel syndrome 
(IBS) (Berni Canani and others 2004; Scarpellini and others 2007). The presence of butyrate also 
decreased proliferation of colon cancer cells in human cell lines (Hague and others 1993; Heerdt 
and others 1994), reduced the incidence of diarrhea (Berni Canani and others 2004), and 
improved overall small intestinal health (Koruda and others 1990; Kotunia and others 1994). 
Because of the intestinal benefits, the target of butyrate delivery extends to all areas in the small 
and large intestines. To accomplish this, butyrate is most commonly administered through total 
parenteral nutrition (TPN) (Koruda and others 1990; Bartholome and others 2004) or rectal 
enemas (Scheppach and others 1992; Patz and others 1996; Steinhart and others 1996). While 
some studies have utilized the oral delivery of butyrate using enterically coated pills (Berni 
Canani and others 2004; Scarpellini and others 2007), the sensory qualities of butyrate (Kotunia 
and others 1994; Edelman and others 2003; Leonel and Alvarez-Leite 2012) and the need for 
targeted intestinal release, greatly limits its potential for oral delivery in foods. Processing 
methods, like microencapsulation, may be helpful in overcoming these challenges. 
Microencapsulation involves the entrapment of compounds into surrounding wall 
matrices in an effort to provide functional benefits. These benefits can include core odor and 
taste masking, isolation from environmental stresses like heat, pH, and moisture, or to control the 
release of a compound (Jackson and Lee 1991; Shahidi and Han 1993; Desai and Park 2005; 
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Gharsallaoui and others 2007). A variety of encapsulation methods, including spray drying and 
chemical complexation (Lee and others 2014; Sobel and others 2014), and wall materials, like 
whey proteins and cyclodextrins (Young and others 1993; Sheu and Rosenberg 1995; Rosenberg 
and Sheu 1996; Picot and Lacroix 2004; Szejtli and Szente 2005; Ubbink and Krüger 2006; 
Tamamoto and others 2010; Ying and others 2012) have been used in the food, pharmaceutical, 
and cosmetic industries to microencapsulate compounds. 
To test delivery and release of biologically relevant encapsulated materials to the human 
gastrointestinal (GI) tract, in vitro GI systems are commonly used (de Vos and others 2010). 
They are beneficial compared with in vivo procedures due to their cost effectiveness, rapidness, 
and reproducible nature (Boisen and Eggum 1991; Ji and Xiao 2006). In vitro digestion 
techniques vary greatly in methodological approach; the measured time points, digestive fluids 
or enzymes employed, and the type of physical stresses used can all vary (Hur and others 2011). 
Monograstic in vitro digestion models typically simulate three major digestion phases: oral, 
stomach, and small intestinal (Boisen and Eggum 1991; Bourquin and others 1993; Bourquin and 
others 1993; Hernot and others 2005; de Godoy and others 2009; Li and others 2012; Benedé and 
others 2014). Simulating large intestinal fermentation is more challenging (McClements and Lia 
2010). Anaerobic microbiotia are esponsible for the fermentation of undigested foods (Alminger 
and others 2014), and simulating the large intestine requires an anaerobic environment 
inoculated with intestinal microflora isolated from human or animal fecal samples (Bourquin and 
others 1993; Guillon and others 1995; Granito and others 2001; Hernot and others 2005; de 
Godoy and others 2009). These fecal innocula simulate the intestinal bacteria responsible for the 
breakdown of food materials in this region of the GI tract. 
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In order to utilize microencapsulated tributyrin (TB), a source of butyric acid, in the 
treatment of intestinal disorders or in the maintenance of intestinal health, understanding its fate 
in the intestinal tract in vitro is essential. The specific aim of this research was identify the 
influence of wall material on the site, release, and production of butyrate from encapsulated 
tributyrin in vitro. During in vitro digestion, it was hypothesized that microencapsulated TB, due 
to its physical or chemical protection from environmental conditions, would result in a decreased 
release of butyrate in the oral, gut, and small intestinal phases as opposed to free TB. It was 
further hypothesized that microcapsules containing GCD, due to their non-digestible but 
fermentable nature, would result in higher protection of TB in the oral, stomach, and small 
intestinal environments and higher release of butyrate in the large intestine than free TB or WPI-
based microcapsules.  
Through monitoring digestion, the effects of wall materials on the isolation of TB in the 
oral, gastric, and small intestinal phases can be observed. Due to the potential of wall materials 
to produce additional butyrate through proteolytic and saccharolytic bacterial fermentation 
(Cummings 1981; Cummings and Macfarlane 1997), modeling the large intestine at three time 
points allowed for the determination of additional information regarding butyrate release in vitro. 
 
 
5.3 Materials and methods 
 5.3.1 Materials 
5.3.1.1 Microcapsule production 
Microencapsulated TB was produced using spray and oven drying. Wall materials 
utilized included TB with combinations of whey protein isolate (WPI), anhydrous milkfat 
(AMF), short-chain inulin (S) or gamma-cyclodextrin (GCD) that were spray or oven dried. 
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Specific information related to microcapsule formulation and preparation can be found in 
Chapter 3, sections 3.3.2.2- 3.3.2.6. The microcapsules used were: 1) WPI, AMF, and TB 
(WAT); 2) WPI, AMF, S, and TB (WAST); 3) GCD and TB spray dried (GCT SD); 4) GCD and 
TB oven dried (GCT OD). Additional controls, microcapsule formulations without TB, were 
produced including: 1) WPI and AMF (WA), 2) WA, and S (WAS), 3) GCD, spray dried (SD) 
(GCD SD), 4) GCD, oven dried (OD) (GCD OD). 
5.3.1.2 Solution preparation for digestion and fermentation 
 Solutions used for in vitro fermentation and digestion were used to create the 
experimental medium. The preparation methods and composition of these solutions can be found 
in Appendix D. 
 5.3.2 Methods 
 5.3.2.1 Experimental design 
 The experimental design used for the microcapsule implementation was a full factorial 
design (10 x 7), with all microcapsules and their respective controls (factor 1, 10 treatments) 
exposed to each time point (factor 2, 7 treatments) within digestion and fermentation. For the in 
vitro testing, a repeated measures design allowed all variables to undergo each time point during 
digestion and fermentation with three replications per time point for each microcapsule or 
control. 
 5.3.2.2 In vitro digestion 
In vitro digestion methods were modeled after those discussed by Boisen (1991), Boisen 
and Eggum (1991), and utilized by Bourquin and others (1993), de Godoy and others (2009), and 
Li and others (2012). 
Before use, samples were ground to 1 mm and included at concentrations not to exceed 
0.1 g of protein per tube. In triplicate, 0.3 g of each microcapsule (WA, WAT, WAS, WAST, 
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GCD SD, GCT SD, GCD OD, GCT OD) and one blank containing no capsule, was weighed into 
50 mL centrifuge tubes containing three glass beads to facilitate agitation. Free TB was added at 
a lower quantity (0.05 g) in order to avoid excess butyrate that could create an inhospitable 
environment for bacteria or later cause quantification challenges. Appropriate amounts of tubes 
were prepared to allow for triplicate pulls at each time point (buffer, stage 1 (6 hours) and stage 2 
(18 hours)) and one set of tubes for each inoculum donor/pull time for fermentation (3 donors, 4 
pull times [0, 4, 8, 12 hours]). 
To each tube, 12.5 mL phosphate buffer (Appendix D, item 1) was added and gently 
mixed. Tubes being pulled at this stage were centrifuged (6,750 x g for 15 minutes), and a 4 mL 
subsample was removed from the supernatant. Then, 1 mL of 25% m-phosphoric acid (Appendix 
D, item 20) was added to the substrate. After standing for 30 minutes, the sample was 
centrifuged (20 minutes at 20,000 x g). Then, supernatant was transferred to two 1.5 mL 
microfuge tubes and frozen for later analysis using a gas chromatograph equipped with a flame 
ionization detector (GC-FID). 
To the remaining tubes continuing on to the first stage of digestion (stomach phase), 5 
mL of HCl: pepsin solution (Appendix D, item 2) was added with the pH adjusted to reach 1.8-
2.0. To the tubes entering the first and second stage, 0.25 mL chloramphenicol (Sigma, St. Louis, 
MO) solution (Appendix D, item 3) was added to act as a bacteriostatic agent. Once all solutions 
were added, tubes were sealed with rubber stoppers and gently vortexed. Tubes were incubated 
at 39°C for 6 hours in a heated, agitated, water bath. 
After incubation, 4 mL of 0.5N NaOH was added to each tube. If necessary, additional 
NaOH was added to reach a pH of 6.8. Tubes pulled at this stage were centrifuged (6,750 x g for 
15 minutes), and a 4 mL subsample was removed from the supernatant. Then, 1 mL of 25% m-
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phosphoric acid was added to the substrate. After standing for 30 minutes, the sample was 
centrifuged (20 minutes at 20,000 x g). Then, supernatant was transferred to two 1.5 mL 
microfuge tubes and frozen for later GC-FID analysis.  
The remaining tubes continuing on to the second phase of digestion (small intestine), 5 
mL of pancreatin (Sigma, St. Louis, MO): phosphate buffer (Appendix D, item 5) was added and 
gently mixed. All tubes were stoppered and placed into the same agitating water bath at 39°C for 
18 hours. Tubes pulled at this stage were centrifuged (6,750 x g for 15 minutes). A sub-sample of 
the supernatant was transferred to a centriprep-10 centrifuge filter for high performance liquid 
chromatography (HPLC) analysis of free monosaccharides.  
From the remaining supernatant, 4 mL was removed and 1 mL of 25% m-phosphoric acid 
was added to each tube. After standing for 30 minutes, the sample was centrifuged (20 minutes at 
20,000 x g). Then, supernatant was transferred to two 1.5 mL microfuge tubes frozen for later 
GC-FID analysis. Those tubes continuing on to the fermentation stage were freeze-dried and 
stored for later use.  
 5.3.2.3 In vitro digestion analysis 
 5.3.2.3.1 Quantification of microcapsule and control total butyrate content 
In order to determine the amount of butyrate contained in each gram of microcapsule, 
their appropriate controls, and free TB, the method of Lepage and Roy (1986) was used. Each 
sample was weighed in 0.1 g amounts into 16 x 125 mm screw-cap test tubes. One mL of a fatty-
acid internal standard solution (C5:0, valeric acid, 1g/L) (Appendix E, item 3) was diluted 50 x 
with hexane. From this diluted internal standard solution (Appendix E, item 4), 2 mL was added 
to each tube. Next, 3 mL of methanolic-HCl solution (Appendix E, item 5) was added before the 
sample was heated at 100°C for 1 hour. Sample tubes then were cooled to room temperature and 
2 mL of hexane (Appendix E, item 1) was added. Slowly, 5 mL of potassium carbonate solution 
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(Appendix E, item 6) was added before the sample was vortexed and centrifuged 300 x g for five 
minutes. The supernatant was pipetted into 16 x 100 mm disposable test tubes and dried under a 
stream of nitrogen protected from light. Samples were brought up to 2 mL using hexane before 
being transferred to GC vials for analysis.  
 Butyrate content was quantified using a GC-FID (HP 5890A) containing a fused silica 
capillary column (100 m, 0.25 mm i.d.) coated with SPTM-2500 (24056, Supelco, Inc., 
Bellefonte, PA), 100% cyanopropylsilicone stationary phase (0.20 μm thickness). GC-FID 
parameters, utilized, including carrier gas, injection volume, temperature programs, calibration 
standards, and other pertinent information, can be found in the American Oil Chemists’ Society 
(AOCS) official method Ce-1J-07. 
The mg of fatty acid/g of sample on a dry matter basis (DMB) expressed as butyrate was 
determined using the following equation: mg fatty acid/ gram of sample (DMB) =  area of butyrate peak
area of internal standard peak ∗  0.4 mg Internal Standardg sample (DMB)  
The external standard used was C4:0 (butyric acid). 
5.3.2.3.2 Quantification of butyrate content released during digestion 
In order to determine the amount of butyrate released on a percentage and molar basis, 
the method of Erwin and others (1961) was used. Prepared samples (section 5.3.2.2) were 
thawed and centrifuged for 5-10 minutes in order to separate out precipitated proteins present 
due to the freeze/thaw process. Sample vials then were directly injected into the GC-FID 
described in section 5.3.2.3.1 with a different column and set of parameters. A glass (6’ x 14” 
OD X 4 mm ID) packed (Supelco, 10% SP1200/ 1% H3PO4 on 80/100 mesh Chromosorb-
WAW) column was used. The GC-FID program used a nitrogen flow (48-52 psi) with an inject 
ion temperature of 175 °C, detector temperature of 180°C, and an oven temperature at 125 °C for 
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20 minutes. Additional information regarding the methodology, column specifics, and 
parameters also can be found in the Supelco Inc., Bulletins 748 C and E. 
Butyrate content then was determined using the following equation: 
µg SCFA/g sample (DMB) = Area count butyrate∗ correlation factor∗ (tube volume)∗1.25
Sample wt.∗ %DM  
5.3.2.4 In vitro fermentation 
In vitro fermentation methods were modeled after those discussed by Boisen (1991), 
Boisen and Eggum (1991), and utilized by Bourquin and others (1993), de Godoy and others 
(2009), and Li and others (2012). 
On the day prior to inoculation, freeze-dried (Dura-Dry, FTS systems, Stone Ridge, NY), 
frozen tubes were thawed and had 26 mL media (Appendix D, item 15) added to each tube. All 
tubes were sealed with stoppers that had Bunsen valves to allow for one way air flow. Tubes 
were hydrated at 4°C for 12 - 16 hours before inoculation.  
In order to prepare an inoculum to simulate the large intestinal microbiota, fecal samples 
were collected from three human subjects. Subjects were screened prior to participation and 
provided informed consent before their participation in the study. All chosen subjects were male, 
over the age of 18, had not taken antibiotics for three months, and consumed a normal diet. 
Subject recruitment, screening materials, collection methods, and panelist remuneration ($50) 
were approved by the University of Illinois Institutional Review Board (IRB) (IRB Protocol 
Number: 14906). 
Subjects were provided with a fecal collection device (Commode Specimen System, 
Coviden, Dublin, Ireland) that they used to collect their first morning stool. Subjects delivered 
their stool within 15 minutes of defecation and their stool was maintained at 37°C prior to use. 
Fecal samples from the three subjects were pooled using an equal weight of feces from each 
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sample to create an inoculum. Weighed feces was diluted 1:10 in anaerobic diluting solution 
(Appendix D, item 19) and blended for 15 seconds in a Waring blender (Waring Products, 
Conair Corporation, Stamford, CT) under CO2. The mixture was filtered through four layers of 
cheesecloth into serum bottles sealed under CO2. All tubes, including blanks, free 
monosaccharides (section 5.3.2.5.1.2), and continuing samples, were aseptically injected with 4 
mL of fecal inoculum and stored at 39°C for 0, 4, 8, and 12 hours with light, regular mixing.  
At each time point, specified tubes were pulled their contents checked for pH (Denver 
Instrument Co). A 4 mL subsample was pulled from the tube, and 1 mL of 25% m-phosphoric 
acid was added to the substrate. Samples sat for 30 minutes, were centrifuged for 20 minutes at 
20,000 x g and the supernatant transferred into two, 1.5 mL microfuge tubes. Samples then were 
frozen and stored until ready for butyrate quantification using GC-FID.  
5.3.2.5 In vitro fermentation analysis 
 5.3.2.5.1 Quantification of butyrate content produced 
To quantify the butyrate content produced in each tube from the microencapsulated 
substrates, the same GC-FID and measurement techniques described in section 5.3.2.3.2 were 
utilized. However, corrections for butyrate content were made for butyrate present in the fecal 
inoculum and free monosaccharides remaining after digestion. Once the amount of butyrate 
produced from the inoculum and the free monosaccharides was quantified, the amount of 
butyrate produced during fermentation could be determined. 
5.3.2.5.1.1 Correction for butyrate content due to fecal inoculum 
 To correct for butyrate content produced from the fecal inoculum, an equal amount of 
inoculum was injected into blank tubes in triplicate for each time point. Butyrate content was 
measured at each time point (0, 4, 8, 12 hours) and subtracted from the total butyrate produced at 
each time point from the tubes that entered fermentation after the other stage of digestion. 
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Butyrate content was quantified using the same GC-FID and methods described in section 
5.3.2.2.2. 
5.3.2.5.1.2 Correction for butyrate content due to free monosaccharides 
 During in vivo digestion, released monosaccharides are normally absorbed in the small 
intestine; in vitro, however, this does not occur. Since these monosaccharides serve as an energy 
source for bacteria to produce butyrate, they must be accounted for. To do this, HPLC was used 
to determine the amount of monosaccharides released in each sample throughout digestion. Each 
sample was analyzed by HPLC (ICS 3000, Dionex, Thermo Scientific, Sunnyvale, CA) using 
water as the eluent with post-column NaOH (0.185 mmol) added to adjust the pH to >12.4. A 
flow rate was set at 1 mL/min at room temperature. The column used was a CarboPac PA1 
(Dionex, Thermo Scientific, Sunnyvale, CA) (4 × 250 mm and 2 × 250 mm) and the unit 
contained an electrochemical pulsed amperometric detector (PED). All other HPLC parameters 
including eluent times, concentrations, conditions, and internal standard solutions are detailed in 
Bourquin and others (1990). 
 Once the monosaccharide content of each tube was calculated, a blank was created to 
contain the exact weight of monosaccharides present in its corresponding tube. These 
monosaccharide blank tubes were placed in the fermentation tubes to undergo the same process 
as sample tubes. At each pull time, these tubes were treated the same as sample tubes described 
in section 5.3.2.2 and underwent butyrate analysis discussed in section 5.3.2.3.2.  
The butyrate content of these tubes, along with that determined from the fecal inoculum 
in section 5.3.2.3.1.1, could then be subtracted from the total butyrate produced during section 
5.3.2.5.1 to quantify the amount of butyrate produced by the test sample only. 
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5.3.2.6 Statistical analysis 
Analysis of variance (ANOVA) was conducted using the PROC ANOVA function of 
Statistical Analysis Software (SAS)® Enterprise Guide® (Version 4.3, SAS Institute Inc., Cary, 
NC) to detect overall significant differences (α<0.05). The least significant difference (LSD) test 
was utilized to find specific differences (α<0.05) in the data when overall differences were 
present.  
 
 
5.4 Results and discussion 
 5.4.1 In vitro digestion 
Overall differences (p<0.001) in butyrate release (percentage and mmol/g DMB) were 
shown between microcapsules at all stages of the simulated digestive tract (buffer, 1st and 2nd 
stage). These differences are shown in Table 5.1. In the buffer (oral) stage, GCT OD released a 
significantly lower amount (%) of its total butyrate than any other TB-containing microcapsule 
(GCT SD, p=0.001; WAST, p=0.003; WAT, p=0.002). While the percentage of released butyrate 
from GCT OD was not significantly different from free TB (p=0.069), these microcapsules 
released different (p<0.0001) mmol/g (DMB) concentrations of butyrate - GCT OD released 
0.011 mmol/g (DMB) and free TB released 0.135 mmol/g (DMB). All GCD-based 
microcapsules released less butyrate on a molar basis in the oral phase than WAT (GCT SD, 
p=0.015 and GCT OD, p=0.011) and WAST (GCT SD, p=0.024 and GCT OD, p=0.018) (Table 
5.2). 
In the buffer (oral) phase, the significant decrease in percentage release of butyrate for 
GCT OD as compared to all other TB-containing microcapsules may partially explain its 
improved sensory performance (Chapter 4). On a molar basis, GCT SD and GCT OD released 
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significantly less butyrate than WAT and WAST. This is likely the improved performance (not 
significantly different from the control) of GCT OD’s in the R-index measure by the rating test. 
However, the lack of a significant difference in the molar concentration of butyrate released 
between GCT SD and GCT OD does not explain why GCT SD was significantly different from 
the control formula. As observed in Chapter 4, GCT SD had an R-index value of 71.62%. This 
was significantly different from the noise (n=165, α=0.05, R-index cutoff= 57.95%) while GCT 
OD was not (50.23%). These two samples are comprised of the same formula (50% solids, 3:1 
GCD: TB ratio) but differ only in their methods of drying. Therefore, their different 
performances in the oral cavity during the rating test (R-index measure) and their similar release 
of butyrate in vitro represents a disparity between the findings. This disparity may be explained 
by 1) morphological structural differences, 2) processing conditions, and 3) compositional 
differences between buffer and actual saliva. 
When examining environmental scanning electron microscopy (ESEM) images (Chapter 
3, Figures 3.7 and 3.8), it is clear that the drying of GCT SD altered the morphological structure 
of the GCD-based microcapsule. The spray drying of materials produces a matrix style 
microcapsule structure (Sheu and Rosenberg 1995; Sheu and Rosenberg 1998; Hogan and others 
2001). These structures contain a large central void (produced during the expansion and 
contraction of the particle) with a thin wall containing small air pockets near the particle surface. 
These small air pockets isolate the microencapsulated core from the surface. As a spray dried 
microcapsule, GCT SD exhibited this morphology. Images taken using ESEM (shown in Chapter 
3) however, revealed that GCT OD maintains its crystalline structure (Figure 3.7) when oven 
dried, lacking the matrix style morphology that GCT SD possesses (Figure 3.8). Due to the 
strong taste qualities of TB, close proximity of TB to the microcapsule surface in GCT SD may 
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have led to its increased detection in the formula system. Therefore, microcapsule structure may 
have influenced TB, and butyrate’s perception in the oral cavity.  
If free TB existed on the surface of either microcapsule and was released into the saliva, 
the potential for possible free GCD to complex free TB exists. However, the exposure of GCT 
SD to temperatures of 90°C during spray drying may have damaged the GCD-TB complex 
releasing TB (Del Valle 2004). Because of the disruption to any free GCD and the GCD-
complex, GCD may be unable to encapsulate any released TB from GCT SD in the oral cavity or 
food matrix. In this case, the equal molar concentration release of butyrate in vitro, but different 
perception in vivo, may be partially explained by the ability of GCD from GCT OD to complex 
free TB in the oral cavity. 
While saliva is 99% water (McClements and Lia 2010), the buffer phase of this in vitro 
model contained only sodium phosphate. It did not contain any salivary digestive enzymes, salts, 
or minerals often found in the saliva (Versantvoort and others 2005; Benedé and others 2014; 
Alminger and others 2014). Therefore, the ability of these enzymes to act on the microcapsule 
structure may have influenced the release of TB in a way not observable by the in vitro model. 
These enzymes, including alpha-amylase, may be able to break down the structure of GCT SD 
and GCT OD differently, improving the release of TB in GCT SD. The ability of free GCD to 
complex free TB in saliva or phosphate buffer may vary. Therefore, the actual release of TB, or 
butyrate, in the oral cavity may be different in vivo explaining the disparity between these two 
capsules performance in the R-index measure. 
In the 1st (stomach) stage of digestion, overall significance was noted between butyrate 
percentage release (p<0.001) and butyrate concentration (p<0.001) between microcapsules. 
Percentage total butyrate release in GCT OD was not significantly different that WAST 
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(p=0.069). GCT SD (p=0.207) was significantly lower than the release of WAT (p=0.013). 
Overall, no TB-containing microcapsule released less than 5% of its total butyrate content in the 
buffer (oral) and 1st (stomach) phase of digestion combined (WAT= 3.87%, WAST= 4.11%, 
GCT SD= 4.4%, GCT OD= 4.48%) as noted in Table 5.1 with specific molar concentrations 
found in Table 5.2.  
The low percentage of total butyrate released in this area is promising for all 
microcapsules. Butyrate elicits its beneficial effects in the intestinal lining and not in the oral or 
gastric cavity. Despite the highly acidic environment present in the stomach (1st) phase (pH 
between 1.6-1.8), these microcapsules were able to avoid degradation and release of their 
internal butyrate contents. Other researchers have shown the ability of protein-based 
microcapsules to protect encapsulated core materials from the acidic environment of the stomach 
(Picot and Lacroix 2004). The whey protein used for the encapsulation of TB was a high-acid 
stable, WPI protein. This acid-stable network, along with the physical separation of TB from the 
acidic environment, may be responsible for its lack of butyrate release at this stage. Similarly, 
GCs are increasingly resistant to acid degradation as compared to linear sugars (Uekama and 
others 1998). This acid stability, however, is a function of pH, time, and temperature (Das and 
others 2013). Previous literature (Schonberger and others 1988) has demonstrated the stability 
(resistance to hydrolysis) of GCD held in an HCl solution (0.2 M, a pH of roughly 0.7) at 70°C, 
to be approximately 7 hours. The conditions of the 1st stage of digestion (pH of 1.8-2.0, 39°C, 6 
hours) were less acidic and at a lower temperature than the environmental conditions observed in 
the Schonberger (1988) research. This may explain the resistance of our complex to survive the 
acidic stomach conditions (Uekama and others 1998). 
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In the 2nd stage (small intestine) of digestion, a majority of total butyrate content for all 
TB-containing microcapsules was released (Table 5.1). All TB-containing microcapsules were 
not different (p>0.05) from one another in total percentage of butyrate release; WPI-based (with 
or without inulin) or GCD-based microcapsules did not vary in their ability to protect butyrate 
from being released at this stage of digestion. While some significant differences were observed 
in the molar concentration of butyrate released at this stage, GCT SD and GCT OD released less 
butyrate (p<0.001) on a molar basis than any WPI-based microcapsules or free TB. Their 
inherent differences in TB content on a DMB basis is the primary reason for this differentiation. 
The reasoning for the large release of butyrate at this section of digestion is primarily related to 
the digestive enzymes used. 
 In this stage of digestion, the enzyme, pancreatin, was included. Pancreatin is a mixture 
of enzymes (such as protease, amylase, and lipase) normally released by the pancreas during 
digestion (Whitcomb and Lowe 2007). With over 80% of the enzymes by weight being proteases 
(Whitcomb and Lowe 2007), the presence of pancreatin contributes to the breakdown of WPI-
based microcapsules and release of TB. The inclusion of inulin did not provide any added 
protection to the WPI-based microcapsules. Despite inulin’s inability to be digested by α-
amylase present in the small intestine, it did not decrease the percentage of total released butyrate 
in WPI-protein based microcapsules. Once the protein wall structure was disrupted by small 
intestinal enzymes, the conversion of TB to butyrate was facilitated by lipases contained in 
pancreatin.  
The digestive enzyme, α-amylase, is primarily responsible for the breakdown of 
carbohydrates in the small intestine (Whitcomb and Lowe 2007). This enzyme is able to act on 
α-1,4-linkages of glucose molecules. Cyclodextrins are repeating units of glucose linked by α-
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1,4-linkages and, thus, susceptible to digestion by these enzymes (Del Valle 2004). This 
enzymatic degradation is what ultimately led to the release of TB in this region of the intestine 
and subsequent conversion to butyrate (Whitcomb and Lowe 2007). 
As shown in Table 5.2, WAT released 1.35 mmol/g (DMB), WAST released 1.29 
mmol/g (DMB), GCT SD released 0.57 mmol/g (DMB), and GCT OD released 0.72 mmol/g 
(DMB) of butyrate. The delivery of butyrate to this section of the gut can play an important role 
in the development of intestinal structure and health for those individuals with disease states such 
as short bowel syndrome (SBS) (Bartholome and others 2004). Barthlome and others (2004), 
using total parenteral nutrition (TPN) supplemented with a molar concentration of butyrate at 9 
mmol/L in piglets with simulated SBS, observed improvements in intestinal structure including 
significant increases in jejunal and ileal weight, cell production in the ileum, duodenum, 
jejunum, and increased ileal villus height and surface area. These improvements in intestinal 
structure and markers are important for the transition of infants with SBS from parenteral to 
enteral feedings (Bartholome and others 2004). Furthermore, the use of SCFA in TPN can help 
to limit mucosal atrophy normally associated with TPN (Koruda and others 1990). The delivery 
of butyrate also can improve overall small intestinal health. Kotunia and others (1994) observed 
significant increases in body weight and jejunum and ileum crypt depth, villus length, and 
mucosal thickness for neonatal pigs fed butyrate-supplemented formulas. The butyrate levels 
used in this research (0.3 g of butyrate/100 g of diet) also could be achieved based on the feeding 
schedule and weight of the target system. The microcapsules examined in this research would be 
able to deliver butyrate at these levels to the small intestine through administration of roughly 7- 
16 g of powder per day. 
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5.4.2 In vitro fermentation 
 Correcting for butyrate content produced by monosaccharide fermentation and butyrate 
presence in the inoculum used, the amount of butyrate produced at the 4th (ascending colon), 8th 
(transverse colon), and 12th (descending colon) hours are shown in Table 5.3.  
During fermentation, the bacteria primarily residing in the colon are carbohydrate-
fermenting bacteria (Cummings and Macfarlane 1997; Wong and others 2006). These bacteria 
are able to break down carbohydrates that were not digested in the small intestine. This anaerobic 
process produces a variety of SCFA’s including acetate, propionate, butyrate, and other gases 
(H2, CO2) (Cummings and Macfarlane 1997; Wong and others 2006). While proteins can serve 
as fermentative source for SCFA production, carbohydrate fermentation dominates as the source 
for colonic SCFA production (Cummings 1981). Therefore, it was expected that across all times, 
WPI-based microcapsules produced significantly less butyrate than GCD-based microcapsules 
during fermentation. This was observed in the 4th hour (ascending colon), 8th hour (transverse 
colon), and 12th hour (descending colon) of fermentation, where WPI-based microcapsules 
produced less butyrate than all GCD-based microcapsules (GCT OD, p<0.001 for WAT and 
WAST; GCT SD= p<0.001 for WAT and WAST) at all time points.  
While proteolytic bacteria will break down proteins to form butyrate, the dominant 
saccharolytic bacteria in this region have a limited source of energy with WPI-based samples. 
This may explain some of the reduction, or negative values, of butyrate production observed 
during fermentation for WAS and WA microcapsules. Due to the limited energy resources 
available, bacteria may breakdown available butyrate to serve as an alternate energy source. 
Even the presence of inulin, a fermentable carbohydrate, in WAST microcapsules led to a 
significant increase in butyrate production during the 4th (0.19 mmol/g, p=0.085) and 8th (0.27 
mmol/g, p=0.092) hour as compared to WAT (hour 4: 0.09 mmol/g; hour 8: 0.12 mmol/g). All 
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WPI-based microcapsules had molar concentrations of butyrate significantly lower than any 
GCD-based microcapsule. Therefore, while WPI-based microcapsules are able to protect and 
deliver butyrate to the small intestine, they are unable to produce butyrate efficiently in the large 
intestine.  
The presence of SCFAs are essential to the health of the entire large intestine. These 
SCFAs are important for colonic epithelium cell transport, and in the metabolism, growth, and 
differentiation of colonocytes (Cummings and Macfarlane 1997). Butyrate is important to the 
proximal and distal colonic epithelium, providing 60-70% of their total energy (Cummings and 
Macfarlane 1997). However, a majority of bacterial fermentation occurs in the proximal colon. 
This leaves distal areas of the colon with lower butyrate concentrations (Macfarlane and others 
1992). Despite its decreased concentration, butyrate plays an important role in the health of distal 
colon tissue as decreased concentrations are associated with certain cancers and intestinal 
disorders (Wong and others 2006). Overall during fermentation, individual GCD-based 
microcapsules significantly increased (GCD OD, GCT OD, GCD SD, and GCT SD, p<0.001) 
their butyrate production over the three specified time points, providing butyrate production at 
higher levels even in later regions of the colon. 
Microcapsules that are GCD-based target all areas of the colon, with increased butyrate 
production across at each time point. Significant differences in butyrate production are observed 
at the 8th and 12th hours of fermentation between microcapsules. At the 8th hour, GCT OD 
produced significantly more butyrate (p=0.043) than GCT SD (1.32 mmol/g vs. 1.14 mmol/g, 
respectively); however, GCD OD produced significantly more butyrate than GCT OD (p=0.032), 
GCT SD (p<0.001), and both WPI-based microcapsules (p<0.001). A similar trend is seen in the 
12th hour with GCD SD. While the difference in butyrate production was not significantly 
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different (p=0.717) between GCT SD and GCT OD, another non-TB-containing microcapsule, 
GCD SD, produced significantly more butyrate than GCT OD (p=0.01), GCT SD (p=0.021), 
WAT (p<0.001), and WAST (p<0.001). The reason for this difference may lie in the ease that 
saccharolytic bacteria can ferment complexed and native GCs.  
Carbohydrate fermentation by bacteria is influenced by carbohydrate complexity (more 
complex, more difficult to ferment), size (larger, more difficult to ferment), and processing 
conditions (changes in microstructure) (Rabiu and Gibson 2002). The exact microstructure of the 
GCD complexes with TB are unknown, but their interaction with TB would alter their structure 
compared to native GCD. This structural alteration most likely affected the ability of bacteria to 
ferment GCD, causing an increase in fermentation to occur in a control or non-complexed GCD. 
Despite these differences, GCT OD and GCT SD were still about to produce butyrate in areas of 
the intestine normally limited in carbohydrate fermentation (Macfarlane and others 1992; Rabiu 
and Gibson 2002; Wong and others 2006). 
Butyrate production and delivery to the large intestine (accomplished only by GCD-based 
microcapsules) has shown improvement for the treatment of selected intestinal disorders and in 
the general maintenance of a healthy colon. The distal colon is primarily where polyps that have 
the potential to cause colon cancer (Hawk and Levin 2005) are found (McIntyre and others 
1993). For all GCD-based microcapsules, there were increases in butyrate production between 
hours 4 and 8 (GCD SD, GCT SD, GCD OD, and GCT OD, p<0.001) and hours 8 and 12 (GCD 
SD, p<0.001; GCT SD, p=0.001; GCD OD, p=0.017; GCT OD, p<0.001). Gamma-cyclodextrin-
based microcapsules produced significantly higher (p<0.001) concentrations of butyrate in the 
descending colon region (12th hour) compared to any other time point. Treatment of human colon 
cancer cell lines with butyrate has been shown to increase cancer cell apoptosis at concentrations 
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ranging from 2-4 mmol (Hague and others 1993) and 5 mmol (Heerdt and others 1994). The 
potential action of butyrate in inducing apoptosis is unknown but heavily debated in the scientific 
literature (Wachtershauser and Stein 2000; Lupton 2004; Wong and others 2006; Hamer and 
others 2008). The concentrations of butyrate administered to colon cancer cell lines mentioned 
above could be easily achieved using the GCD-based microcapsules investigated in this research. 
The efficacy of this capsule, however, in the treatment of colon cancer in vivo would need to be 
investigated before recommendations surrounding its use could be made. 
Butyrate usage also has been helpful to patients with ulcerative colitis (UC). This disease 
can affect specific parts of the colon (most typically the descending/ rectum regions) or the entire 
colon and is characterized by cramping, abdominal pain, and loose stools. It is brought on by an 
immune response that induces inflammation and ulceration in the large intestine (The Mayo 
Clinic 2014). Connections between low butyrate concentrations and utilization by the intestinal 
lining have been associated with UC (Roediger 1980; Wachtershauser and Stein 2000; Wong and 
others 2006; Hamer and others 2008). Microcapsules containing GCD that produced 
significantly higher quantities of butyrate than WPI-based microcapsules would thus be better 
candidates for the targeting of all areas of the large intestine affected by UC. Treatment of UC 
using butyrate or mixed SCFA enemas has been examined in the scientific literature using 
human models with varied results. Some studies have noted reductions in inflammation, the 
onset of clinical remission (Patz and others 1996), reductions in stool frequency, blood 
discharge, and inflammation (Scheppach and others 1992) while others have observed no 
significant clinical effects (Steinhart and others 1996). Discrepancies in results may be due to a 
variety of factors including molar concentrations utilized, patient prior health, and duration and 
frequency of use (Wong and others 2006). Butyrate concentrations utilized in human enema 
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treatment exist within a wide range (40-100 mmol) (Scheppach and others 1992; Patz and others 
1996; Steinhart and others 1996). Reaching these butyrate concentrations may be challenging 
with the orally developed microcapsules; however, the use of enemas comes with its own 
challenges. This form of treatment has low long-term compliance rates, the potential to be easily 
improperly used, and difficulties controlling exposure time (Breuer and others 1997; Immerseel 
and others 2010; Leonel and Alvarez-Leite 2012). Therefore, use of a controlled release of 
butyrate in the form of the GCD-based microcapsules developed may be able to accomplish 
similar improvements at lower butyrate concentrations. The efficacy of this capsule, however, in 
the treatment of colon cancer in vivo also would need to be investigated before conclusions 
surrounding its use could be made. 
 
 
5.5 Conclusion 
With less than 5% of total butyrate content released in the oral and gastric phases of 
digestion for all microcapsules, WPI and GCD-based microcapsules successfully delayed 
butyrate release to the small intestine. Once in the small intestine, microcapsule formulation did 
not play a significant role in the release of butyrate; all microcapsules released roughly 75% of 
their butyrate contents. The production of butyrate in the large intestine is best accomplished by 
GCD-based microcapsules. Gamma-cyclodextrin acts as a readily available source of energy for 
the saccharolytic bacteria residing in the large intestine to produce additional butyrate. TB 
containing GCD-based microcapsules were the only microcapsules investigated that were able to 
deliver butyrate to the small intestine and stimulate significant butyrate production across all 
areas of the large intestine. As shown in Chapter 4, GCT OD was not significantly different from 
a control infant formula without TB in the R-index measure. This microcapsule formulation is 
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also able to protect butyrate from gastric release and provides a good substrate for butyrate 
production in the large intestine. The microcapsule GCT OD is advantageous compared with 
WPI-based microcapsules in its ability to release and produce butyrate in vitro. GCT OD is also 
advantageous compared with GCT SD due to GCT SD’s significant sensory difference from a 
control formula as determined by the rating method (Chapter 4). Therefore, GCT OD is the most 
effective microcapsule at minimizing the sensory impact of TB and for oral delivery of butyrate 
to the small intestine and butyrate production in the large intestine. 
The utilization of GCT OD may benefit the lives of individuals with butyrate-responsive 
intestinal disorders of the small and large intestines (Scheppach and others 1992; Hague and 
others 1993; Kotunia and others 1994; Patz and others 1996; Bartholome and others 2004). It 
also could be used for the possible improvement or maintenance of overall intestinal health as 
butyrate plays an essential function in the maintenance of normal intestinal structure (Cummings 
1984; Cummings and Macfarlane 1997). Understanding the impact GCT OD on specific sensory 
modalities in different food matrices is important for the utilization of this compound in oral 
delivery. While R-index measurements can determine how microcapsules alter a food system 
compared to a control on a global sensory level, it does not provide information related to the 
specific impact on product sensory modalities. Additionally, it is unknown how a complex such 
as GCT OD will behave in a food system with different physical and chemical properties than 
formula. When the impact of GCT OD on the specific sensory properties of several foods is 
known, additional recommendations for food products can be made to facilitate the use of this 
complex for a therapeutic benefit. 
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5.7 Tables 
Table 5.1: Average butyrate release (%) within all stages of digestion 
 Butyrate release (%) 
Sample Buffer Phase: 
Oral† (±SEM)# 
1st Phase: 
Stomach† (±SEM)# 
2nd Phase: Small 
Intestine† (±SEM)# 
Free TB 1.32 (±0.12)AB 2.73 (±0.10)AB 77.16 (± 2.15)C 
WA 0.85 (±0.22)C 0.66 (±0.24)C 93.88 (± 1.56)A 
WAT 1.51 (±0.01)A 2.27 (±0.01)B 76.32 (±1.86)C 
WAS -0.09 (±0.03)D 0.10 (±0.04)C 87.92 (±0.25)B 
WAST 1.51 (±0.10)A 2.60 (±0.10)AB 76.66 (±1.00)C 
GCD SD 0.00D†† 0.00C†† 0.00D†† 
GCT SD 1.54 (±0.03)A 2.86 (±0.03)AB 76.07 (±0.58)C 
GCD OD 0.00D†† 0.00C†† 0.00D†† 
GCT OD 1.08 (±0.01)BC 3.40 (±0.01)A 73.93 (±0.26)C 
Free TB: unencapsulated tributyrin; WA: whey protein isolate, anhydrous milk fat; WAT: whey protein 
isolate, anhydrous milk fat, tributyrin; WAS: whey protein isolate, anhydrous milk fat, short chain inulin; 
WAST: whey protein isolate, anhydrous milk fat, short chain inulin, tributyrin; GCD SD: gamma-
cyclodextrin spray dried; GCT SD: gamma-cyclodextrin and tributyrin spray dried; GCD OD: gamma-
cyclodextrin oven dried; GCT OD: gamma-cyclodextrin and tributyrin oven dried 
All averages were taken from triplicate measurements 
†Samples within the same phase of digestion with the same superscript letter are not different from one 
another (p<0.001) 
# Standard error of the mean values 
††These samples did not contain tributyrin and had no ingredients that act as a source of butyrate; 
therefore, they had no potential to release butyrate 
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Table 5.2: Average butyrate release (mmol/g DMB) within all phases of digestion 
 Butyrate release (mmol/g DMB) 
Sample Buffer Phase: Oral† 
(±SEM)# 
1st Phase: Stomach† 
(±SEM)# 
2nd Phase: Small 
Intestine† (±SEM)# 
Free TB 0.135 (±0.01)A 0.28 (±0.01)A 7.89 (±0.22)A 
WA -2.0x10-3 (±4.7x10-4)C 1.4x10-3 (±6.3x10-4)D 0.20 (±3.0x10-3)D 
WAT 0.03 (±2.5x10-4)B 0.04 (±3.4x10-4)B 1.35 (±0.33)B 
WAS -1.4x10-4 (±3.8x10-5)C 1.0x10-4 (±6.9x10-5)D 0.13 (±1.7x10-4)D 
WAST 0.03 (±1.6x10-3)B 0.04 (±1.0x10-3)B 1.29 (±0.02)B 
GC SD 3.0x10-3 (±1.4x10-4)C 2.0 x10-3 (±1.5x10-3)D 5.0x10-3(±0.07)D 
GCT SD 0.01 (±2.2x10-4)C 0.02 (±2.5x10-4)C 0.57 (±4.4x10-3)C 
GC OD 7.0x10-3 (±1.1x10-3)C 3.3x10-3 (±3.4x10-3)D -1x10-3 (±2.1x10-4)D 
GCT OD 0.01 (±7.5x10-5)C 0.03 (±8.4x10-3)BC 0.73 (±3.2x10-3)C 
Free TB: unencapsulated tributyrin; WA: whey protein isolate, anhydrous milk fat; WAT: whey protein 
isolate, anhydrous milk fat, tributyrin; WAS: whey protein isolate, anhydrous milk fat, short chain inulin; 
WAST: whey protein isolate, anhydrous milk fat, short chain inulin, tributyrin; GCD SD: gamma-
cyclodextrin spray dried; GCT SD: gamma-cyclodextrin and tributyrin spray dried; GCD OD: gamma-
cyclodextrin oven dried; GCT OD: gamma-cyclodextrin and tributyrin oven dried 
All averages were taken from triplicate measurements 
†Samples within the same phase of digestion with the same superscript letter are not different from one 
another (p<0.001) 
# Standard error of the mean values 
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Table 5.3: Butyrate production (mmol/g DMB) within each stage of fermentation 
 Sample 4th Hour (mmol/g)† 8th Hour (mmol/g)† 12th Hour (mmol/g)† 
Free TB 1.21 (±7.4x10-2)A 1.87 (±5.0x10-2)B 1.52 (±8.0x10-2)C 
WA -0.02 (±6.0x10-3)A 4.0x10-3 (±4.0x10-2)A 0.26 (±2.0x10-2)B 
WAT 0.09 (±2.7x10-2)A 0.12 (±2.0x10-2)A 0.63 (±4.0x10-2)B 
WAS -0.15 (±1.6x10-2)A -0.19 (±2.0x10-2)A 0.25 (±0.12)B 
WAST 0.19 (±5.1x10-2)A 0.27 (±7.0x10-2)A 0.89 (±4.0x10-2)B 
GC SD 0.41(±3.8x10-2)A 1.12 (±6.0x10-2)B 1.90 (±2.0x10-2)C 
GCT SD 0.42 (±1.9x10-2)A 1.14 (±0.11)B 1.68 (±2.0x10-2)C 
GC OD 0.49 (±3.0x10-2)A 1.52 (±7.0x10-2)B 1.78 (±6.0x10-2)C 
GCT OD 0.43 (±3.0x10-2)A 1.32 (±5.0x10-2)B 1.65 (±1.0x10-2)C 
Free TB: unencapsulated tributyrin; WA: whey protein isolate, anhydrous milk fat; WAT: whey protein 
isolate, anhydrous milk fat, tributyrin; WAS: whey protein isolate, anhydrous milk fat, short chain inulin; 
WAST: whey protein isolate, anhydrous milk fat, short chain inulin, tributyrin; GCD SD: gamma-
cyclodextrin spray dried; GCT SD: gamma-cyclodextrin and tributyrin spray dried; GCD OD: gamma-
cyclodextrin oven dried; GCT OD: gamma-cyclodextrin and tributyrin oven dried 
All averages were taken from triplicate measurements 
†Within the same point, samples with the same superscript letter are not different from one another (p<0.05) 
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Table 5.4: Butyrate production (mmol/g DMB) over the course of fermentation 
 Sample 4th Hour (mmol/g) #† 8th Hour (mmol/g) #† 12th Hour (mmol/g)# † 
Free TB 1.21 (±7.4x10-2)A 1.87 (±5.0x10-2)C 1.52 (±8.0x10-2)B 
WA -0.02 (±6.0x10-3)B 4.0x10-3 (±4.0x10-2)B 0.26 (±2.0x10-2)A 
WAT 0.09 (±2.7x10-2)B 0.12 (±2.0x10-2)B 0.63 (±4.0x10-2)A 
WAS -0.15 (±1.6x10-2)B -0.19 (±2.0x10-2)B 0.25 (±0.12)A 
WAST 0.19 (±5.1x10-2)B 0.27 (±7.0x10-2)B 0.89 (±4.0x10-2)A 
GC SD 0.41 (±3.8x10-2)C 1.12 (±6.0x10-2)B 1.90 (±2.0x10-2)A 
GCT SD 0.42 (±1.9x10-2)A 1.14 (±0.11)B 1.68 (±2.0x10-2)C 
GC OD 0.49 (±3.0x10-2)C 1.52 (±7.0x10-2)B 1.78 (±6.0x10-2)A 
GCT OD 0.43 (±3.0x10-2)C 1.32 (±5.0x10-2)B 1.65 (±1.0x10-2)A 
Free TB: unencapsulated tributyrin; WA: whey protein isolate, anhydrous milk fat; WAT: whey protein 
isolate, anhydrous milk fat, tributyrin; WAS: whey protein isolate, anhydrous milk fat, short chain inulin; 
WAST: whey protein isolate, anhydrous milk fat, short chain inulin, tributyrin; GCD SD: gamma-
cyclodextrin spray dried; GCT SD: gamma-cyclodextrin and tributyrin spray dried; GCD OD: gamma-
cyclodextrin oven dried; GCT OD: gamma-cyclodextrin and tributyrin oven dried 
#All averages were taken from triplicate measurements 
†Across the same sample, time points with the same superscript letter are not different from one another 
(p<0.05) 
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Chapter 6: Descriptive Analysis of Food Products Containing 
Microencapsulated Tributyrin in Gamma-cyclodextrin 
 
6.1 Abstract 
Descriptive analysis (DA) is a sensory testing method used to characterize the complete 
attribute profile of a food product. This method is useful in the evaluation of foods with 
functional ingredients to observe the global impact these new ingredients may have on the food 
system. Tributyrin (TB) is a source of butyric acid, an important short-chain fatty acid in the 
intestinal health of humans. The use of TB and butyric acid in foods is limited by the poor 
sensory qualities they possess. Gamma-cyclodextrins and TB microcapsules that were oven dried 
(GCT OD) may enable TBs use in foods with minimal sensory impact. Utilizing a hybrid 
methodology, a DA panel examined the effect GCT OD and free TB had on three food matrices: 
apple sauce, infant formula, and crackers. Descriptive Analysis panelists (n=10, 5 females, 5 
males, ages 25-53) participated in reference generation, reference refinement, attribute scaling, 
and sample testing. Key attributes in aroma, aroma-by-mouth, texture, taste, and aftertaste 
(particularly bitter) were influenced upon the addition of free TB or GCT OD. Principal 
component analysis (PCA) biplots indicated that samples containing free TB were highly 
characterized by bitter taste and aftertaste. Infant formula and apple sauce containing GCT OD 
samples were significantly (p<0.05) reduced in bitter taste and aftertaste intensity as compared to 
TB samples. These bitter attribute intensities, however, were still significantly (p<0.05) higher 
than the control formulation for both apple sauce and infant formula. Apple sauce was also 
significantly (p<0.05) impacted by GCT OD addition with decreased apple aroma/aroma-by-
mouth and saturation as compared to the control sample. Colorimiter measures incicated that the 
panel observation of this decreased saturation was associated with the significant (p<0.05) 
increase in L values, or lightness, of the apple sauce sample. Cracker samples containing GCT 
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OD were not significantly different (p>0.05) for all measured attributes intensities as compared 
to free TB containing crackers except in bitter taste and aftertaste; GCT OD samples were 
significantly higher (p<0.05) for these two attributes. This may be attributed to heat-induced 
damage to the GCT OD complex. Overall, the inclusion of GCT OD had the least impact on the 
characterizing sensory attributes of the control infant formula sample. The impact GCT OD and 
free TB on food matrices may be related to the panel performance, product inherent bitterness, 
and the physical characteristics of the food matrix. Findings from this research can be used to 
guide the application of this encapsulated matrix in additional food products for intestinal health 
or treatment of intestinal disorders. 
 
 
6.2 Introduction 
 The incorporation of functional ingredients into food products has the potential to impact 
a variety of sensory modalities including aroma, taste, aroma-by-mouth (ABM), appearance, and 
texture. While many considerations are taken by consumers when choosing foods with added 
health benefits (Urala and Liisa Lähteenmäki 2003), the general population is unwilling to 
compromise taste in order to receive health benefits (Urala and Lähteenmäki 2004). Taste 
remains the most important factor when considering food choice for consumers (Drewnowski 
1997; Glanz and others 1998; Drewnowski and Gomez-Carneros 2000; Verbeke 2006). Many 
functional health ingredients may add bitter or other negative sensory qualities to foods 
(Drewnowski and Gomez-Carneros 2000). Due to the importance of sensory properties in food 
selection, these negative properties must be reduced or eliminated in order to produce an 
acceptable products (Ley 2008). 
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As a functional health ingredient, tributyrin (TB) is a triglyceride containing three butyric 
acid esters that possesses negative odor (cheesy, fecal) and taste (bitter) qualities. Its major 
component, butyric acid, is naturally present as butyrate in the intestine (Guilloteau and others 
2010) and is an important short chain fatty acid (SCFA) produced via microbial fermentation 
(Wong and others 2006). Butyrate is important to overall intestinal health (Cummings 1984; 
Koruda and others 1990; Kotunia and others 1994; Cummings and Macfarlane 1997) and an 
energy source for colonic epithelium (Wong and others 2006; Hamer and others 2008). Butyrate 
use has conferred beneficial effects on individuals with intestinal maladies such as short bowel 
syndrome (SBS) (Bartholome and others 2004), inflammatory bowel disease (IBD) (Scheppach 
and others 1992; Steinhart and others 1996; Vieira and others 2012), and irritable bowel 
syndrome (IBS) (Berni and others 2004; Scarpellini and others 2007). Butyrate has also been 
used in human colon cancer cell lines to decrease cancer cell proliferation (Hague and others 
1993; Heerdt and others 1994). Due to the negative sensory quality and beneficial intestinal 
activity of TB, microencapsulation may provide a method to improve these sensory properties 
and modify the intestinal release of this compound. 
Microencapsulation involves the entrapment of molecules (cores) in one or more 
materials (walls) to confer functional or protective benefits to the core or matrix, into which it is 
included. These benefits include: protection from environmental stresses, other ingredients in the 
system, improved handling and transport, controlled release, or odor and taste masking (Shahidi 
and Han 1993; Gibbs and others 1999; Desai and Park 2005; Sobel and others 2014). 
Microencapsulation is a solution for the addition of functional health ingredients that may impart 
negative sensory attributes or stability issues within the matrix they are added (Boccio and others 
1997; Szejtli and Szente 2005; Tamamoto and others 2010; Serfert and others 2010). The 
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protective effects of microencapsulation can be accomplished by either physical isolation, using 
technology such as spray drying, or chemical complexation, using compounds such as 
cyclodextrins (CDs) (Shahidi and Han 1993; Hedges 1998; Szente and Szejtli 2004; Del Valle 
2004; Gharsallaoui and others 2007). Although microencapsulation may modulate the 
functionality or sensory character of an ingredient, the overall impact of the microencapsulated 
system on the sensory properties of the food as a whole should be investigated. Descriptive 
analysis (DA) is a sensory method that is used to create a profile of product attributes and 
intensities by trained judges (Lawless and Heymann 1999; Murray and others 2001; Drake and 
Delahunty 2011). With this, an understanding of how attribute intensities change with the 
addition or adjustment of product formulations can be observed.  
The specific aim of this research was to evaluate the sensory properties of food products 
containing microencapsulated TB. It was hypothesized that overall, GCT OD and free TB would 
significantly impact the intensity of sensory attributes of food matrices based on the physical and 
chemical properties of each system. It was further hypothesized, that due to the complexation of 
TB by GCD, free TB would have increased intensity for the attributes of bitter taste and 
aftertaste than GCT OD in all food matrices. It also was hypothesized that GCT OD would result 
in a greater decrease of bitter taste and aftertaste intensity in infant formula and apple sauce 
samples, due to the ability of solubilized GCD to complex excess free TB in the higher water 
content matrices, and their lack of heat treatment, than in cracker samples.  
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6.3 Materials and methods 
 6.3.1 Materials 
 6.3.1.1 Experimental design 
The experimental design of the DA panel was a full factorial design (3 x 3), with the food 
matrices (factor 1, 3 treatments) being treated with all treatments (factor 2, 3 treatments). For 
individual booth testing, two replications were performed each session with a randomized 
blocked design. The treatment presentation order across judges was randomized within the block 
by the Williams Design. A total of two sessions were performed for four replications per 
treatment for each food matrix. 
6.3.1.2 Microcapsule production and analysis 
Microencapsulated TB was produced using gamma-cyclodextrin (GCD) and TB that was 
oven dried (OD) (GCT OD). Specific information related to microcapsule formulation and 
preparation can be found in Chapter 3, sections 3.3.2.5-3.3.2.6. The amount of TB/gram of 
particle was quantified using methods outlined in Chapter 3, section 3.3.2.8-9. 
6.3.1.3 Tributyrin dosage information 
All samples had free TB (Tributyrin 97%, FG, Sigma Aldrich, St. Louis, MO) or the 
microcapsule GCT OD included at a TB concentration of 0.2 g of TB/serving of food product. 
This concentration was chosen to be similar to the therapeutic levels used in Bartholome and 
others (2004) and similar to the physiologic levels naturally present in the intestinal tract of 9 
mmol of butyric acid. This concentration of butyric acid (9 mmol) equates to roughly 0.79 g of 
butyric acid/day, or 0.90 g of TB/day. At 0.2 g of TB per serving, the recommended amount 
could be achieved in roughly 4.5 servings of sample per day.  
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6.3.1.4 Apple sauce: rationale and preparation  
6.3.1.4.1 Apple sauce selection rationale 
 Apple sauce (Mott’s Natural Apple Sauce, Mott’s LLP, Plano, TX) was used for the 
semi-solid food matrix. General dietary guidelines for individuals with intestinal disorders (SBS, 
Colon Cancer, and IBD including Crohn’s Disease and UC) exist, however, many treatment 
resources and organizations do not advocate the use of one specialized diet (NPS 
Pharmaceuticals 2012; Crohn's and Colitis Foundation of America 2012; Beating Bowel Cancer 
2012). Individuals impacted by these intestinal disorders commonly follow suggestions to limit 
foods high in insoluble fiber, fat, dairy, grains or nuts, and wheat (NPS Pharmaceuticals 2012; 
Memorial Sloan-Kettering Cancer Center 2012; Short Bowel Syndrome Foundation 2013) as 
they can cause irritation to the bowel. It is suitable for these individuals to consume low residue 
foods such as pureed fruit. Additional information related to recommended foods and those that 
should be avoided can be found in Appendix F. Based on these guidelines, apple sauce was 
chosen. Nutritional and ingredient information for the apple sauce can be found in Appendix G.  
6.3.1.4.2 Apple sauce preparation 
 GCT OD or free TB was added with the specified amount of GCT OD (based on 
retention) or free TB to reach a TB concentration of 0.2 g TB/ serving. The additive was 
vigorously stirred for two minutes, stored at 4°C for one hour, and then divided into 20 g 
portions in 2 oz. plastic cups. Samples were stored at 4°C and removed 30 minutes before testing 
to reach room temperature. Information related to TB or GCT OD inclusion based on retention 
and serving size can be found in Appendix H. 
6.3.1.5 Infant formula: rationale and preparation  
6.3.1.5.1 Infant formula selection rationale 
Specialized infant formulas are designed for those with a variety of intestinal maladies 
such as protein sensitive colitis, diarrhea, SBS (Abad-Sinden and Sutphen 2003) or nutrient 
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malabsorption (Abbot Laboratories 2014). One such infant formula is EleCare® Amino Acid-
based Infant Formula with Iron (http://elecare.com) manufactured by Abbot Nutrition (Abbot 
Laboratories Inc., Abbott Park, IL). This was the chosen infant formula for this DA panel. 
Nutritional and ingredient information for this formula can be found in Appendix I.  
6.3.1.5.2 Infant formula preparation 
Infant formula was prepared according to package directions (18.8 g of powder/4 oz. 
water) with the specified amount of GCT OD (based on retention) or free TB to reach a TB 
content of 0.2 g TB/ serving as indicated in Appendix J. The infant formula was vigorously 
shaken for 2 minutes, stored at 4°C for one hour, and 2 oz. was poured into a 5 oz. plastic cup. 
Samples were stored at 4°C and removed 30 minutes before testing to reach room temperature. 
6.3.1.6 Cracker: rationale and preparation 
6.3.1.6.1 Cracker selection rationale 
 Crackers were chosen as a food matrix that would be more applicable to a general 
population, or those with less serious food intolerances or digestive restrictions. The cracker, 
however, still fits within many of the guidelines listed in Appendix F (low in fat, gluten free, low 
sodium, lactose free). It is important to note that this cracker may not be suitable for all patients 
as chickpeas may not tolerated well by some individuals with IBS (Gibson and Shepherd 2010). 
It would be important that the potential use of this product is approved by a registered dietician 
caring for an individual before its use. 
6.3.1.6.2 Cracker preparation 
 An available cracker recipe (http://goo.gl/3xZLnw) was modified and used for this 
product; ingredient and nutritional information can be found in Appendix K. The dry ingredients 
including chickpea flour (garbanzo bean flour, Bob’s Red Mill National Foods, Inc., Milwaukie, 
OR), white rice flour (stone ground white rice flour, Bob's Red Mill National Foods, Inc., 
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Milwaukie, OR), flax seed meal (organic whole ground flaxseed meal, Bob’s Red Mill National 
Foods, Inc., Milwaukie, OR), baking powder (double acting baking powder, Clabber Girl 
Corporation, Terre Haute, IN), salt (Morton table salt, Morton Salt, Inc., Chicago, IL), and 
turmeric (organic turmeric, Topco Associates, LLC, Skokie, IL) were mixed thoroughly together 
in quantities listed in Appendix M. Mixing was done in a KitchenAid® mixer (KitchenAid® 
Professional 600, 6 quart, St. Joseph, MI) at a speed setting of “stir” for one minute or until all 
ingredients were evenly dispersed. If GCT OD was included, it was included with the dry 
ingredients in an amount specific to its retention, as indicated in Appendix L, to deliver 0.2 g of 
TB/ serving (28 g). Water and canola oil (All Natural Crisco Pure Canola Oil, J.M. Smucker 
Company, Orrville, OH) were added over a period of two minutes while mixing at a speed on 
“2” with the same KitchenAid® mixer. If free TB was included, it was added according to the 
amount stated in Appendix L into the canola oil. 
After two minutes of mixing, the dough was rolled into a thin sheet (~2.5 mm) using a 
dough roller (Oliver Dough Roller, model: 641-21R, Oliver Packaging & Equipment Company, 
Walker, MI), cut into 4.6 mm diameter circles using a mold, and perforated to aid in the release 
of air and gasses during baking. Crackers were then placed on parchment paper lined aluminum 
baking sheets (18” by 26”, 9 crackers in 6 rows) and placed into a commercial convection oven 
(Imperial ICVE-2, Imperial Commercial Cooking Equipment, Corona, CA) for 13 minutes. Once 
baked (~3.0 mm thickness), crackers were cooled for 30 minutes, and packaged into vacuum 
sealed (Meal Saver, VS400 Food Saver, Sunbeam Products, Inc., Boca Raton, FL) plastic 
containers (Food Saver vacuum storage containers, Sunbeam Products, Inc., Boca Raton, FL) 
and stored under ambient temperatures (25°C) away from light for no more than five days before 
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use. Prior to testing, one cracker was placed into a 2 oz. plastic soufflé cup 30 minutes before 
panel. 
 6.3.2 Methods 
6.3.2.1 Subject recruitment 
All materials related to the recruitment and panelist remuneration were approved by the 
Institutional Review Board (IRB) at the University of Illinois Urbana-Champaign (IRB Exempt 
Protocol Number: 15323). Panelists were recruited through departmental email listservs and by 
individually contacting panelists who previously participated in DA panels. Potential panelists 
were screened for basic taste acuity and 6-n-propylthiouracil (PROP) taster status. Potential 
panelists were required to identify several basic taste solutions with 80% accuracy: sucrose 
(0.7% wt/vol), sodium chloride (0.1% wt/vol), citric acid (0.05% wt/vol), and caffeine (0.024% 
wt/vol) (Mojet and others 2001). Panelists were also screened for their ability to taste the bitter 
compound PROP. Determining PROP taster status was accomplished using PROP filter paper 
(Zhao and others 2003). Only PROP tasters were invited to participate on the panel as they are 
generally regarded as more sensitive (increased numbers of taste papilla) than PROP non-tasters 
(Tepper and Nurse 1997; Tepper and Nurse 1998). The ballot used for screening can be found in 
Appendix N. After granting informed consent (Appendix O), ten chosen panelists participated in 
a DA panel. 
6.3.2.2 Descriptive analysis procedure 
A hybrid form of Quantitative Descriptive Analysis® (Stone 1992) and the Spectrum 
Method ™ (Meilgaard and others 1999) was used. Each product matrix (apple sauce, infant 
formula, and crackers) were evaluated separately for 8 days, for a total panel length of 24 days. 
The same 10 panelists evaluated all products matrices and variables. On the first day of testing, 
panelists were introduced to the specific DA hybrid method used in this study. Three sessions (1 
193 
 
hour each) were devoted to group discussion surrounding term generation, reference generation, 
reference refinement, and rinse protocol development. After references were determined, three 
sessions (1 hour each) focused on determining reference intensities to be used as anchors on a 
15-point intensity scale (discussed below). During this time, panelists worked together to 
calibrate their intensity ratings with one another to reduce variation. Before the first testing 
replication, panelists conducted practice sessions in individual sensory testing booths in Bevier 
Hall on the University of Illinois Campus for one hour using the Compusense five Plus (Version 
5.0: Guelph ON, Canada) data acquisition system. 
During individual testing, panelists were presented with a tray of references that 
corresponded to developed attributes and a list of definitions and intensity ratings for review. 
The reference tray and attribute list were made available for panelists during testing if they 
wished to exit the testing area and refresh their memory. In the individual booths, under 
incandescent lighting at 25°C, panelists were presented with the three product variables: control 
product, product containing GCT OD microcapsules, and product containing free TB during each 
of the four replications. Panelists evaluated all modalities indicating individual attribute 
intensities on 15 point, category scale. Each scale ranged from 0 to 15; with 0 indicating no 
presence of the attribute and 15 being the highest intensity of the attribute relative to the samples 
and references. Procedures relating to modality evaluation and rinse protocol established by the 
panel were strictly followed and unique to each product.  
When all replications for each panelist were completed, a new product was introduced 
and the entire DA procedure was repeated with the same panelists. Specific information relating 
to the procedures used each day can be found in Appendix P. Information related to each product 
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and the attributes developed, references chosen, and intensities agreed upon by the panel can be 
found in Appendix Q (apple sauce), Appendix R (infant formula), and Appendix S (crackers). 
6.3.2.3 Color measurements 
Due to the visual differences observed by the panelists with the addition of GCT OD to 
the apple sauce sample (discussed in 6.4.2), analytical color measurements of the three apple 
sauce samples (control, GCT OD, and free TB) were collected. Using a colorimeter (HunterLab 
Scan ® XE, Hunter Associates Laboratory, Inc., Reston, VA) the values of lightness (L*), a* 
(red/green), and b* (yellow/blue) were collected using HunterLab Universal Software (Version 
4.3, Hunter Associates Laboratory, Inc., Reston, VA). The colorimeter was standardized using 
the white tile standard (X=78.74, Y= 83.52, Z=8.38). Values on the colorimeter were collected 
by placing 12.2 g of apple sauce evenly across a 60 x 20 mm plastic Petri dish with the following 
paramters set: 0/45 mode, 44.45 mm area view, 17.78 mm port size. Values were not calculated 
for infant formula or cracker samples (all varieties) due to the lack of visual differences noted by 
the panelists. 
6.3.2.4 Statistical analysis 
 Using Statistical Analysis Software (SAS)® Enterprise Guide® (Version 4.3, SAS 
Institute Inc., Cary, NC), overall significant differences (p<0.05) were analyzed using the 
analysis of variance (ANOVA) PROC GLM function to determine the presence of significant 
differences (α=0.05) for the variations within the samples, reps, judges, and their corresponding 
interactions, rep-by-judge (R×J), rep-by-sample (R×S), judge-by-sample (J×S). When a 
significant J×S interaction existed, an adjusted sample F-ratio were calculated using Microsoft 
Excel 2013 (Version 15.0: Microsoft Corporation, Redmond, WA) by dividing the sample mean 
square by the J×S interaction mean square and calculating the new probability with the FDIST 
function. Differences in Hunter L*a*b* values were also determined using the same software 
195 
 
and statistical methods. Hunter L*a*b* values were converted to the Munsell notation of Hue 
(H), Value (V), and Chroma (C) using the Munsell conversion CMC15d sotware (Version 
12.15.1.d, Wallkill Color, wallkillcolor.com). If significant differences were present among the 
samples, the least significant difference (LSD) test was conducted to identify specific differences 
using SAS.  
Principal Component Analysis (PCA) biplots were constricted using XLSTAT (XLStat 
Pro 2015.1.01, Addinsoft SARL, New York, NY) and Microsoft Excell to further examine the 
relationships between attributes and samples by creating a visual representation of what 
attributes characterize particular samples (Meilgaard and others 1999). Pearson correlation 
coefficients were determined using the same XLSTAT software, with significgance determined 
at α=0.05, 0.01, and 0.001. 
 
 
6.4 Results and discussion 
 6.4.1 Panel training 
Due to the high amount of training DA panels undergo, their performance and ability to 
rate uniformly is important to the panel’s success. In general, panelists showed a high degree of 
training and uniformity in the ratings of all three samples. Sample replications were not a 
significant (p>0.05) source of variation for a majority of attributes for apple sauce (except apple 
aroma, p<0.05), infant formula (except soy ABM, p<0.05), and crackers. The general lack of 
significant differences indicates consistent panelist performance and sample uniformity over the 
four replications (N'Kouka and others 2004). Significant variation (p<0.05) did, however, exist 
for judges in all attributes for apple sauce, infant formula (except potato aroma, p>0.05), and 
crackers (except fracturability, p>0.05). This general significant variation typical for DA results 
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(Stone and others 2012) and is likely due to panelists not using the entire scale or using different 
parts of the scale. Non-significant (p>0.05) R×J interaction (except in apple sauce for bitter 
aftertaste) indicated that judges agreed across replications in terms of sample intensities 
(N'Kouka and others 2004). In general, except for apple sauce bitter aftertaste and taste and 
cracker umami taste, non-significant (p>0.05) R×S interaction indicated that while panelists used 
different parts of the scale, they rated samples similarly across all replications.  
Significant (p<0.05) differences in J×S interaction existed for all apple sauce and most 
infant formula attributes (except for sweet aftertaste). The cracker sample had fewer significant 
(p<0.05) attributes; only salty, sweet, and umami taste, grassy ABM, and salty, bitter, grassy 
aftertaste and chickpea aftertaste were significant. When attributes were significant, this 
indicates that panelists did not agree upon the order of intensity across all attributes. Additional 
training on group rating and attribute intensities may have been beneficial for these attributes. To 
account for the significant J×S interaction, an adjusted F-test was conducted using the J×S 
interaction mean square as the error term. This data can be found in Table 6.1 (apple sauce), 
Table 6.6 (infant formula), and Table 6.9 (crackers). 
6.4.2 Overall characterizing attributes for each sample 
The addition of GCT OD and free TB in each of the three food matrices resulted in 
varying changes to the sensory character of the matrix. On an individual basis, these changes can 
be examined to see how GCT OD and free TB uniquely affect the food matrices. 
 Focusing on apple sauce, the addition of GCT OD and free TB resulted in significant 
(p<0.05) changes in all examined sensory attributes except lumpiness (F=1.68, p=0.241) as 
compared to the control (Table 6.2). According to PCA biplots (Figure 6.1), control apple sauce 
was characterized by, and had the highest average intensity for, attributes such as apple aroma 
(F=54.68, p<0.001), sour taste (F=13.25, p=0.002), sour aftertaste (F=9.62, p=0.006), sweet taste 
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(F=20.13, p<0.001), and cooked fruit ABM (F=12.54, p=0.002). Apple sauce PCA biplots 
(Figure 6.1) represented 98.4% of the total variance explained in two principal components; PC1 
with 76.3% and PC2 with 22.1% of this variance. Factor correlations (Appendix T) indicated a 
majority of attributes clustered around PC1. Principal component 1 contrasted samples high in 
apple aroma and ABM, sour taste and aftertaste, sweet taste, and cooked fruit with those samples 
high in bitter taste, aftertaste, astringent aftertaste, and cheesy and dairy aroma. Principal 
component 2 characterized samples high in dairy aroma with those high in saturation and 
astringency. 
Apple sauce containing GCT OD had the highest average score and was significantly 
higher in the attributes of cheesy aroma (F=5.42, p=0.028) and dairy aroma (F=41.26, p<0.001) 
than control or free TB containing sample. The GCT OD containing apple sauce was 
characterized by cheesy and dairy aromas, astringency, and significantly reduced saturation 
(F=656.19, p<0.001). By colorimeter measures, L*, a*, and b* values were significantly 
(p<0.05) amoung all three samples. The GCT OD containing sample had significantly increased 
(p<0.001) L values, or lightness, compared to the free TB or control apple sauce (Table 6.5). 
Samples with free TB had the highest average score, and were statistically higher in bitter taste 
(F=133.13, p<0.001), bitter aftertaste (F=441.52, p<0.001), and astringent aftertaste (F=8.94, 
p=0.007) than control or GCT OD containing samples. The apple sauce containing free TB was 
characterized by bitter taste, aftertaste, and astringency. 
 Focusing on infant formula, average intensities for all attributes and LSD differentiations 
are shown in Table 6.7. The control sample was significantly higher in potato ABM (F=6.81, 
p<0.05), soy ABM (F=26.55, p<0.001), sweet taste (F=29.83, p<0.001), sweet aftertaste 
(F=67.18, p<0.001), and soy aftertaste (F=17.10, p<0.001) than samples containing GCT OD or 
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free TB. GCT OD resulted in a significant (p<0.001) reduction of bitter taste and aftertaste as 
compared to the sample containing free TB, but was significantly higher than the control. 
Samples with free TB were statistically higher for metallic ABM (F=16.25, p=0.001), bitter taste 
(F=73.03, p<0.001), bitter aftertaste (F=62.68, p<0.001), and astringent aftertaste (F=4.97, 
p=0.05) than control or GCT OD infant formula.  
Selected significant correlations (Table 6.7) for infant formula include bitter taste with 
potato (r=-0.97, p<0.001) and soy (r=-0.92, p<0.001) ABM attributes. Bitter aftertaste was also 
correlated with sweet aftertaste (r=-0.96, p<0.001) and metallic ABM (r=0.97, p<0.001). 
According to the covariance PCA biplot (Figure 6.2) PC1 and PC2 represent 98.2% of the total 
variance of the data. Factor correlations (Appendix U) indicated that all attributes clustered 
around PC1. This principal component contrasted samples high in potato and soy ABM, sweet 
taste and aftertaste, and soy aftertaste, with samples high in metallic ABM, bitter taste and 
aftertaste, astringent aftertaste, and chalky texture. Principal component 2 explained little of the 
sample variance (2.0 %) and was not strongly characterized by any attribute. The control infant 
formula was highly characterized by the attributes of sweet taste and aftertaste, soy and potato 
ABM, and soy aftertaste. The GCT OD infant formula was characterized by the same attributes 
as the control, but also, the attributes of chalky texture and astringent aftertaste. Infant formula 
containing free TB was characterized by bitter taste and aftertaste, and metallic ABM. 
 Lastly, cracker average intensities for all attributes and LSD differentiations are shown in 
Table 6.10. The control sample was significantly higher in crumbly texture (F=8.2, p<0.001), 
salty taste (F=10.61, p=0.004) and aftertaste (F=13.61, p=0.0019), and chickpea ABM (F=23.16, 
p<0.001), and aftertaste (F=12.66, p=0.0024) than GCT OD or free TB samples. The only 
attribute where GCT OD and free TB containing samples varied significantly (p<0.05) in were 
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the attributes of bitter taste (F=362.75, p<0.001) and aftertaste (F=424.4, p<0.001) where GCT 
OD had the highest attribute intensity as compared to free TB crackers. 
Selected significant correlations for the cracker samples (Table 6.11) include those 
between bitter taste and wheat aroma (r=-0.84, p<0.001), cheese aroma (r=0.87, p<0.001), 
chickpea ABM (r=-0.91, p<0.001) and chickpea aftertaste (r=-0.89, p<0.001). Cracker attributes 
and samples represented on a covariance PCA biplot (Figure 6.3) showed PC1 and PC2 
explained 98.4% of the total variance of the data. Factor correlations (Appendix V) indicated all 
attributes clustered around PC1. Principal component 1 contrasted samples high in wheat aroma, 
crumbly texture, salty taste, chickpea ABM, and salty and chickpea aftertaste with samples high 
in cheese aroma, fracturability, bitter taste and aftertaste, and chickpea aftertaste. Principal 
component 2 is not strongly characterized by any sensory attribute. The control cracker was 
highly characterized by many attributes including wheat aroma, chickpea ABM, salty taste, 
crumbly texture, and chickpea and salty aftertaste. The GCT OD and free TB containing crackers 
were characterized only by bitter taste, aftertaste, cheesy aroma, and fracturability. 
6.4.3 Appearance and aroma changes in food matrices 
The addition of GCT OD to the apple sauce matrix resulted in a significant increase 
(p<0.05) in dairy aroma. With any complexation, the potential for free core or unoccupied CD to 
be present is possible; complexation is not always a 100% efficient process. It may be 
hypothesized that potential free TB was serving as the source of the dairy aroma; however, the 
free TB apple sauce sample was significantly (p<0.05) lower in dairy aroma. It is unlikely that 
GCD, an odorless compound, caused the presence of this dairy aroma. In terms of appearance, 
apple sauce was the only matrix significantly affected by the addition of GCT OD. A white or 
milky appearance to the apple sauce developed upon GCT OD inclusion. This was indicated by 
the significantly decreased saturation intensity (lighter color) assigned by the panelists to GCT 
200 
 
OD apple sauce, the significantly increased (p<0.05) lightness (L*) and value (V) measurements 
determined by the colorimeter (Table 6.4). Pearson correlation analysis (Table 6.6) indicated 
significant negative correlations between the colorimeter measurements of value (V) and 
lightness (L*) with the sensory attribute of saturation (r=-1.000, p<0.01 for both) in the apple 
sauce sample. Lightness is a metric from the Hunter color space; its values represent differences 
in black (0) and white (100) (Hunter Labs, 1996). Value is a measurement in the Munsell color 
system; its values represent differences in black (0) and white (10). During training, the panelists 
used the Munsell term saturation (also refered to as Chroma), as they beliebed it best described 
the visual changes seen in the apple sauce. While the sensory attribute saturation and the Munsell 
metric Chroma do not significantly correlate, the significant correlation between the Munsell 
metric Value and the sensory attribute saturation indicates the panelists were using the term 
saturation to describe the Munsell metric Value. 
Pearson correlation analysis (Table 6.3) also indicated significant negative correlations 
between dairy aroma and saturation (r=-0.96, p<0.001). Unlike the apple sauce samples, the 
identified aroma attributes of cheesy and dairy were not significantly different (p>0.05) between 
the infant formula samples (Table 6.7). The non-significant differences in dairy aroma for infant 
formula may be due in part to the already high presence of these attributes in the control infant 
formula. However, it is also important to note that GCT OD did not have the same significant 
effect of decreased saturation in the infant formula. That lack of significant difference in dairy 
aroma and visual appearance for the infant formula, but significant differences seen in apple 
sauce, may be directly been related to the lighter (less saturated, and higher V and L* values) 
appearance of the GCT OD apple sauce. This process, the association of two or more 
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characteristics, is known as the psychological influence of logical error (Meilgaard and others 
1999).  
The relationship between color and the intensity of other sensory modalities is complex, 
and has been investigated and reviewed extensively in the literature (Delwiche 2004). 
Investigating the influence of color on the perception of carbonated beverage attributes, previous 
research has observed that the addition of a caramel color significantly increased the aroma 
attributes of caramel and vanilla (Kappes and others 2006). This research discussed that prior 
consumer associations, referred to as prior conditioning (Zellner and Kautz 1990), between 
darkened carbonated beverages and vanilla/caramel aroma attributes may have been the source 
of the increased attribute intensities. In this DA panel, a similar phenomenon may have been 
observed with the presence of higher dairy aroma in GCT OD apple sauce samples. Prior 
conditioning may have linked the association of dairy attributes and white/milky colors. This 
prior conditioning may have influenced panelist decisions and led to the psychological influence 
of logical error to occur for these apple sauce samples. 
Other aroma attributes were also significantly affected by the addition of GCT OD in 
apple sauce. Cyclodextrins are well known for the ability to mask flavors, odors, and tastes in 
food products (Szente and Szejtli 2004; Del Valle 2004; Astray and others 2009). The ability of 
CDs to retain aroma or taste active compounds is highly dependent on the CD and the target 
aroma compound (Reineccius and others 2002; Decock and others 2008). Fresh apples contain 
over 200 different volatile compounds (Dimick and others 1983) and current literature has 
identified 15 of these to be principal odorant compounds (Mehinagic and others 2006). Many of 
these odor compounds may be important to the characteristic aroma profile of apple sauce. 
Previous research has shown the ability of GCD to retain ethyl butanoate, an odor-active 
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compound in apples (Mehinagic and others 2006; Reineccius and others 2002). This DA panel 
observed a significant decrease in the apple aroma and apple ABM of GCT OD containing apple 
sauce as compared to free TB and control samples. The application of free CDs to foods has been 
used to reduce the sensory properties of certain foods (Hashimoto 1996; Shaw and others, 1984; 
Tamamoto and others 2010). It is possible that the GCT OD complex may also contain free 
GCD. This free GCD could complex some odor-active compounds important in apple sauce, 
which may explain the reduction of apple aroma and ABM in the GCT OD apple sauce.  
6.4.4 Taste, texture, and aroma-by-mouth changes in food matrices 
Taste attributes were significantly altered by the addition of GCT OD and free TB to the 
infant formula matrix. While sweet taste was significantly reduced in GCT OD infant formula as 
compared to the control, the difference was minute (average intensity difference=0.98). GCT OD 
still remained significantly (p<0.05) sweeter than free TB containing samples for both sweet 
taste and aftertaste. It is import that the sweetness of a sample is minimally impacted, as this is 
an attribute innately liked by individuals (Drewnowski 1997; Drewnowski and others 2012) and 
characteristic of the control infant formula (Figure 6.2). Comparing apple sauce and infant 
formula in one unified PCA biplot (Appendix X), it was noted that the infant formula containing 
GCT OD was characterized by the attribute of sweet taste similar to the control infant formula 
and apple sauce. All of these attributes were significantly (p<0.05) correlated (Appendix Y) and 
highly loaded on PC1 (Appendix W). The minimal impact of GCT OD on sweetness of the 
sample may be important for the ultimate consumer acceptance of this product. 
The attribute of metallic ABM was significantly (p<0.05) different among the three infant 
formula samples, with free TB being the highest (Table 6.7). The control sample does, however, 
exhibit a high level of metallic ABM due to the presence of minerals (zinc, copper, and iron) in 
the formula (average metallic ABM intensity of control: 7.48). The additional metallic nature of 
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the apple sauce containing free TB, shown as a characterizing attribute in the PCA biplot (Figure 
6.2), is indicative of the metallic quality free TB confers on the matrix. With a decreased metallic 
ABM intensity in GCT OD infant formula, this complex is efficient at decreasing the metallic 
quality of free TB.  
The modality of afterfeel, unaffected in apple sauce, was significantly changed upon the 
addition of GCT OD and free TB to infant formula. Both of these additions caused a significant 
(p<0.05) increases in the attribute of chalkiness. It is likely that GCT OD, a fine powder, results 
in a residual mouth coating upon expectoration leading to the increased chalkiness perceived by 
the panel. Free TB, may have imparted its textural changes through a different mechanism. With 
a pH of roughly 3.6, TB is below the isoelectric point for many free amino acids in the infant 
formula (Lide 1991). The acidic nature of TB may impact the solubility of free amino acids in 
the infant formula. While the overall measured pH of the infant formula was not significantly 
affected by the addition of GCT OD or free TB (control: 7.45; GCT OD: 7.41; free TB: 7.39, 
p=0.383), localized regions of aggregated insoluble free TB in the formula may have altered free 
amino acid solubility. Amino acids such as L-valine, L-phenylalanine, L-alanine, and L-glycine 
can exhibit decreased solubility when in liquid systems below their isoelectric points (Needham 
and others 1971). These free amino acids are present in the infant formula, and their interaction 
with localized regions of insoluble free TB could have resulted in decreased their solubility.  
6.4.5 Bitterness changes and its effects on food matrices 
Foods that are strongly bitter are problematic; highly bitter foods are often rejected by 
consumers as an innate survival instinct against potentially toxic substances (Rozin 1986; 
Drewnoswki and Gomez-Carneros 2000). It is therefore the focus of many functional foods and 
pharmaceutical applications to reduce the bitterness of products containing compounds with 
bitter qualities (Drewnoswki and Gomez-Carneros 2000; Lee 2008; Sun-Waterhouse 2013). 
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Since bitterness is the universal sensory attribute associated with all TB containing foods (Table 
6.12 and Figures 6.4-6.6), it is important to investigate the influence GCT OD and free TB have 
on bitterness in food matrices. 
All products containing free TB were highly characterized by bitter taste and aftertaste as 
shown in Figures 6.4-6.7. The GCT OD microcapsule had a similar effect in apple sauce and 
infant formula in its ability to significantly (p<0.05) reduce the bitter taste and aftertaste intensity 
compared to the free TB containing sample. However, GCT OD containing apple sauce and 
infant formula were still significantly higher in bitter taste compared to their respective controls. 
The ability of GCT OD to significantly reduce the bitter taste and aftertaste opposed to free TB 
was not observed in the cracker matrix (Table 6.10). GCT OD crackers were significantly higher 
in bitter taste than free TB containing crackers. Correlation analysis (Table 6.11) revealed all 
common attributes among the three products were significantly correlated and that these 
attributes were highly loaded on PC1 (Appendix W) in the common attribute biplot (Figure 6.6). 
For common attributes held by all samples, PC1 represented 99.67% of the total variance of the 
data. From the common attribute PCA biplot (Figure 6.6), it was observed that all control 
samples were not characterized bitter taste and aftertaste while all samples containing free TB 
were strongly characterized by these attributes.  
The influence and explanation of GCT OD on the bitterness of each food matrix is 
unique. While GCT OD was able to make the infant formula not statistically significant from the 
control during the R-index measure (Chapter 4), the difference in results for this test may relate 
to differences in panel training. The influence of GCT OD on bitterness of infant formula and 
apple sauce may be more strongly related to each control products innate bitterness and the 
physical properties of the matrices. The influence of GCT OD on the bitterness of crackers may 
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be related to many of the same principles explored for infant formula and apple sauce, but may 
also primarily be related to the heat treatment of the microcapsule during baking. 
Descriptive Analysis, in general, has panelists that are extensively trained to detect fine 
sensory differences between products (Meilgaard and others 1999). Panelists participating in the 
previous R-index by rating method (Chapter 4) were not formally trained. Therefore, it would be 
expected that this DA panel would notice finer sample differences than the untrained participants 
in the R-index measure by rating method test. The other explanation for the difference in results 
between the DA and R-index measurements may be related to the low inherent bitterness of the 
apple sauce as opposed to the infant formula control. The infant formula control sample exhibits 
an inherent bitterness higher than the apple sauce control (Figure 6.4). The difference in bitter 
intensity is much lower between GCT OD and control infant formula. This may have lead 
untrained panelists in the rating method (Chapter 4) to not observe a statistical difference while 
the trained DA panel did note significant differences. Using GCT OD at the same concentration, 
the low inherent bitterness of the apple sauce sample may have influenced the DA panelists to 
rate the difference in bitterness intensity caused by GCT OD as even greater than when in the 
infant formula. It is likely that if included into the rating method test, even an untrained panel 
would notice an 8.7 intensity difference between a control and GCT OD containing apple sauce. 
When choosing a food product to include GCT OD, it may be important to consider the products 
inherent bitterness as it may make the bitterness imposed by the GCT OD microcapsule less 
obvious.  
The bitterness contributed by GCT OD in the apple sauce sample may be more related to 
the physical state of apple sauce. This viscous, semi-solid, matrix may limit the molecular 
movement and solubility of free GCD and TB throughout the matrix. While previous retention 
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(Chapter 3), sensory (Chapter 4), and in vitro results (Chapter 5) indicated complexation has 
occurred between GCD and TB, there is still a possibility for free TB and GCD to be present. It 
would, therefore, be important for additional complexation of TB to occur in the food matrix to 
aid in bitterness reduction. Complexation best occurs when the CD of interest is well solubilized; 
the more soluble the CD, the more available it is for complexation (Del Valle 2004). The 
significantly lightened (less saturated) apple sauce with GCT OD indicated that this complex was 
not well solubilized. Remaining in its crystalline form (as GCT OD was, shown in Chapter 3) a 
limited amount of free GCD would be available for additional complexation (Del Valle 2004). 
Furthermore, lipids, such as TB, tend to aggregate in an insoluble matrix (Del Valle 2004). 
Without a high degree of shear, the TB droplets may have been more likely to associate with 
themselves than the free GCD. With limited movement, smaller molecules (such as the aroma 
active compounds) adjacent to free GCD may have been able to more readily be complexed than 
free TB. All of these factors together created an environment in the apple sauce where excess TB 
could not be complexed, leading to its increased bitterness. In conclusion, considering solubility 
and TB dispersion, these two factors may have influenced the ability free GCD in apple sauce to 
complex additional free TB. This may be the cause of the high disparity in bitterness among the 
control and GCT OD apple sauce sample. 
As mentioned with apple sauce, the ability of GCT OD in infant formula to influence 
bitterness is dependent on the physical state of the matrices. The liquid infant formula sample 
provides an optimal environment for additional complexation of free TB. Increased water 
content allowed for GCT OD to solubilize readily in the infant formula while agitation (during 
preparation, storage, and immediately before serving) also aided in the dispersion of insoluble 
TB. Both of these factors, created an environment where free TB had increased contact with free 
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GCD (Del Valle 2004). This may have aided in the reduction of residual bitterness from the GCT 
OD microcapsule, making it characterized by similar attributes as the infant formula control and 
apple sauce control in the common attribute biplot for these two samples (Appendix X).  
The cracker matrix behaved much differently during sensory testing than the apple sauce 
and infant formula samples. Of the ten significant (p<0.05) attributes, GCT OD and free TB 
samples were not significantly different between each other, but significantly different from the 
control. The only two instances where GCT OD and free TB showed significant (p<0.05) 
differences between one other was in bitter taste and aftertaste. In these two cases, GCT OD had 
significantly higher bitter taste and aftertaste intensities than crackers containing free TB. When 
in the cracker, unlike in the infant formula, GCT OD was not characterized by any of the 
attributes the control cracker. The performance of GCT OD in this matrix may be related to heat-
induced complexation damaged caused by baking. 
Cyclodextrin complexations are known to decompose at temperatures in excess 60°C 
(140°F), with methods to liberate complexed compounds for quantification purposes using 
temperatures of 80-90°C (Bhandari and others 1998; Reineccius and others 2002; Reineccius and 
others 2004; Kawakami and others 2009). These crackers were baked at the much higher 
temperature than this (177°C). The negative effects of heat on the retention (Chapter 3) of TB 
and sensory perception (Chapter 4) of microcapsules has been previously shown. In the cracker 
matrix, heating GCT OD was enough to release TB from the complex. With free TB released, 
and in an extremely low moisture system, there was no opportunity for additional complexation 
to occur in the matrix or the oral cavity. This sensory effect of TBs release in the cracker was so 
strong, the common attribute PCA biplot (Figure 6.6) characterized the GCT OD cracker in a 
similar manner as the free TB containing apple sauce and infant formula. Due to the necessity for 
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the crackers to be baked, it would be challenging to avoid high heat treatment in this type of 
system; limiting the use of GCT OD in baked products. 
The release of TB made the GCT OD samples have a marginal, but significant (p<0.005), 
increase in bitter taste (1.4 point intensity increase) and aftertaste (1.0 point intensity increase) 
intensity (Table 6.10, Figures 6.4 and 6.5). No other attributes are significantly different between 
(p>0.05) GCT OD and free TB crackers. Replications were not a significant source of variation 
for the panel, so changes in the GCT OD load/serving of crackers were not a source of variation 
that may have led to localized increases in bitterness for cracker samples. Therefore, this 
significant increase in bitterness for GCT OD may be the result of an increase in some additional 
attributes conferred by GCT OD not examined by the panel. During panel training, panelists are 
asked to limit examined attributes to 10-15. Often, attributes need to be eliminated through group 
consensus. For this sample, over 30 attributes were initially generated and reduced to 16. It is 
therefore possible that GCT OD inclusion in crackers strongly influenced one of these eliminated 
attributes. Without that attribute, some panelists in this DA panel may be placing the intensity of 
this unexplored attribute into the bitter taste and aftertaste of the GCT OD sample, thereby 
increasing its intensity. This is referred to as the dumping effect (Lawless and Heymann 1999). 
This phenomena has been investigated in carbonated beverages (Kappes and others, 2006) where 
mouthfeel attributes were rated higher when investigated alone than when all attributes 
(including aroma, ABM, taste, and afterfeel) were rated. While this method of DA training 
sought to maintain the key attributes important to the cracker samples, it is possible that one may 
have been eliminated during training. Further investigation into these attributes in the cracker 
matrix may elucidate the exact origin of the increase in bitter taste and aftertaste. 
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The liberation of TB from the GCD-complex did not only affect bitter taste and aftertaste 
of the crackers. A significant reduction in intensity for almost all attributes including wheat 
aroma, salty taste, chickpea ABM, salty aftertaste, and chickpea aftertaste was observed. These 
are all attributes important to the characterization of the control cracker as shown in the PCA 
biplot (Figure 6.3). It is not likely that the presence of GCD caused the reduction of these 
attribute intensities as hypothesized in the apple sauce samples. This is because if free GCD from 
the GCT OD microcapsule was complexing aroma and taste-active compounds, as it was 
believed to be in the GCT OD apple sauce sample, GCT OD cracker attributes would have had 
significantly lower in intensity than the free TB cracker as well. Instead, the GCT OD cracker 
was not significantly different (p>0.05) from the free TB containing cracker in all attributes other 
than bitter taste. It is hypothesized that the reduction of GCT OD and free TB cracker attribute 
intensities compared to the control was the result of their increased bitterness intensity.  
While taste preferences are highly dependent on many factors, increasing unpleasant 
attributes (such as bitterness) can lead to the reduction of other possibly pleasant attribute 
intensities. This is referred to as the horns effect (Lawless and Heymann 1999). Researchers have 
previously investigated the horns effect that functional ingredients have on other sensory 
attributes in beverages (Tamamoto and others 2010). The addition of both caffeine and ginseng, 
two bitter functional ingredients, significantly decreased the intensity of fruity (pear, artificial 
lemon-lime, mango, and pineapple) ABM and sweet taste when bitterness increased (Tamamoto 
and others 2010). It is believed that this reduction in intensity may have been due to the horns 
effect caused by the bitter functional ingredients. This is what was similarly seen in the GCT OD 
and free TB cracker samples, with significant reductions in ABM (chickpea), taste (salty), 
aftertaste (salty and chickpea), and aroma (wheat) attributes. It is believed that the bitterness 
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associated with the released and free TB in these crackers may have led to the reduction in 
attribute intensity seen here. 
 
 
6.5 Conclusions 
It has been well documented that consumers in general are not willing to compromise on 
the sensory qualities of foods for health benefits (Urala and Lähteenmäki 2004; Verbeke 2006). 
Therefore, using GCT OD in a food where it imparts the least difference from the original 
product would create a food system that would be accepted by consumers. When considering of 
the use of GCT OD in a food system for the purpose of a therapeutic effect, the findings from 
this research can help guide the use of GCT OD in these and other foods (Appendix Z).  
In general, suggestions for choosing an optimal food system involve creating an 
environment where free TB can still be complexed. The existence of free TB, even at low levels, 
can be a problem for the sensory properties of a food product. Utilizing a high-shear mixed, 
liquid matrix, would allow for additional complexation of any free TB remaining and for the 
GCT OD microcapsule to solubilize. Not heating this matrix would protect the GCT OD 
microcapsule from releasing TB into the food matrix. A matrix with a degree of inherent 
bitterness and a lightened (less saturated) color may make the difference between a GCT OD 
included and the original product less apparent. Examples of suitable matrices for the 
incorporation of GCT OD include beverages such as fruit or vegetable based-smoothies, dairy 
beverages, and yogurt drinks. All of these systems utilize shear mixing, have a high water 
content, have varying inherent bitterness, and may be less impacted by the decreased saturation 
GCT OD may impart. It should be noted, however, that the inclusion of GCT OD should be done 
after any thermal treatment in order to minimize damage to the GCT OD matrix. 
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The results of this DA panel make it possible for broader recommendations based off the 
individual matrix findings for the use of GCT OD in foods for therapeutic use. As consumer, 
liking is important to the success of GCT OD in food matrices, future consumer testing should be 
conducted to evaluate acceptance of these and all future food matrices.  
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6.7 Tables and figures 
Table 6.1: Analysis of variance (ANOVA) F-ratios for sensory attributes rated for three apple 
sauce samples† 
Modality Attribute Rep  Judge  Sample R×J††  R×S††  J×S††  Adjusted 
Sample F 
Aroma 
Apple 4.35** 9.36*** 193.01*** 1.12 1.18 3.53*** 54.68*** 
Cheesy 2.14 12.19*** 104.88*** 1.48 1.25 19.34*** 5.42* 
Dairy 0.46 11.83*** 348.23*** 1.14 0.69 8.44*** 41.26*** 
Appearance Saturation 1.38 16.82*** 1378.00*** 1.02 1.38 2.1*** 656.19*** 
Taste 
Sour  0.53 15.97*** 123.53*** 0.3 1.39 9.32* 13.25** 
Sweet  1.67 16.54*** 199.88*** 1.27 0.52 9.93*** 20.13*** 
Bitter  0.23 9.27*** 1424.50*** 1.13 0.54 10.7*** 133.13*** 
Aftertaste 
Sour 1.03 11.36*** 132.66*** 0.76 0.82 13.79*** 9.62** 
Bitter 1.76 8.51*** 2662.41*** 1.82* 2.44* 6.03*** 441.52*** 
Astringent 2.35 19.02*** 81.18*** 1.65 0.81 9.08*** 8.94*** 
Aroma-by-
mouth 
Apple 0.63 11.51*** 306.53*** 1.01 1.16 5.43*** 56.45*** 
Cooked 
Fruit 
0.63 18*** 135.32*** 1.27 0.60 10.79*** 12.541** 
Texture Lumpiness 0.36 6.44*** 4.61*** 0.35 0.59 2.75** 1.68 
† F-ratios are shown as a source of variation. *, **, *** stand for significance at p < 0.05, p < 0.01, and p 
< 0.001, respectively. 
†† R×J, R×S, and J×S represent the interaction between replications and judges, replications and samples, 
and judges and samples, respectively. 
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Table 6.2: Mean intensity ratings for significant aroma, appearance, taste, aftertaste, and aroma-
by-mouth attributes of three apple sauce samples, categorized by the presence of tributyrin 
(control, encapsulated, or free) for all replications † 
Modality Attribute Control†† GCT OD†† Free TB†† 
Aroma 
Apple 14.03A 7.08C 10.60B 
Cheesy 6.43C 11.88A 10.35B 
Dairy 4.05C 13.95A 7.33B 
Appearance Saturation 14.05A 3.85C 13.13B 
Taste 
Sour 13.9A 8.75B 8.93B 
Sweet 13.13A 10.40B 6.70C 
Bitter 1.10C 9.80B 14.45A 
Aftertaste 
Sour 13.03A 7.88B 7.95B 
Bitter 1.18C 11.55B 14.56A 
Astringent 9.18C 10.73B 13.00A 
Aroma-by-
mouth 
Apple 14.53A 7.73C 9.25B 
Cooked Fruit 13.78A 9.38B 9.45B 
† Superscripts of the same letter within an attribute indicate no significant difference by Fisher’s Least 
Significant Difference (LSD) test at α=0.05   
†† “Control” is apple sauce with no tributyrin added, “GCT OD” is apple sauce with gamma-cyclodextrin 
and tributyrin oven dried microcapsules, and “Free TB” is applesauce with unencapsulated tributyrin  
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Figure 6.1: Principal component analysis biplot of significant attributes present on principal 
component 1 (PC1) and 2 (PC2) by the covariance matrix of mean significant attribute intensity 
ratings across all three apple sauce samples†# 
 
†  Capital letters after the attributes – A, AP, T, AT, and ABM – refer to aroma, appearance, taste, 
aftertaste, and aroma-by-mouth, respectively 
#  “Control” is apple sauce with no tributyrin added, “Encapsulated” is apple sauce with gamma-
cyclodextrin and tributyrin oven dried GCT OD (microcapsules), and “Free” is applesauce with 
unencapsulated tributyrin. The number after each sample refers to its replicate. 
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Table 6.3: Pearson correlation matrix for three apple sauce samples and significant sensory attributes†# 
Attributes Apple 
AR 
Cheesy 
AR 
Dairy 
AR 
Saturation 
AP 
Sour T Sweet T Bitter T Sour 
AT 
Bitter 
AT 
Astringent 
AT 
Apple 
ABM 
Cooked 
Fruit 
ABM 
Apple AR 1                       
Cheesy 
AR -0.83*** 1           
Dairy AR -0.96*** 0.86*** 1          
Saturation 
AP 0.93*** -0.73** -0.96*** 1         
Sour T 0.69* -0.92*** -0.76** 0.58* 1        
Sweet T 0.19 -0.61* -0.24 0.01 0.80* 1       
Bitter T -0.45 0.80** 0.50 -0.28 -0.94*** -0.95*** 1      
Sour AT 0.68* -0.89*** -0.79** 0.62* 0.96*** 0.70* -0.87*** 1     
Bitter AT -0.53 0.85*** 0.59* -0.38 -0.97*** -0.92*** 0.99*** -0.90*** 1    
Astringent 
AT -0.25 0.59* 0.31 -0.06 -0.80** -0.92*** 0.92*** -0.72** 0.90*** 1   
Apple 
ABM 0.79** -0.96*** -0.87*** 0.74** 0.97*** 0.67* -0.85*** 0.96*** -0.90*** -0.67* 1  
Cooked 
Fruit 
ABM 0.69* -0.93*** -0.75** 0.57 0.98*** 0.81** -0.94*** 0.95*** -0.96*** -0.78** 0.97*** 1 
† Capital letters after the attributes – A, AP, T, AT, and ABM – refer to aroma, appearance, taste, aftertaste, and aroma-by-mouth, respectively 
# Values with *, **, and *** correspond to those correlations with significance from zero at p < 0.05, 0.01, and 0.001, respectively  
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Table 6.4: Average L* (lightness), a* (red/green), b* (yellow/blue), and H (hue), V (value), and 
chroma (C) measurements for all three apple sauce samples † 
Sample L  a*  b*  H# V# C# 
Control 44.36C -3.96B 15.56C 8.72B 4.30C 2.18C 
Free TB†† 45.43B -3.65A 16.03B 9.00A 4.40B 2.25B 
GCT OD†† 60.86A -2.25C 18.36A 5.55C 5.92A 2.49A 
Values displayed are averages of three experimental replications 
Measurements are averages of at least 3 experimental replicates, with three measurements taken per 
replicate 
† Superscripts of the same letter within an color measurement indicate no significant difference by 
Fisher’s Least Significant Difference (LSD) test at α=0.05   
†† “Control” is apple sauce with no tributyrin added, “GCT OD” is apple sauce with gamma-cyclodextrin 
and tributyrin oven dried microcapsules, and “Free TB” is applesauce with unencapsulated tributyrin  
# H (hue), V (value), and C (chroma) values were calculated from L, a*, and b* values using the Munsell 
Conversion CMC15d (Version 12.15.1.d, Wallkill Color, wallkillcolor.com) 
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Table 6.5: Correlation coeffieients for average insumental values and sensory color attributes for 
all apple sauce samples †# 
Variables Saturation L a b H V C 
Saturation 1             
L -1.000* 1      
a 0.224 -0.247 1     
b -0.997* 0.995 -0.150 1    
H 0.988 -0.991 0.372 -0.974 1   
V -1.000* 1.000** -0.250 0.995 -0.992 1  
C -0.991 0.987 -0.091 0.998* -0.958 0.987 1 
† Capital letters after the attributes – ABM, T, AT, and AF stand for aroma-by-mouth, taste, aftertaste, and 
afterfeel, respectively 
# Values with * and ** correspond to those correlations with significance from zero at p < 0.05 and 0.01, 
respectively 
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Table 6.6: Analysis of variance (ANOVA) F-ratios for sensory attributes rated for all three infant 
formula samples† 
Modality Attribute Rep Judge Sample R×J†† R×S†† J×S†† Adjusted Sample F 
Aroma 
Potato 0.52 1.72 4.47* 0.54 1.86 2.91** 1.54 
Cheesy 0.34 3.31** 1.3 0.5 1.47 2.24* 0.58 
Dairy 0.56 3.81*** 3.3* 0.85 2.35* 3.29*** 1.00 
Aroma-
by-mouth 
Potato 0.17 8.95*** 24.12*** 0.68 0.29 3.54*** 6.81* 
Metallic 0.59 13.08*** 172.29*** 0.77 0.71 10.6*** 16.25** 
Soy 3.37* 12.67*** 81.23*** 1.23 1.54 3.06*** 26.55*** 
Cheese 0.68 16.61*** 1.38 0.17 0.37 3.15*** 0.44 
Taste 
Sweet 0.26 9.35*** 96.34*** 0.72 2.23 3.23*** 29.83*** 
Bitter 1.4 2.12* 189.15*** 0.48 0.90 2.59** 73.03*** 
Aftertaste 
Astringent 0.39 5.94*** 34.02*** 0.7 0.34 6.84*** 4.97* 
Sweet 0.38 3.47** 67.18*** 0.66 1.61 1.3  
Bitter 0.95 2.23* 194.92*** 0.35 0.88 3.11*** 62.68*** 
Soy 1.07 6.75*** 54.2*** 1.09 0.57 3.17*** 17.10*** 
Afterfeel Chalky 1.97 4.77*** 13.47*** 0.47 0.92 2.66*** 5.06* 
† F-ratios are shown as a source of variation. *, **, *** stand for significant at p < 0.05, p < 0.01, and p < 
0.001, respectively. 
†† R×J, R×S, and J×S represent the interaction between replications and judges, replications and samples, 
and judges and samples, respectively. 
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Table 6.7: Mean intensity ratings for significant aroma-by-mouth, taste, aftertaste, and texture 
attributes of all three infant formula samples, categorized by the presence of tributyrin (control, 
encapsulated, or free) for all replications† 
Modality Attribute Control†† GCT OD†† Free TB†† 
Aroma-by-mouth 
Potato 12.95A 11.98B 10.33C 
Metallic 7.48C 9.55B 13.95A 
Soy 13.53A 11.98B 9.85C 
Taste 
Sweet 13.05A 12.08B 8.05C 
Bitter 4.40C 8.50B 14.50A 
Aftertaste 
Astringent 9.40C 11.23B 13.10A 
Sweet 12.70A 10.45B 7.03C 
Bitter 4.05C 8.35B 14.63A 
Soy 13.50A 11.85B 10.08C 
Afterfeel Chalky 10.00B 12.03A 12.28A 
† Superscripts of the same letter within an attribute indicate no significant difference by Fisher’s Least 
Significant Difference (LSD) test at α=0.05   
††  “Control” is infant formula with no tributyrin added, “GCT OD” is infant formula with gamma-
cyclodextrin and tributyrin oven dried microcapsules, and “Free TB” is infant formula with 
unencapsulated tributyrin 
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Figure 6.2: Principal component analysis biplot of significant attributes present on principal 
component 1 (PC1) and 2 (PC2) by the covariance matrix of significant mean attribute intensity 
ratings across all three infant formula samples†# 
 
† Capital letters after the attributes – ABM, T, AT, and AF stand for aroma-by-mouth, taste, aftertaste, and 
afterfeel, respectively 
# “Control” is infant formula with no tributyrin added, “GCT OD” is infant formula with gamma-
cyclodextrin and tributyrin oven dried microcapsules, and “Free TB” is infant formula with 
unencapsulated tributyrin. The number after each sample refers to its replicate.
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Table 6.8: Pearson correlation matrix for all three infant formula samples and significant sensory attributes†# 
Attributes Potato 
ABM 
Metallic 
ABM 
Soy 
ABM Sweet T Bitter T 
Astringent 
AT 
Sweet 
AT 
Bitter 
AT 
Soy 
AT 
Chalky 
AF 
Potato ABM 1                   
Metallic ABM -0.97*** 1         
Soy ABM 0.95*** -0.94*** 1        
Sweet T 0.95*** -0.96*** 0.92*** 1       
Bitter T -0.97*** 0.97*** -0.92*** -0.95*** 1      
Astringent AT -0.96*** 0.94*** -0.97*** -0.90*** 0.96*** 1     
Sweet AT 0.96*** -0.96*** 0.94*** 0.97*** -0.96*** -0.93*** 1    
Bitter AT -0.97*** 0.97*** -0.93*** -0.94*** 1.00*** 0.97*** -0.96*** 1   
Soy AT 0.96*** -0.95*** 0.91*** 0.91*** -0.98*** -0.93*** 0.95*** -0.98*** 1  
Chalky AF -0.62* 0.67* -0.57 -0.52 0.73** 0.73** -0.60* 0.72** -0.68* 1 
† Capital letters after the attributes – ABM, T, AT, and AF stand for aroma-by-mouth, taste, aftertaste, and afterfeel, respectively 
# Values with *, **, and *** correspond to those correlations with significance from zero at p < 0.05, 0.01, and 0.001, respectively 
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Table 6.9: Analysis of variance (ANOVA) F-ratios for sensory attributes rated for all three 
cracker samples† 
Modality Attribute Rep Judge Sample R×J†† R×S†† J×S†† Adjusted Sample F 
Aroma 
Nutty 0.13 3.31** 1.46 0.36 1.11 0.78  
Wheat 0.18 2.76** 7.51** 0.54 0.66 0.79  
Turmeric 0.2 2.84** 1.61 0.24 0.47 1.41  
Cheese 0.08 2.64* 11.29*** 0.26 0.16 0.78  
Texture 
Fractur-
ability 
0.21 1.28 6.49** 0.53 0.87 0.72  
Crumbly 0.1 2.26* 8.2*** 0.28 0.55 1.65  
Taste 
Salty 0.66 2.12* 32.56*** 0.62 0.25 3.07*** 10.61** 
Sweet 0.75 2.42* 16.51*** 0.45 1.36 4.34*** 3.80 
Bitter 0.91 2.31* 362.75*** 1.03 0.94 1.58  
Umami 0.87 7.41*** 4.4* 0.97 3.15* 15.45*** 0.28 
Aroma-by-
mouth 
Grassy 0.54 2.15* 14.23*** 0.59 1.19 3.84*** 3.71 
Chickpea 1.22 3.7** 23.16*** 0.31 0.7 1.29  
Aftertaste 
Salty 1.29 4.5*** 59.32*** 0.73 0.25 4.36*** 13.61** 
Bitter 1.09 3.56** 1294.42*** 0.6 1.22 3.05*** 424.40**
* 
Chickpea 0.43 6.54*** 31.65*** 1.13 1.45 2.5** 12.66** 
Grassy 1.14 3.91*** 10.4*** 0.59 0.34 4.54*** 2.29 
† F-ratios are shown as a source of variation. *, **, *** stand for significant at p < 0.05, p < 0.01, and p < 
0.001, respectively. 
†† R×J, R×S, and J×S represent the interaction between replications and judges, replications and samples, 
and judges and samples, respectively. 
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Table 6.10: Mean intensity ratings for significant aroma, texture, taste, aroma-by-mouth, and 
aftertaste attributes of all three cracker samples, categorized by the presence of tributyrin 
(control, encapsulated, or free) for all replications † 
Modality Attribute Control†† GCT OD†† Free TB††   
Aroma 
Wheat 13.38A 12.15B 11.90B 
Cheese 10.35B 12.08A 12.93A 
Texture 
Fracturability 10.95B 12.78A 12.15A 
Crumbly 13.13A 11.8B 11.23B 
Taste 
Salty 13.30A 10.45B 10.65B 
Bitter 2.68C 13.93A 12.53B 
Aroma-by-mouth Chickpea 13.20A 10.80B 11.38B 
Aftertaste 
Salty 13.40A 10.25B 10.43B 
Bitter 2.13C 14.10A 13.05B 
Chickpea 13.40A 11.20B 11.33B 
† Superscripts of the same letter within an attribute indicate no significant difference by Fisher’s Least 
Significant Difference (LSD) test at α=0.05   
††  “Control” is a cracker with no tributyrin added, “GCT OD” is a cracker with gamma-cyclodextrin and 
tributyrin oven dried microcapsules, and “Free TB” is cracker with unencapsulated tributyrin 
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Figure 6.3: Principal component analysis biplot of significant attributes present on principal 
component 1 (PC1) and 2 (PC2) by the covariance matrix of significant mean attribute intensity 
ratings across all three cracker samples†# 
 
† Capital letters after the attributes – A, TX, T, ABM, and AT stand for aroma, texture, taste, aroma-by-
mouth, and aftertaste, respectively 
#  “Control” is a cracker with no tributyrin added, “GCT OD” is a cracker with gamma-cyclodextrin and 
tributyrin oven dried microcapsules, and “Free TB” is a cracker with unencapsulated tributyrin. The 
number after each sample refers to its replicate.
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Table 6.11: Pearson correlation matrix for all three cracker samples and significant sensory attributes†# 
Attributes Wheat A 
Cheese 
A 
Fracturability 
TX 
Crumbly 
TX Salty T Bitter T 
Chickpea 
ABM Salty AT Bitter AT 
Chickpea 
AT 
Wheat A 1                   
Cheese A -0.89*** 1         
Fracturability 
TX -0.48 0.53 1        
Crumbly TX 0.80** -0.84*** -0.72** 1       
Salty T 0.78** -0.87*** -0.80** 0.78** 1      
Bitter T -0.84*** 0.87*** 0.80** -0.82*** -0.98*** 1     
Chickpea ABM 0.72** -0.75** -0.84*** 0.78** 0.91*** -0.91*** 1    
Salty AT 0.86*** -0.88*** -0.74** 0.85*** 0.93*** -0.97*** 0.86*** 1   
Bitter AT -0.85*** 0.89*** 0.81** -0.85*** -0.97*** 1.00*** -0.92*** -0.97*** 1  
Chickpea AT 0.87*** -0.88*** -0.701* 0.80** 0.86*** -0.89*** 0.85*** 0.90*** -0.92*** 1 
† Capital letters after the attributes – A, TX, T, ABM, and AT stand for aroma, texture, taste, aroma-by-mouth, and aftertaste, respectively 
# Values with *, **, and *** correspond to those correlations with significance from zero at p < 0.05, 0.01, and 0.001, respectively 
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Figure 6.4: Average bitter taste intensity for crackers, infant formula, and apple sauce†# 
 
† Superscripts of the same letter within the same sample indicate no significant difference by Fisher’s 
Least Significant Difference (LSD) test at p<0.05   
# “Control” is a sample with no tributyrin added, “GCT OD” is sample with gamma-cyclodextrin and 
tributyrin oven dried microcapsules, and “Free TB” is sample with unencapsulated tributyrin. Values 
shown are averages of all replicates. 
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Figure 6.5: Average bitter aftertaste intensity for crackers, infant formula, and apple sauce†# 
 
† Superscripts of the same letter within the same sample indicate no significant difference by Fisher’s 
Least Significant Difference (LSD) test at p<0.05   
#  “Control” is a sample with no tributyrin added, “GCT OD” is sample with gamma-cyclodextrin and 
tributyrin oven dried microcapsules, and “Free TB” is sample with unencapsulated tributyrin. Values 
shown are averages of all replicates. 
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Figure 6.6: Principal component analysis biplot of common significant attribute intensities 
present on principal component 1 (PC1) and 2 (PC2) by the covariance matrix for all samples†# 
 
† Capital letters after the attributes –T, AT, CR, AS, and IF stand for taste, aftertaste, cracker, apple sauce, 
and infant formula, respectively 
#  “Control” is a sample with no tributyrin added, “GCT OD” is a sample with gamma-cyclodextrin and 
tributyrin oven dried microcapsules, and “Free TB” is a sample with unencapsulated tributyrin. Samples 
represent averages across all four replications. 
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Table 6.12: Pearson correlation matrix for all samples (apple sauce, infant formula, and crackers) 
with common significant attributes †# 
Attributes Bitter T Bitter AT   
Bitter T 1    
Bitter AT 0.993*** 1   
†  Capital letters after the attributes T, and AT stand for taste, and aftertaste, respectively 
#  Values with *, **, and *** correspond to those correlations with significance from zero at p < 0.05, 
0.01, and 0.001, respectively 
  
235 
 
Chapter 7: Conclusions and Future Directions 
 The optimal wall materials and processing methods for maximum retention of TB 
included spray dried whey protein isolate (WPI)-inulin and gamma-cyclodextrin (GCD) and TB 
oven dried (GCT OD) microcapsules. The inclusion of inulin, regardless of chain length, 
modified microcapsule morphology and improved the retention of the TB over WPI-based 
microcapsules without inulin. Spray dried gamma-cyclodextrin and TB microcapsules (GCT SD) 
had the lowest retention (62%) while GCT OD retained significantly more (p<0.05) TB (95%) 
than any other microcapsule. The R-index measure by rating method showed that GCT OD was 
the only microcapsule able to reduce the sensory perception of TB to a level indistinguishable 
from a control infant formula. The remaining WPI, WPI-inulin, and GCT SD microcapsules 
investigated were significantly different from the control infant formula (R-index above 57%) 
and not significantly different (p>0.05) from free TB in infant formula. Microcapsule 
formulation did not play a significant role in the release of butyrate in vitro; all microcapsules 
released roughly 75% of their butyrate in the small intestinal phase. The GCT OD and GCT SD 
microcapsules were the ones able to deliver butyrate to the small intestinal phases and stimulate 
significant butyrate production across the large intestinal phases. Considering microcapsule 
retention, sensory impact, and in vitro release, GCT OD was the only microcapsule that 
continued on to descriptive analysis (DA) testing. 
Results from the DA panel showed that GCT OD varied in its ability to reduce the 
sensory qualities of TB in apple sauce, infant formula, and crackers. All samples containing free 
TB were highly characterized by bitter taste and aftertaste. When GCT OD was included into the 
three food matrices, it was able to significantly (p<0.05) reduce the bitter taste and aftertaste 
compared to free TB containing apple sauce and infant formula. This significant difference was 
not seen in the cracker matrix. Despite the success of GCT OD in infant formula and apple 
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sauce, GCT OD containing infant formula and apple sauce was still significantly different 
(p<0.05) and higher in bitter taste and aftertaste intensity compared to their respective controls. 
 The confirmation of complexation by analytical methods was not a focus or aim of this 
research. However, TB retention and sensory findings support the belief that complexation has 
occurred between GCD and TB. The GCT OD and GCT SD microcapsule only differed in their 
drying techniques, yet, a significant reduction (p<0.05) of TB retention in GCT SD indicated that 
TB was lost or released during spray drying. This was most likely due to heat-induced disruption 
of the complexation. The complexation of GCT OD was most likely not disrupted, leading the 
microcapsules high TB retention. The second, and perhaps strongest indication of GCT OD 
complexation, lies in the sensory results obtained in the R-index measure (Chapter 4) and DA 
testing (Chapter 6). If complexation had not occurred in GCT OD, it would have behaved 
identically to GCT SD in the infant formula sample in the rating test. Further, sensory 
investigation in the DA panel showed that GCT OD was able to reduce the bitter taste and 
aftertaste compared to free TB in apple sauce and infant formula. Considering all these findings, 
it is believed that a high degree of complexation is being formed between GCD and TB. In the 
future, the confirmation of complexation by analytical methods (such as high performance liquid 
chromatography (HPLC), nuclear magnetic resonance (NMR), differential scanning calorimetry 
(DSC), or other spectroscopy methods such as Fourier transform (FT)-Raman, FT-infrared (FT-
IR) and ultraviolet-visible (UV-VIS)) may be of interest to researchers.  
With the disruption of the GCD-TB complex in the GCT SD microcapsule, and matrix-
style morphology of all other spray dried WPI-based microcapsules, it is believed that the TB not 
lost during spray drying may reside on the microcapsule surface. This TB, not complexed by 
GCD or protected by WPI, may be the driving force behind the significantly different sensory 
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behavior between microcapsules. Therefore, future research may want to investigate an 
optimized particle washing techniques with a TB-soluble solvent to elucidate the surface TB 
content of all microcapsules to confirm if this is related to the sensory perception of the particle. 
With the understanding of surface TB content, and the analytical techniques to observe GCD-TB 
complexation mentioned previously, researchers would have a more complete understanding of 
the location and complexation of TB in the microcapsules investigated. 
With GCT OD, the possibility for the oral treatment of intestinal disorders, syndromes, 
and related cancers using TB as a source of butyrate in food may be possible. Looking into 
additional food matrices, such as fruit or vegetable-based smoothies, yogurts, or dairy beverages, 
future studies could explore how GCT OD impacts these other foods using sensory 
discrimination, descriptive, and consumer testing. Ultimately, consumer testing will be necessary 
before the commercialization of this GCT OD to ensure consumer acceptability and liking. 
While the creation of GCT OD has laid the groundwork for future discovery, the 
production of GCT OD could be optimized by using different spray drying parameters (solids 
content, inlet/outlet temperatures), modifying existing complexation methods (GCD: TB ratio, 
shear mixing time/speed, drying time/temperature, centrifugal separation methods/speeds) or the 
use of new methods (ultra-high pressure homogenization, extrusion, freeze-drying). In its current 
formulation, GCT OD provides a simple, easy, and cost efficient (see Appendix AA) way to 
deliver butyrate in food for those suffering from intestinal illnesses or those wishing to maintain 
their overall intestinal health. Once a final formulation and product has been determined, in vivo 
testing to investigate the ability of GCT OD, or any modified version of this microcapsule, 
would be required before its ultimate therapeutic utilization. 
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Appendix A: Publishing permission granted for the reprinting of, "Stability Characterization and 
Sensory Testing in Food Products Containing Microencapsulants" in this dissertation 
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Appendix B: Email sent to recruit panelists for the rating method test 
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Appendix C: Pre-survey questionnaire sent to interested panelists 
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Appendix C (continued): Pre-survey questionnaire sent to interested panelists  
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Appendix D: Solution preparation for digestion and fermentation 
1. Phosphate Buffer, 0.1M, pH 6.0 - Dissolve 2.1 g of sodium phosphate dibasic, anhydrous, 
and 11.76 g of sodium phosphate monobasic, monohydrate in a 1 liter volumetric flask. 
Bring up to volume with distilled/deionized (dd) water. Check by pH measurement. This 
solution will keep for up to 48 hours if kept refrigerated.  
2. HCl:Pepsin Solution - Dissolve 1 g pepsin (Sigma P-7000) with 500 mL dd water in a 1 liter 
volumetric flask. Add 17.0 mL HCl. Bring up to volume with dd water. Store in the 
refrigerator. Stable for 60 days. Adjust the pH of the HCl: pepsin solution to reach pH 1.8 – 
2.0 before use. 
3. Chloramphenicol Solution - Place 0.5 g chloramphenicol (Sigma C-0378) in a 100 mL 
volumetric flask. Bring up to volume with 95% ethanol.  
4. Sodium Hydroxide Solution, 0.5N - Place 20 g NaOH in a 1 liter volumetric flask. Bring up 
to volume with dd water.  
5. Pancreatin:Phosphate Buffer, 0.2M, pH 6.8 - Dissolve 16.5 g of sodium phosphate dibasic, 
anhydrous, and 11.56 g of sodium phosphate monobasic, monohydrate in a 1 liter volumetric 
flask. Add 5 g porcine pancreatin (Sigma P-1750). Bring up to volume with distilled water. 
Check by pH measurement. The buffer portion of this solution will keep for up to 48 hours if 
refrigerated. Add pancreatin on the day of use.  
6. Mineral Solution A - In a 1 liter volumetric flask, place 5.4 g sodium chloride, 2.7 g 
potassium phosphate monobasic anhydrous, 0.18 g calcium chloride dihydrate, 0.12 g 
magnesium chloride hexahydrate, 0.06 g manganese chloride tetrahydrate, 0.06 g cobalt 
chloride hexahydrate, and 5.4 g ammonium sulfate. Bring up to volume with dd water. Store 
in the refrigerator. Stable.  
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Appendix D (continued): Solution preparation for digestion and fermentation 
7. Mineral Solution B - Place 2.7 g potassium phosphate dibasic anhydrous in a 1 liter 
volumetric flask. Bring up to volume with dd water. Store in the refrigerator. Stable 48 hours.  
8. Trace Mineral Solution - In a 1 liter volumetric flask, place 0.5 g EDTA (disodium salt), 0.2 
g ferrous sulfate heptahydrate, 0.01 g zinc sulfate heptahydrate, 0.003 g manganese chloride 
tetrahydrate, 0.03 g phosphoric acid, 0.02 g cobalt chloride hexahydrate, 0.001 g cupric 
chloride dihydrate, 0.002 g nickelous chloride hexahydrate, and 0.003 g sodium molybdate 
dihydrate. Bring up to volume with dd water. Store in the refrigerator. Stable.  
9. Water Soluble Vitamin Solution - In a 100 mL volumetric flask, place 0.0025 g vitamin B-
12. Bring up to volume with dd water. Set aside. In a 1 liter volumetric, place 0.1 g thiamin 
HCl, 0.01 g pantothenic acid, 0.1 g niacin, 0.1 g pyridoxine, and 0.005 g p-aminobenzoic 
acid. Add 10 mL of the vitamin B-12 mixture. Bring up to volume with dd water. Store in the 
refrigerator. Stable.  
10. Folate:Biotin Solution - In a 1 liter volumetric flask, place 0.01 g folic acid, 0.002 g biotin, 
and 0.1 g ammonium carbonate. Bring up to volume with dd water. Store in the refrigerator. 
Stable.  
11. Riboflavin Solution - In a 100 mL volumetric flask, place 0.001 g riboflavin and 0.13 g 
HEPES. Bring up to volume with dd water. Store in the refrigerator. Stable.  
12. Hemin Solution - In a 100 mL volumetric flask, place 0.05 g hemin and 0.04 g sodium 
hydroxide. Bring up to volume with dd water. Store in the refrigerator. Stable.  
13. Short Chain Fatty Acid Mix - Mix together equal volumes of n-valerate & isovalerate.  
14. Resazurin Solution 0.1% - Place 0.1 g resazurin in a 100 mL volumetric flask. Bring up to 
volume with dd water. Stable.  
244 
 
Appendix D (continued): Solution preparation for digestion and fermentation 
15. Media - In an autoclavable flask, mix 330 mL Solution A, 330 mL Solution B, 10 mL Trace 
Mineral Solution, 1 mL Resazurin Solution, 0.5 g yeast extract, 0.5 g trypticase, 4 g sodium 
carbonate monohydrate, and 296 mL dd water. Add 0.5 g cysteine HCl monohydrate. Reduce 
for 30 minutes with copper dried carbon dioxide, seal and autoclave for 20 minutes. After the 
solution has cooled, add 0.4 mL Short Chain Fatty Acid Mix. Add, filter sterilized, 20 mL 
Water Soluble Vitamin Solution, 5 mL Folate: Biotin Solution, 5 mL Riboflavin Solution, 
and 2.5 mL Hemin Solution.  
16. Mineral Solution No. 1 - Place 3 g potassium phosphate dibasic anhydrous and 1 g sodium 
citrate dihydrate in a 500 mL volumetric flask. Bring up to volume with dd water. Store in 
the refrigerator. Stable.  
17. Mineral Solution No. 2 - In a 500 mL volumetric flask, dissolve successively 6 g sodium 
chloride, 6 g ammonium sulfate, 3 g potassium phosphate monobasic anhydrous, 0.6 g 
calcium chloride dihydrate, 1.23 g magnesium sulfate heptahydrate, and 10 g sodium citrate 
dihydrate. Bring up to volume with dd water. Store in the refrigerator. Stable.  
18. Sodium Bicarbonate Solution - Place 91 g sodium bicarbonate in a 1 liter volumetric flask. 
Bring up to volume with dd water. Store at room temperature. Stable.  
19. Anaerobic Diluting Solution - Mix together 37.5 mL of Mineral Solution No. 1, 37.5 mL of 
Mineral Solution No. 2, 1 mL of Resazurin Solution, 70 mL of Sodium Bicarbonate Solution, 
and 854 mL dd water. Purge with dried CO2 for 30 minutes. Add 0.5 g cysteine HCl 
monohydrate and allow to dissolve. Dispense required amounts into carbon dioxide purged 
autoclavable containers. Seal and autoclave 20 minutes. Discard any containers that remain 
pink after autoclaving.  
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Appendix D (continued): Solution preparation for digestion and fermentation 
20. 25% m-Phosphoric Acid - Place 25 g meta-phosphoric acid in a 100 mL volumetric flask. 
Bring up to volume with water. This solution is not stable, make fresh every day. 
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Appendix E: Reagent preparation for butyrate quantification 
1. Hexane: GC grade or better. 
2. Methanol: Anhydrous. GC Grade or better. 
3. Internal Standard Solution: Place 1 g of a known fatty acid (C5:0, or any that will not 
interfere with sample peaks) in a 1 L volumetric. Bring up to volume with hexane. 
4. Internal Standard, Dilute: Pipet 1 mL of concentrated internal standard solution into a 50 
mL volumetric flask. Bring up to volume with hexane (20 μg/mL) 
5. Methanolic-HCl: Add 10 mL of acetyl chloride, dropwise, to 80 mL of cold anhydrous 
methanol. This is unstable and must be made immediately before use. 
6. Potassium Carbonate Solution (6%): Place 60 g of K2CO3 in a 1 L volumetric flask. 
Bring up to volume with dd water. 
247 
 
Appendix F: Summary of common foods acceptable and limited by populations affected with 
intestinal disorders† 
Food category Acceptable foods# Limited foods# 
Grains 
• Sources of soluble fiber 
• White Bread 
• White Rice 
• Crackers (without whole or 
wheat grains) 
• Oatmeal 
• Pasta (without whole or wheat 
grains) 
• Sources of insoluble fiber 
• Whole wheat or grain containing 
products (bread, crackers) 
• Brown rice 
 
Fruits and 
vegetables 
• Fruits and vegetables without 
skin, pulp, seeds or membranes 
• Canned, cooked, or pureed 
fruits and vegetables 
 
• Raw or unpeeled vegetables 
• Membrane, skin, and seed containing 
fruits and vegetables 
• Crucifers 
• Onions 
• Leafy greens 
Dairy 
• Milk 
• Yogurt (without fruit seeds, 
nuts, or particulates) 
• Cheese (smooth) 
• Lactose (only if intolerance exists) 
 
Meat 
• Poultry 
• Fish 
• Eggs 
• Fatty or fried meats 
 
Miscellaneous 
foods 
• Smooth nut butters (peanut, 
cashew, almond) 
 
• Whole nuts or seeds 
• Popcorn 
• Caffeine sources (coffee, tea) 
• High in refined sugar (candy, soda) 
† Specific disorders include: Shortened Bowel Syndrome (SBS), Colon Cancer, and Irritable Bowel 
Disease (IBS) which includes Crohn’s Disease and Ulcerative Colitis  
# Food suggestions should only serve as guidelines. Adapted from: (Beating Bowel Cancer 2012; Crohn's 
and Colitis Foundation of America 2012; Memorial Sloan-Kettering Cancer Center 2012; NPS 
Pharmaceuticals 2012) 
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Appendix G: Nutritional and ingredient information for applesauce 
Food product name Motts Natural Applesauce 
Food physical state Semi-solid 
Ingredients Apples, water, ascorbic acid 
Nutritional Information (in 123 g serving) Calories: 50 
Fat: 0 g 
Cholesterol: 0 mg 
Sodium: 0 mg 
Total Carbohydrates: 14 g 
Fiber: 1 g 
Sugar: 12 g 
Protein: 0 g 
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Appendix H: Preparation guidelines for apple sauce samples based on GCT OD† tributyrin (TB) 
retention and free TB inclusion 
Sample 
Additive 
Grams of 
TB/ g of 
additive 
Grams added 
to reach 0.2 g 
TB per 
serving 
Weight of 
serving/number 
of servings 
required# 
Grams of 
apple 
sauce per 
day# 
Grams of 
additive 
needed 
each day# 
GCT OD 
(9.24.14) †† 0.068 2.94 50 g / 4.5  225 13.2 
GCT OD 
(10.09.14) †† 0.073 2.74 50 g / 4.5  225 12.3 
GCT OD 
(11.18.14) †† 0.075 2.67 50 g / 4.5  225 12.0 
Free TB --- 0.2 50 g / 4.5  225 0.9 
† GCT OD represents the gamma-cyclodextrin and tributyrin oven dried microcapsule and Free TB 
represents unencapsulated tributyrin 
†† Date of production 
# Based off of administering a 9 mmol of butyric acid (0.792 g of butyric acid, 0.9 g of TB) per day   
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Appendix I: Nutritional and ingredient information for infant formula 
Food product name Abbott EleCare for Infants Amino Acid-Based Infant Formula with Iron 
Food physical state Liquid 
Ingredients Corn Syrup Solids (55%), High Oleic Safflower Oil (9%), Medium-Chain 
Triglycerides (8%), Soy Oil (7%), L-Glutamine (2%). Less than 2% of the 
Following: C. Cohnii Oil, M. Alpina Oil, L-Asparagine, L-Leucine, L-Lysine 
Acetate, DATEM, Calcium Phosphate, L-Valine, Potassium Phosphate, L-
Isoleucine, L-Arginine, L-Phenylalanine, L-Tyrosine, L-Threonine, Potassium 
Citrate, Sodium Citrate, L-Proline, L-Serine, L-Alanine, Glycine, L-Histidine, 
L-Methionine, Ascorbic Acid, Magnesium Chloride, Calcium Carbonate, L-
Cystine Dihydrochloride, L-Tryptophan, Salt, Choline Chloride, m-Inositol, 
Ferrous Sulfate, Taurine, Ascorbyl Palmitate, Zinc Sulfate, dl-Alpha-
Tocopheryl Acetate, L-Carnitine, Niacinamide, Calcium Pantothenate, 
Thiamine Chloride Hydrochloride, Cupric Sulfate, Manganese Sulfate, 
Vitamin A Palmitate, Riboflavin, Pyridoxine Hydrochloride, Folic Acid, Beta-
Carotene, Biotin, Phylloquinone, Chromium Chloride, Potassium Iodide, 
Sodium Selenate, Sodium Molybdate, Vitamin D3, and Cyanocobalamin. 
Nutritional 
information (per 5 
fl. oz. preparation) 
Calories: 100 
Fat: 4.8 g 
Sodium: 45 mg 
Total Carbohydrates: 10.7 g 
Sugar: 211 g 
Protein: 3.1 g 
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Appendix J: Preparation guidelines for infant formula samples based on GCT OD† tributyrin 
(TB) retention and free TB inclusion 
 Sample 
Additive 
Grams TB/ 
g of additive 
Grams added to 
reach 0.2 g TB 
per serving 
Weight of 
serving/number 
of servings 
required# 
Grams of 
formula 
per day# 
Grams of 
additive 
needed 
each day# 
GCT OD 
(12.10.14) †† 0.080 2.50 
4 oz. liquid+ 
18.8 formula/ 
4.5 
18 oz. liq/ 
84.6 g 
formula 
11.3 
GCT OD 
(11.19.14) †† 0.079 2.53 
4 oz. liquid+ 
18.8 formula/ 
4.5 
18 oz. liq/ 
84.6 g 
formula 
11.4 
GCT OD 
(12.03.14) †† 0.078 2.56 
4 oz. liquid+ 
18.8 formula/ 
4.5 
18 oz. liq/ 
84.6 g 
formula 
11.52 
Free TB --- 0.2 
4 oz. liquid+ 
18.8 formula/ 
4.5 
18 oz. liq/ 
84.6 g 
formula 
0.9 
† GCT OD represents the gamma-cyclodextrin and tributyrin oven dried microcapsule and Free TB 
represents unencapsulated tributyrin 
†† Date of production 
# Based off of administering a 9 mmol of butyric acid (0.792 g of butyric acid, 0.9 g of TB) per day 
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Appendix K: Nutritional and ingredient information for cracker 
Food product name Chickpea and turmeric cracker 
Food physical state Solid  
Ingredients Chickpea flour, water, rice flour, flax seed meal, 
encapsulated powder, canola oil, baking powder, salt, 
turmeric 
Nutritional Information  
(28 g serving) 
Calories: 108  
Fat: 2.9 g 
Saturated Fat: 0 g 
Cholesterol: 0 mg 
Sodium: 101 mg 
Total Carbohydrate: 17 g 
Fiber: 4 g 
Sugar: 2 g 
Protein: 4 g 
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Appendix L: Preparation guidelines for cracker samples based on GCT OD† tributyrin (TB) 
retention and free TB inclusion 
Sample 
Additive 
Grams of 
TB/ g of 
additive 
Grams added 
to reach 0.2 g 
TB per 
serving 
Weight of 
serving/number 
of servings 
required# 
Grams of 
crackers per 
day# 
Grams of 
additive 
needed each 
day# 
GCT OD 
(12.10.14)†† 0.080 2.50 28 g / 4.5 126 11.25 
GCT OD 
(1.31.15)†† 0.073 2.74 28 g / 4.5 126 12.33 
Free TB --- 0.2 28 g / 4.5 126 0.9 
† GCT OD represents the gamma-cyclodextrin and tributyrin oven dried microcapsule and Free TB 
represents unencapsulated tributyrin 
†† Date of production 
# Based off of administering a 9 mmol of butyric acid (0.792 g of butyric acid, 0.2 g of TB) per day 
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Appendix M: Cracker formulations expressed as wet-weight (WW) and dry-weight (DW) 
percentages for all three varieties 
  Control cracker 
Ingredient Percentage (WW)  Percentage (DW) 
Chickpea flour 39.91 59.03 
Rice flour 17.96 26.56 
Flax seed meal 6.12 9.05 
Canola oil 1.93 2.85 
Baking powder 0.77 1.13 
Salt  0.61 0.91 
Turmeric 0.32 0.47 
Water 32.40   
Total percentage 100.00 100 
   
 GCT OD cracker 
Ingredient Percentage (WW) Percentage (DW) 
Chickpea flour 36.98 54.51 
Rice flour 16.64 24.53 
Flax seed Meal 5.67 8.35 
Canola oil 1.79 2.63 
Baking powder 0.71 1.05 
Salt  0.57 0.84 
Turmeric 0.29 0.43 
GCT OD† 5.20 7.67 
Water 32.16   
Total 100.00 100 
   
  Free TB cracker 
Ingredient Percentage (WW) Percentage (DW) 
Chickpea flour 39.73 58.63 
Rice flour 17.88 26.38 
Flax seed meal 6.09 8.99 
Canola oil 1.92 2.83 
Baking powder 0.76 1.12 
Salt  0.61 0.90 
Turmeric 0.31 0.46 
Free TB†† 0.46 0.68 
Water 32.25   
Total percentage 100.00 100 
†† GCT OD represents the gamma-cyclodextrin and tributyrin oven dried microcapsule 
††Free TB represents free tributyrin 
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Appendix N: Screening procedure ballot used during subject recruitment 
TASTE IDENTIFICATION 
 
PART I: Basic Taste Test 
1. Rinse your mouth with water before you begin. 
2. Take a sip of the sample into your mouth and move it around so it touches all parts of 
your tongue. Do not swallow the sample; expectorate it into the provided spit cup. 
3. Write which of the basic tastes (sweet, salty, sour, bitter, umami or none) you perceive in 
the sample on the corresponding blank. If you are unsure of the identification, write a “?” 
after the basic taste name (e.g. “sweet?”). Re-tasting is allowed. 
4. Rinse your mouth with water before tasting the next sample. 
 
 Sample Basic Taste Sample Basic Taste 
 814 ________________ 275 ________________ 
 670 ________________ 190 ________________ 
 512 ________________ 403 ________________ 
 
 
 
PART II: Paper Test 
Place the piece of paper on your tongue, close your mouth, and wet the paper with saliva for 10 
seconds. 
Do you perceive a taste?    Yes  No 
 
 If you answered “Yes,” what do you taste? _________________ 
  
If you answered “Yes,” circle a number on the following scale that represents how strong 
the taste you perceive is: 
 
1 2 3 4 5 6 7 8 9 10 
Very 
Weak 
        Very 
Strong 
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Appendix O: Informed consent statement for descriptive analysis panel 
 
INFORMED CONSENT FORM FOR SENSORY EVALUATION PANELISTS 
“SENSORY PROPERTY DETERMINATION OF ENCAPSULATED FLAVORS IN FOOD 
PRODUCTS” 
You are invited to participate in a study involving sensory evaluation of three food 
products containing an encapsulated flavor. The goal of this research is to identify the sensory 
attributes (flavor, taste, aroma, texture, and appearance) of three food products (apple sauce, 
nutritional formula, and crackers). The food products will be evaluated using a descriptive 
analysis method commonly used in the food industry. Descriptive analysis involves you and a 
group of panelists identifying all sensory attributes for each product. You will be trained in this 
method and asked to taste each sample in groups and individually. You will rate each sample in 
terms of a series of descriptive attributes using references identified by the panel. You should not 
be allergic or intolerant to any food ingredients to participate. Since the reference products used 
to rate the samples have yet to be decided by the panel, potential allergens involved in the study 
not known at this time. Therefore if you have any food allergies you should not participate. 
The study will be conducted in Bevier Hall Room 376. We anticipate that there will be 5-
7 panel evaluations per week for 5 weeks. Panel evaluations include group panel activities 
lasting approximately 60 minutes or booth testing session days where you will be asked to attend 
two 30 minute sessions equaling 60 minutes each day. The total number of sessions required for 
each panelist is 24 and the total time commitment is 21 hours.  
Upon completion of the study, you will be compensated monetarily in the amount of 
$210. Participation in the study will be voluntary, and you are free to withdraw at any time 
during the course of the study. The experimenter(s) also reserve the right to terminate the 
participation of an individual subject at any time. You will be terminated if you miss sessions, 
are consistently late, or cannot follow directions. If you do not complete the study or are 
terminated, you will be compensated for your time at a rate of $10/hour. 
Your performance in this study is confidential. Prescreening responses will be coded and 
separated from identifying information to maintain confidentiality. Sample evaluation responses 
are coded to be anonymous and any publications or presentations of the results of the research 
will only include information about group performance.  
You are encouraged to ask any questions about this study whether before, during, or after 
your participation. However, specific questions about the samples that could influence the 
outcome of the study will be deferred to the end of the experiment. Questions can be addressed 
to Dr. Soo-Yeun Lee (217-244-9435, soolee@illinois.edu) or Joseph Donovan (217-265-8459, 
jddonov2@illinois.edu). You may also contact the IRB Office (217-333-2670, irb@illinois.edu) 
for any questions about the rights of research subjects. If you live outside the local calling area, 
you may also call collect. 
I understand the above information and voluntarily consent to participate in the study 
described above. I have been offered a copy of this consent form. I do not have any allergies or 
intolerances. I am 18 years of age or older. 
 
Signature       Date 
 
Print Name 
257 
 
Appendix P: Detailed procedural explanation for each day of the descriptive analysis panel 
conducted for each sample 
Session 1: Introductory session, term generation, and reference refinement for sample set 1 
(apple sauce)-1 hour 
 After granting informed consent (Appendix O), the panel facilitator introduced 
themselves and described their role in the panel. Panelists then introduced themselves to one 
another. The panel facilitator gave a short presentation that introduced basic sensory science 
principles and focused on DA methodology. The facilitator then presented panelists with one 
sample and asked the panelists to develop terms that described the samples attributes for all 
modalities (appearance, taste, aftertaste, texture, aroma-by-mouth, chemical feeling factors). The 
panel discussed their findings briefly and were then presented with the remaining two samples. 
The panelists analyzed all three samples (control, GCT OD, free TB) and were asked to generate 
attributes for all sensory modalities. Panelists were also encouraged to identify corresponding 
definitions and references matching these attributes. During group discussion, the panelists 
mentioned all attributes, definitions and corresponding references generated. Through discussion, 
the panelists compiled an extensive list of all possible attributes and corresponding references to 
be investigated the following day. For apple sauce, this initial list comprised of over 30 attributes 
and over 40 references. 
 While rating, the panelists were asked to determine an effective rinsing procedure. Rinses 
such as water (warm (43°C), room (25°C), and carbonated (Meijer Sparkling water, Meijer, Inc., 
Walker, MI)), crackers (Nabisco Premium Unsalted Tops Saltine Crackers, Naibsco, East 
Hanover, NJ), carrots (carrot chips, Bolthouse Farms, Bakersfield, CA), bread (Bimbo soft white 
bread, Bimbo Bakeries USA, Inc., Horsham, PA), heavy whipping cream (Ultra-pasteurized 
heavy whipping cream, Prairie Farms Dairy, Inc., Carlinville, IL), and a 0.55% carboxymethyl-
cellulose (CMC) solution in water (Brannan and others 2001) were made available. 
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Appendix P (continued): Detailed procedural explanation for each day of the descriptive 
analysis panel conducted for each sample 
Session 2: Term generation and reference refinement for sample set 1 (apple sauce)-1 hour 
 After signing in, panelists were presented with all of the references corresponding to the 
attributes generated in the first session. Panelists determined if these references correctly 
represented the sensory attributes present in the food products in both quality and concentration. 
After examining all references, further refinement and generation of references and attributes 
took place through group discussion. Panelists were encouraged by the facilitator to eliminate 
references that did not characterize the samples, were redundant, or represented attributes that 
did not differentiate the samples. Panelists reached consensus agreement on attributes that 
needed to be added, modified, or eliminated for the next session. Panelists were also asked to 
continue refining the rinse protocol and develop concrete definitions for each attribute. The 
facilitator then dismissed the panel and complied the daily observations in order to prepare 
references for the following day. 
Session 3: Term generation and reference refinement for sample set 1 (apple sauce)-1 hour 
 After signing in, modified references from the previous session were made available for 
comparison to samples and assessed. Panelists continued to further refine the remaining 
references by comparing them to attributes described in the samples. Panelists indicated if the 
given references matched the attributes indicated in both quality and concentration. If additions, 
adjustments, or eliminations needed to be made, they were noted by the panel facilitator. 
Panelists were encouraged by the facilitator to develop a concise list of 10-15 attributes, 
references, and supporting definitions for all of the samples. On this day, panelists were  
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Appendix P (continued): Detailed procedural explanation for each day of the descriptive 
analysis panel conducted for each sample 
 
encouraged to reach consensus on the rinse protocol as well as the tasting protocol for the 
samples and each attribute. The facilitator then dismissed the panel and compiled the daily 
observations in order to prepare references for the following day. The final rinse protocol for the 
apple sauce sample was: heavy whipping cream, bread, carbonated water, room temperature 
water. 
Session 4: Introduction to scaling method and group discussion of intensity ratings for sample set 
1 (apple sauce)-1 hour 
 After signing in, panelists were presented with the modified references based on the 
previous day’s feedback. Panelists were asked to discuss any final concerns or adjustments to the 
references that needed to be made briefly. 
 Panelists were then introduced to the concept of scaling attribute intensities by the panel 
facilitator. Panelists used an intensity scale ranging from 0 (no presence of attribute intensity) to 
15 (the highest intensity of that attribute in the samples). Individually, panelists were instructed 
to indicate the sample that had the highest intensity of the given attribute and assign it a value of 
15. They then placed the given reference and two other samples along the 0-15 scale in relation 
to the anchored sample at the intensity level of 15. Panelists were free to provide feedback 
related to how reference, definitions, or tasting procedures may need to be adjusted if necessary. 
Time permitting, panelists discussed as a group their ratings to compare their performance to the 
rest of the panel and if references needed to be adjusted. The facilitator then dismissed the panel 
and complied the reference and sample intensities for each attribute in order to provide feedback 
on overall and individual panelist performance the next day. 
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Appendix P (continued): Detailed procedural explanation for each day of the descriptive 
analysis panel conducted for each sample 
 
Session 5: Scaling and group discussion of intensity ratings for sample set 1 (apple sauce)-1 hour 
 During the next session, the same (or modified, if necessary) references and samples 
returned to the group for continued scaling and rating. Panelists were provided with their 
individual scores along with the group averages in order to aid in training. Using the reference as 
an anchor for all intensity ratings, panelists continued, through individual rating and group 
discussions, to rate each sample for all attributes generated. Panelists were free to provide 
feedback related to how reference, definitions, or tasting procedures may need to be adjusted if 
necessary. The facilitator then dismissed the panel and complied the reference and sample 
intensities for each attribute in order to provide feedback on overall and individual panelist 
performance the next day. 
Session 6: Scaling and group discussion of intensity ratings for sample set 1 (apple sauce)- 1 
hour 
 On the final scaling session, references and samples returned to the group for continued 
scaling and rating. Panelists were again provided with their individual scores along with the 
group averages in order to guide them in rating more uniformly with the group. Using the 
reference as an anchor for all intensity ratings, panelists continued, through individual rating and 
group discussions, to rate each sample for all attributes generated to come to a consensus. 
Panelists were encouraged by the facilitator to decide on final intensity ratings, definitions, and 
tasting procedures for all reference attributes. The facilitator then complied the reference and 
sample intensities for each attribute in order to provide feedback on overall and individual 
panelist performance the next day. The facilitator complied a final list of all sample modalities, 
attributes, references, intensities, and definitions in Appendix Q for the apple sauce sample. 
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Appendix P (continued): Detailed procedural explanation for each day of the descriptive 
analysis panel conducted for each sample 
Sessions 7: Individual booth practice ratings for sample set 1 (apple sauce)- two, 30 minute 
sessions 
 Panelists came to two, 30 minute sessions (at least 1 hour apart) in order to become 
familiar with the individual testing and used Compusense five Plus (Version 5.0: Guelph ON, 
Canada). Upon entering the lab, panelists were presented with the following: their scoring results 
from the previous day compared to overall panel performance, a tray of references, their rinses, 
and a table detailing each modality, its corresponding attribute, reference, intensity, and 
definition. Panelists were allowed to review their scores and the reference tray for as long as they 
wanted before entering the booths to individually rate each sample. Panelists were encouraged to 
exit the booth and review references as often as they liked but were not permitted to being the 
references in the booth. While in the booths, panelists interacted with Compusense five Plus and 
rated each sample for its attribute intensities keeping the references and their intensities in mind. 
Panelists strictly adhered to the developed rinse protocol and tasting guidelines while testing. 
When panelists return for the second session that day, they were informed of how their 
performance compared to other participants or order to make adjustments for their second rating 
session. 
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Appendix P (continued): Detailed procedural explanation for each day of the descriptive 
analysis panel conducted for each sample 
 
Sessions 8: Final individual rating of sample set 1 (apple sauce)- two, 30 minute sessions, 4 
replications 
 Panelists came to two, 30 minute sessions (at least 1 hour apart) to individually rate the 
intensities of sample attributes according to the set references. Upon entering the lab, panelists 
were presented with the following: their scoring results from the previous day compared to 
overall panel performance, a tray of references, their rinses, and a table detailing each modality, 
its corresponding attribute, reference, intensity, and definition. Panelists were allowed to review 
their scores and this reference tray for as long as they wanted before entering the booths to  
individually rate each sample according to the references. Panelists were allowed to review their 
scores and the reference tray for as long as they wanted before entering the booths to individually 
rate each sample. While in the booths, panelists interacted with Compusense five Plus and rated 
each sample for its attribute intensities keeping the references and their corresponding intensities 
in mind. Panelists strictly adhered to the developed rinse protocol and tasting guidelines while 
testing. Panelists performed two replications in the morning and two in the afternoon for a total 
of four replications per panelist per sample.  
Sessions 9, 10, 11: Term generation/reference refinement for sample set 2 (infant formula)- 1 
hour each 
 The procedure for sample 2 was the same as described previously for the given dates 
outlined in sample 1. On the first day of testing, panelists generated over 30 terms and over 40 
references for the infant formula. The final rinse protocol for the infant formula sample was: 
0.55% CMC solution (Brannan and others 2001), carbonated water, room temperature water. 
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Appendix P (continued): Detailed procedural explanation for each day of the descriptive 
analysis panel conducted for each sample 
 
Sessions 12, 13, 14: Scaling and group discussion of intensity ratings for sample set 2 (infant 
formula)- 1 hour each 
 The procedure for sample 2 was the same as described previously for the given dates 
outlined in sample 1. A final list of all sample modalities, attributes, references, intensities, and 
definitions for use in the following sample rating sessions which can be found in Appendix R for 
the infant formula sample. 
Session 15: Individual booth practice ratings for sample set 2 (infant formula)- two, 30 minute 
sessions 
 The procedure for sample 2 was the same as described previously for the given dates 
outlined in sample 1. 
Session 16: Final individual rating of sample set 2 (infant formula)- two, 30 minute sessions, 4 
replications  
The procedure for sample 2 was the same as described previously for the given dates outlined in 
sample 1. 
Sessions 17, 18, 19: Term generation/reference refinement for sample set 3 (crackers)- 1 hour 
each 
 The procedure for sample 3 was the same as described previously for the given dates 
outlined in sample 1.On the first day of testing, over 30 attributes and over 40 references were 
identified. The final rinse protocol for the cracker sample was: heavy whipping cream, carrots, 
carbonated water, and room temperature water. 
Sessions 20, 21, 22: Scaling and group discussion of intensity ratings for sample set 3 (crackers)- 
1 hour each 
 The procedure for sample 3 was the same as described previously for the given dates 
outlined in sample 1. A final list of all sample modalities, attributes, references, intensities, and 
definitions for use in the following sample rating sessions which can be found in Appendix S for 
the cracker sample. 
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Appendix P (continued): Detailed procedural explanation for each day of the descriptive 
analysis panel conducted for each sample 
 
Session 23: Individual booth practice ratings for sample set 3 (crackers)- two, 30 minute sessions 
 The procedure for sample 3 was the same as described previously for the given dates 
outlined in sample 1. 
Session 24: Final individual rating of sample set 3 (crackers)- two, 30 minute sessions, 4 
replications 
The procedure for sample 3 was the same as described previously for the given dates 
outlined in sample 1. On the final day of panel, panelists were paid $210 for their participation. 
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Appendix Q: Modalities, terms, reference, reference intensities, definitions, and preparation instructions for apple sauce samples 
Modality Term Reference Reference 
Value 
Definition Preparation Sample 
Information 
Appearance 
Saturation Canned 
pears in 
syrup 
12 The degree of 
saturation of a 
canned pear on 
white paper 
20 g in a 5 oz. cup Del Monte pear 
chunks in heavy 
syrup 
            
Aroma 
Apple Washed 
canned 
apple 
14 The aroma 
associated with a 
canned apple 
Wash off syrup and coating from 
canned apple pie filling, soak 1 
can in 600 mL of water for 1 hour. 
Store in fridge. Place 26 g in 5 oz. 
Duncan Heinz 
comstock more 
fruit apple pie 
filling 
Cheesy Shredded 
Parmesan 
cheese 
13 The aroma of 
aged cheese 
0.005 g of cheese in a 5 oz. cup Kraft natural cheese 
shredded parmesan 
cheese 
Dairy Dilute 
condensed 
milk 
14 The aroma of 
dairy 
50 g of condensed milk in 200g of 
water. Place 1/2 tsp (1.75 g) in a 5 
oz. cup                                        
Eagle Brand 
sweetened 
condensed milk                                  
            
Texture 
Lumpiness Baby 
Oatmeal 
10 The softness of 
food particulates 
in a matrix 
Make 30 minutes before panel. ¼ 
cup cereal and ¼ cup room 
temperature water. Microwave 15 
sec on 50% power. Dilute with 2 
tbsp. of water. 1 tsp in 2 oz. cup 
Gerber oatmeal 
cereal 
       
Aroma-By- 
Mouth 
Apple Unfiltered 
apple 
juice 
14 The aroma-by-
mouth of apple 
juice 
1 tbsp. of juice (9.8 g) in a 2 oz. 
cup 
Field Day organic 
100% unfiltered 
apple juice                              
Cooked 
fruit 
Canned 
pears in 
juice 
13 The aroma-by-
mouth of washed 
canned pears in 
juice 
Pears in juice: 26 g in a 2 oz. cup                                                    Del Monte pears in
100% juice 
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Appendix Q (continued): Modalities, terms, reference, reference intensities, definitions, and preparation instructions for apple sauce 
samples 
Modality Term Reference Reference 
Value 
Definition Preparation Sample 
Information 
Taste 
Sour Sour taste 13 The taste associated with citric acid 
0.75 g citric acid in 1000 
mL; 15 mL in a 2 oz. cup Ball citric acid 
Sweet Sweet taste 12 The taste associated with sucrose 
15 g sucrose in 1000 mL;15 
mL in a 2 oz. cup 
Domino premium 
cane granulated 
sugar 
Bitter Bitter taste 10 The taste associated with caffeine  
0.5 g caffeine in 1000 mL;15 
mL in a 2 oz. cup 
Fisher Scientific 
caffeine 
            
Aftertaste 
Bitter Bitter aftertaste 9 
The aftertaste 
associated with 
caffeine 3 seconds 
after expectoration 
0.5 g caffeine in 1000 mL;15 
mL in a 2 oz. cup 
Fisher Scientific 
caffeine 
Sourness Sour aftertaste 10 
The aftertaste 
associated with citric 
acid 3 seconds after 
expectoration 
0.75 g citric acid in 1000 
mL;15 mL in a 2 oz. cup Ball citric acid 
Astringent Astringent aftertaste 11 
The perception of 
dryness perceived 3 
seconds after 
expectoration 
Steep one tea bag in 300 mL 
of boiling water for 30 
seconds. Place 1 tbsp. in a 2 
oz. cup 
Lipton 100% 
natural black tea 
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Appendix R: Modalities, terms, reference, reference intensities, definitions, and preparation instructions for infant formula samples 
Modality Term Reference Reference 
Value 
Definition Preparation Sample 
Information 
Aroma 
Potato Canned potato liquid solution 12 
The aroma of the 
liquid in canned 
potatoes 
100 g canned potato water and 
300 g water; 5 g in 5 oz. cup 
Liquid from Del 
Monte canned 
diced new 
potatoes 
Chees Cheez-it (Aroma) 12 
The aroma of 
processed cheese 
in a Cheez-it 
1 cheez-it (1 g) in a 2 oz. cup                                                                                                    
Sunshine Cheez-
it baked snack 
crackers                                                                 
Dairy  Powdered milk 10 The aroma of cooked dairy 
1/3 cup powdered milk, 3 cups 
water; 1 tbsp (26 g) in a 2 oz. 
cup                                                                                 
Nestle Carnation 
instant nonfat 
dry milk                                                                                                                            
           
Aroma-By- 
Mouth 
Potato Instant mashed potatoes 13 
The aroma-by-
mouth of instant 
mashed potatoes 
1/3 cup potato flakes and 1 cup 
boiling water. 1/2 tbsp  (8.5 g) 
in a 2 oz. cup 
Idahoan Original 
mashed potatoes 
made with 100% 
real Idaho 
potatoes 
Cheese 
Cheez-it 
(aroma-by-
mouth)  
13 
The aroma-by-
mouth of 
processed cheese 
in a Cheez-it 
3 Cheddar Cheez-its (3 g) in a 2 
oz. cup 
Sunshine Cheez-
it baked snack 
crackers 
Metallic Baby vitamin solution 12 
The aroma-by-
mouth of 
metallic vitamins 
0.5 mL drop of baby vitamin in 
1000 mL of water. Place 10 mL 
in a 2 oz. cup 
Enfamil Poly-vi-
sol with Iron 
multivitamin 
supplement 
drops    
Soy Unsweetened soy milk 12 
The aroma-by-
mouth of soy 
milk 
2 tbsp (27 g) in a 2 oz. cup      
WestSoy organic 
unsweetened 
plain soymilk 
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Appendix R (continued): Modalities, terms, reference, reference intensities, definitions, and preparation instructions for infant formula 
samples 
Modality Term Reference Reference 
Value 
Definition Preparation Sample 
Information 
Taste 
Sweet Sweet solution 11 
The taste associated with 
a sucrose solution 
11 g of sucrose in 1000 mL 
of water; 15 mL in a 2 oz. 
cup 
Domino 
premium cane 
granulated sugar 
Bitter Bitter solution 12 
The taste associated with 
a caffeine solution 
0.5 g caffeine in 1000 mL; 
15 mL in a 2 oz. cup 
Fisher Scientific 
caffeine 
            
Afterfeel Chalky Cornstarch solution  13 
The afterfeel of a fine, 
chalky mouth coating 3 
seconds after 
expectoration 
2 g of corn starch in 200 
mL of water; 10 mL in 2 
oz. cup 
Clabber Girl 
corn starch 
            
Aftertaste 
Astringent Tea 12 
The perception of 
dryness perceived 4 
seconds after 
expectoration 
Steep one tea bag in 300 
mL of boiling water for 30 
seconds. Place 1 tbsp. in a 
2 oz. cup 
Lipton's natural 
black tea 
Sweet Sweet solution 10 
The aftertaste associated 
with a sucrose solution 4 
seconds after 
expectoration 
11 g of sucrose in 1000 mL 
of water; 15 mL in a 2 oz. 
cup 
Domino 
premium cane 
granulated sugar 
Bitter Bitter solution 10 
The aftertaste associated 
with a caffeine solution 4 
seconds after 
expectoration 
0.5 g caffeine in 1000 mL; 
15 mL in a 2 oz. cup 
Fisher Scientific 
caffeine 
Soy Unsweetened soy milk 13 
The aftertaste associated 
with a soy milk 4 
seconds after 
expectoration 
2 tbsp. (27 g) in a 2 oz. cup 
WestSoy organic 
unsweetened 
plain soymilk 
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Appendix S: Modalities, terms, reference, reference intensities, definitions, and preparation instructions for cracker samples 
Modality Term Reference Reference Value Definition Preparation Sample Information 
Aroma                        
Nutty Pistachio 13 The nutty aroma of pistachios 
4 pistachios (2 g) in a 2 
oz. cup 
Wonderful roasted & 
salted pistachios 
without shells 
Wheat Wheat-thin 12 
The wheat aroma of 
Wheat-thins 
3 Wheat-thins (6.0 g) 
broken in ¼ pieces in a 
2 oz. cup 
Wheat Thins 100% 
whole grain hint of salt 
Turmeric Turmeric solution 11 
The spice aroma of 
turmeric 
0.024 g of turmeric in 
300 mL of water, 1.0 g 
in a 5 oz. cup;  
Spice Islands Turmeric 
Cheese 
White 
cheddar 
popcorn  
13 The cheese aroma of white cheddar popcorn 
0.20 g of popcorn in a 5 
oz. cup 
Smartfood popcorn 
white cheddar  
             
Texture 
Fracturability Wheat-thin 11 
The first-bite force 
required to fracture the 
sample using the front 
side teeth 
1 Wheat-thin (0.2 g) in 
a 2 oz. cup 
Wheat Thins 100% 
whole grain hint of salt 
Crumbly Melba toast 11 
The ease that small 
pieces are formed 
from the sample in the 
first 3 chews  
1 Melba toast (3.7 g) in 
a 2 oz. cup 
Old London Melba 
whole grain snacks 
             
Aroma-by-
mouth 
Grassy Flax seed  13 
The grassy aroma-by-
mouth associated with 
flax seed 
0.15 g of flax in a 1 oz. 
cup  
Bob's Red Mill whole 
ground flaxseed mill 
Chickpea 
Chickpea 
flour 
solution 
12 
The chickpea aroma-
by-mouth of a 
chickpea flour solution 
Mix 15 g flour in 325 g 
boiling water Place 15 
g into a 2 oz. cup 
Bob's Red Mill Stone 
ground garbanzo bean 
flour 
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Appendix S (continued): Modalities, terms, reference, reference intensities, definitions, and preparation instructions for cracker 
samples 
Modality Term Reference Reference Value Definition Preparation 
Sample 
Information 
Taste                       
Salty Salt solution 10 
The taste associated with a salt 
solution 
0.70 g of salt in 1000 mL 
of water; 15 mL in a 2 oz. 
cup 
Meijer great 
value salt 
Savoy MSG solution 11 
The taste associated with a 
MSG solution 
0.50 g of MSG in 1000 
mL of water, 15 mL in a 2 
oz. cup 
Accent all natural 
flavor enhancer 
Bitter Caffeine solution 12 
The taste associated with a 
caffeine solution 
0.40 g caffeine in 1000 
mL; 15 mL in a 2 oz. cup                                                                                                  
Fisher Scientific 
caffeine
Sweet Sucrose solution 11 
The taste associated with a 
sucrose solution 
10 g of sucrose in 1000 
mL of water; 15 mL in 
each cup 
Domino premium 
cane granulated 
sugar 
             
Aftertaste                      
Salty Salt solution 10 
The aftertaste associated with a 
salt solution 4 seconds after 
expectoration 
0.70 g of salt in 1000 mL 
of water; 15 mL in a 2 oz. 
cup 
Walmart great 
value salt 
Bitter Caffeine solution 12 
The aftertaste associated with a 
caffeine solution 4 seconds 
after expectoration 
0.40 g caffeine in 1000 
mL; 15 mL in a 2 oz. cup                                                                                                  
Fisher Scientific 
caffeine
Chickpea 
Chickpea 
flour 
solution 
12 
The aftertaste associated with a 
chickpea flour solution 4 
seconds after expectoration 
Mix 15 g flour in 325 g 
boiling water Place 15 g 
into a 2 oz. cup 
Bob's Red Mill 
stone ground 
garbanzo bean 
flour 
Grassy Flax seed  13 
The grassy aftertaste 
associated with flax seed 4 
seconds after expectoration 
0.15 g of flax in a 1 oz. 
cup (2 per panelist) 
Bob's Red Mill 
whole ground 
flaxseed mill 
271 
 
 
 
Appendix T: Principal component analysis factor correlations of significant attributes on 
principal component (PC1) and 2 (PC2) for all three apple sauce samples 
Modality Attribute PC1 PC2 
Aroma 
Apple -0.74 0.62 
Cheesy 0.95 -0.20 
Dairy 0.79 -0.60 
Appearance Saturation -0.62 0.78 
Taste 
Sour -0.99 -0.05 
Sweet -0.77 -0.62 
Bitter 0.92 0.38 
Aftertaste 
Sour -0.96 0.03 
Bitter 0.96 0.28 
Astringent 0.78 0.54 
Aroma-by-mouth 
Apple -0.98 0.15 
Cooked Fruit -0.99 -0.06 
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Appendix U: Principal component analysis factor correlations of significant attributes on 
principal component 1 (PC1) and 2 (PC2) for all three infant formula samples 
Modalities Attributes PC1 PC2 
Aroma-by-
mouth 
Potato -0.98 0.08 
Metallic 0.98 -0.06 
Soy -0.95 0.14 
Taste 
Sweet -0.96 0.24 
Bitter 1.00 0.06 
Aftertaste 
Astringent 0.97 0.07 
Sweet -0.97 0.15 
Bitter 1.00 0.05 
Soy -0.98 -0.03 
Afterfeel Chalky 0.70 0.67 
 
  
273 
 
 
 
Appendix V: Principal component analysis factor correlations of significant attributes on 
principal component 1 (PC1) and 2 (PC2) for all three cracker samples 
Modality Attribute PC1 PC2 
Aroma 
Wheat -0.85 -0.43 
Cheese 0.89 0.41 
Texture 
Fracturability 0.80 -0.47 
Crumbly -0.84 -0.19 
Taste 
Salty -0.98 0.07 
Bitter 1.00 -0.03 
Aroma-by-mouth Chickpea -0.92 0.18 
Aftertaste 
Salty -0.97 -0.10 
Bitter 1.00 0.01 
Chickpea -0.91 -0.20 
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Appendix W: Factor correlations for significant attributes on principal component I (PC1) and 2 
(PC2) for apple sauce (AS), infant formula (IF) and crackers (CR) with common significant 
attributes, and for AS and IF only common significant sensory attributes (PC1’ and PC2’) 
Common attributes for: AS, IF, CR 
Modality Attribute PC1 PC2 
Taste Bitter 0.998 0.058 
Aftertaste Bitter 0.998 -0.058 
    
Common attributes for: AS, IF 
Modality Attribute PC1’ PC2’ 
Taste 
Bitter 0.992 0.113 
Sweet -0.983 0.247 
Aftertaste 
Bitter 0.983 0.214 
Astringent 0.979 -0.012 
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Appendix X: Principal component analysis biplot of common significant attribute intensities 
present on principal component 1 (PC1) and 2 (PC2) by the covariance matrix for apple sauce 
and infant formula†# 
 
†  Capital letters after the attributes –T, and AT stand for taste, and aftertaste, respectively 
#  “Control” is a sample with no tributyrin added, “Encap” is a sample with gamma-cyclodextrin and 
tributyrin oven dried (GCT OD) microcapsules, and “Free” is a sample with or free tributyrin 
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Appendix Y: Pearson correlation matrix for common significant sensory attributes shared by 
apple sauce and infant formula†# 
Attributes Bitter T Bitter AT Sweet T Astringent AT 
Bitter T 1    
Bitter AT 0.991*** 1   
Sweet T -0.931** -0.924** 1  
Astringent AT 0.967** 0.937** -0.932** 1 
†  Capital letters after the attributes T, and AT stand for taste, and aftertaste, respectively 
#  Values with *, **, and *** correspond to those correlations with significance from zero at p < 0.05, 
0.01, and 0.001, respectively 
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Appendix Z: Best practices for the use of gamma-cyclodextrin and tributyrin oven dried (GCT 
OD) microcapsules in food matrices considering highlighting processing, physical, and consumer 
characteristics. 
 
1. Processing considerations:  
a. The product used should undergo mixing or shear: The shear applied by shaking 
allows for the fine distribution of the poorly soluble free tributyrin (TB) into smaller 
particles to associate with remaining free gamma-cyclodextrin (GCD) and will 
facilitate additional complexation (Hedges 1998; Del Valle 2004; Das and others 
2013). 
b. The product should not be heated: It is believed that heating disturbed the GCT OD 
complex, resulting in releasing bound TB and heat is commonly used to liberate core 
compounds from complexes (Bhandari and others 1998; Reineccius and others 2002; 
Reineccius and others 2004; Kawakami and others 2009).  
2. Physical considerations:  
a. The product should be liquid: Water allows for any free GCD to dissolve and become 
active for complexation (Del Valle 2004) allowing for the complexation of free TB 
remaining in the matrix or oral cavity (Szente and Szejtli 2004).  
b. The product should have a small inherent degree of bitterness: Choosing this may 
help to lessen the degree of difference that GCT OD may confer on the bitterness of 
the matrix as compared to a control sample. 
c. The product should be minimally impacted by color change: GCT OD will impart 
color change (lightening) on systems where it is unable to be thoroughly solubilized. 
It is important that this change in color not dramatically influence other sensory 
attributes or consumer acceptance. 
3. Target consumer characteristics 
a. The product should be appropriate for the target consumer: Choosing a product that 
is appropriate for the target consumers age, nutritional requirements, and dietary 
restrictions is especially important. While it may be challenging to satisfy all 
restrictions, the end consumer of the product should always be kept in mind. This is 
especially important in instances where individuals are restricted to specialized diets 
due to illnesses.  
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Appendix AA: Cost breakdown for the price of gamma-cyclodextrin and tributyrin oven dried 
microcapsule 
The price range for gamma-cyclodextrin (CAVAMAX® W8 Food) of 44-75$/ kg was 
provided on 03/09/2015 via email by Anslem Goonetilleke, a sales manager at Wacker Chemie., 
the gamma-cyclodextrin supplier. 
• 1 g of gamma-cyclodextrin and tributyrin (TB) oven dried (GCT OD) microcapsule contains 
0.076 g of tributyrin (based off of average retention). At $0.10 a gram (Sigma Aldrich prices 
as of 05/05/2015): $0.0076/g 
• 1 g of powder contains roughly 9% water, or 0.09 g of water. The cost of water is not 
considered in this estimate 
• With 0.076 g TB and 0.09 g water, 0.834 g of GCT OD is gamma-cyclodextrin 
• At $44 a kg ($0.044/g) that comes to $0.03/g of GCT OD bringing the total material cost to 
$0.0376/g. Total dosage around 12 g a day (to achieve 0.90 g TB a day) would 
approximately cost $0.45 a day. 
• At $75 a kg ($0.075/g) that comes to $0.06/g of GCT OD bringing the total material cost to 
$0.0676/g. Total dosage around 12 g a day (to achieve 0.90 g TB a day) would 
approximately cost $0.81 a day. 
 
